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Cellular homeostasis is important for retaining cellular viability and functions, 
and often manipulated by bacterial pathogens as an effective target for 
remodeling the host environment for colonization. Helicobacter pylori, a human 
gastric pathogen that impacts more than a half the human population as the only 
recognized biological carcinogen, colonizes the highly acidic human gastric 
environment by modulating host cellular homeostasis. Vacuolating cytotoxin A 
(VacA) is a pore-forming exotoxin of H. pylori, that, once secreted, enters the 
host cells and targets mitochondria. Previous studies revealed that VacA 
supports H. pylori colonization by altering host energy metabolism, specifically, 
by collapsing the proton gradients that are required for mitochondrial energy 
production. However, how such VacA cellular actions alter host cell biology 
during H. pylori infection has not been well understood, and was the major gap in 
knowledge addressed in this dissertation.  
Here, the studies revealed that VacA-induced metabolic stress is sensed by 
host cells in a manner mediated by mTORC1, a central metabolic sensor in 
mammalian cells. VacA-mediated inhibition of mTORC1, which is also a major 
metabolic regulator, indicated a global metabolic shift from a biosynthetic state to 
a catabolic state, as manifested by two major cellular changes; 1) induction of 
autophagy, a catabolic recycling mechanism that can generate extra carbon and 
energy sources to support a restoration of the metabolic balance, and, 2) 
inhibition of host protein synthesis. Furthermore, the studies unexpectedly 
revealed that cellular amino acids, which are the building blocks for de novo 
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protein synthesis, also often utilized as carbon and energy sources at 
mitochondria, were depleted by H. pylori infection in a VacA-dependent manner. 
In addition, the amino acid deficiencies within VacA-intoxicated cells were largely 
attributed to the loss of cellular capabilities of importing extracellular amino acids 
in an energy-dependent manner, and the continuous consumption of amino acids 
at mitochondria resulted in the depletion of intracellular amino acid pools. Lastly, 
the studies provided the premise for evaluating how VacA manipulation of host 
metabolism alters host cell biology during H. pylori infection. In particular, 
reduction in host production of mucus proteins, key innate immune factors 
secreted to repel approaching pathogens, could possibly result in a VacA-
dependent manner during H. pylori infection. 
In conclusion, the studies in this dissertation investigated how VacA could 
contribute to H. pylori infection biology, and revealed that VacA induces a global 
metabolic shift towards a less biosynthetic and more catabolic state, which could 
alter host effectiveness to respond to H. pylori infection. I speculate that future 
investigation on how the VacA-dependent metabolic shift within host cells alters 
host capacity to produce immune/protective factors against infection will extend 
our understanding in microbial infection biology, and, may contribute to 
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CHAPTER 1: Introduction 
 
1.1. Helicobacter pylori infection 
Helicobacter pylori is a Gram-negative spiral bacterium that primarily 
colonizes human stomach (Fig. 1.1). The last three decades of extensive 
investigation on H. pylori since its first discovery by Robin Warren and Barry 
Marshall (Marshall et al., 1985) revealed H. pylori as a major causative agent for 
human gastric pathology. 
H. pylori has a long history of human adaptation. Since approximately 58,000 
years ago when humans first migrated out of Africa (Yamaoka, 2010), H. pylori 
has co-evolved with the human species and developed highly sophisticated 
strategies to colonize the human gastric environment, which is extremely 
challenging for other bacterial colonizers. With no apparent competitors Fighting 
for the limited replicative niche, H. pylori became the dominant colonizer of the 
human stomach, causing one of the most prevalent microbial infections 
worldwide, estimated in over 50% of the human population (Suerbaum and 
Josenhans, 2007).  
Upon initial exposure to H. pylori bacteria, susceptible individuals acquire H. 
pylori generally during their childhood, most commonly through oral-oral or oral-
fecal route, which can be facilitated by particular host intrinsic or socio-economic 
factors (poor nutritional condition, personal hygiene, or genetic predisposition). 
Upon initial transmission, the infection becomes high persistent and can last up 
to the lifetime of the host (Salama et al., 2013). H. pylori infection can remain 
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asymptomatic in the majority of infected individuals, which allows the infection to 
remain undetected for a long period of time, and eventually to progress to a 
pathological state. Among chronically infected individuals, approximately 10 – 
20 % of infected individuals can progress into chronic gastritis, with 1 – 2 % can 
progress into more severe clinical states including peptic ulcer, primary gastric B-
cell lymphoma, or, gastric adenocarcinoma (Polk and Peek, 2010), thus 
classifying H. pylori as a group 1 human carcinogen (NIH Consensus 
Conference, 1994). 
Therefore, the importance of H. pylori infection from epidemiological and 
clinical standpoints, as manifested by its high prevalence, persistence, and 
clinical severity, necessitates extensive research on H. pylori pathogenesis, 
particularly with regards to the mechanism by which H. pylori colonize and persist 
within the harsh gastric environment. 
 
1.2. H. pylori pathogenesis 
The unique environmental condition within the stomach can be manifested by 
the extreme acidity (pH 1 - 2), which allows the stomach to serve as an effective 
barrier against bacterial infections. To effectively retain such acidic conditions, 
the stomach protects itself by maintaining a mucosal layer, which turns highly 
rigid and impermeable under acidic conditions (Celli et al., 2009), resulting in a 
near-neutral pH (~7) at the proximity of the gastric epithelia. Unlike other orally 
entering bacteria that are effectively eliminated upon exposure to the gastric acid, 
H. pylori is a highly successful colonizer of human stomach, which implies unique 
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mechanisms by which H. pylori quickly evacuate from the harsh conditions, and 
create a suitable niche for persistent colonization (Fig. 1.2). 
Many scientific studies that investigated the H. pylori survival in the acidic 
condition of stomach revealed several extraordinary survival strategies (Salama 
et al., 2013). The pH-driven chemotaxis allows H. pylori to orient themselves 
towards the gastric epithelia (Howitt et al., 2011, Lertsethtakarn et al., 2015). The 
multiple flagella effectively propel the helical rod-shaped bacterial body (Fig. 1.3) 
through the mucosal layer (Sycuro et al., 2010, Sycuro et al., 2012). 
Furthermore, the periplasmic and secreted ureases neutralize the gastric acids, 
and also revert the pH-dependent rigidity of the gastric mucosal layer, promoting 
the bacterial motility (Celli et al., 2009) (Fig. 1.4).  
Upon arrival to the host gastric epithelia, H. pylori establish a replicative 
niche by employing diverse strategies to evade or subvert the ongoing immune 
surveillance, or, to usurp nutrient sources from host cells (Fig. 1.2), which are 
mediated by effectors or secreted toxins. Several H pylori factors were identified 
to be important for the H. pylori pathogenesis, including Cytotoxin associated 
gene A (CagA) (Fig. 1.5) and Vacuolating cytotoxin A (VacA) (Fig. 1.6-1.8), which 
are often detected as the fully functional form in the most virulent H. pylori strains 
(Yamaoka, 2010) .  
CagA is a bacterial effector protein that is directly injected into the host 
cytosol through the type IV secretion system (Yamaoka, 2010). CagA disrupts 
cellular functions by directly binding or occupying various host cell regulators 
(Fig. 1.5). Within host cells, CagA molecules can be found in a 
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unphosphorylated-, or, phosphorylated-form. CagA can be phosphorylated by the 
host’ Src or Abl family kinases on the Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs, and 
when phosphorylated, interacts with at least 10 distinct host cell targets (Fig. 
1.5). The unphosphorylated CagAs form dimers via the CagA multimerization 
(CM) sequences, and disrupt several host signaling proteins that regulate the 
cell-cell junctions or cell polarity. The loss of cell polarity and the cell-cell junction 
by the unphosphoryated CagA may assist in the bacterial colonization, and ease 
the bacterial infiltration through the epithelial barrier. In contrast to the multimeric 
unphosphorylated CagA, the phosphorylated CagA can act as monomers, and 
interact with several signaling proteins that regulate cell motility, cytoskeletal 
arrangement, proliferation, and inflammation. 
Interestingly, because CagA is a type IV secretion effector and delivered only 
to host cells that are directly associated with the bacteria, the effect of CagA is 
strictly limited to those directly associated cells, where CagAs can facilitate the 
bacterial colonization by promoting proliferation of the cells that consist of the 
bacterial replicative niche (Kim and Blanke, 2012). Additionally, CagA modulation 
of cellular inflammatory response chronically activates the NF-kB dependent host 
inflammatory signaling (Karin et al., 2002), resulting in intracellular accumulation 
of highly carcinogenic reactive oxygen species (ROS), (Karin et al., 2002), 
dysregulating the cell proliferation. 
In addition to CagA, the highly virulent H pylori strains secrete VacA, a 




1.3. VacA and H. pylori infection 
Since the discovery of VacA nearly 25 years ago as the proteinacious factor 
within H. pylori culture filtrates that intoxicates epithelial cells and induces 
vacuole biogenesis, the study of this toxin has been challenging in part, because 
the toxin possesses a number of surprising and unusual characteristics that don’t 
fit neatly into current concepts of bacterial toxins. Nonetheless, several 
interesting and important properties of VacA have become apparent. First, the 
gene encoding VacA (vacA) is characterized by a high degree of genetic 
variation; strains with specific allelic variants of vacA that exhibit greater levels of 
VacA-mediated cytotoxic activity in vitro are associated with a greater risk of 
gastric disease in H. pylori-infected humans. Moreover, experimental evidence 
supports the idea that VacA may promote H. pylori colonization, persistence, and 
infection-associated disease pathophysiology 
 
1.4.     Structural properties of VacA 
H. pylori synthesize VacA as an approximately 140 kDa pre-protoxin (Fig. 
1.6), which undergoes sequential proteolytic processing during Type V secretion 
as an auto-transporter protein (Fischer et al., 2001a). The secreted mature form 
of VacA is a 88 kDa monomer (Cover and Blaser, 1992), that is purified from H. 
pylori growth medium (Gonzalez-Rivera et al., 2010) as water-soluble hexameric 
or heptameric rings (Fig. 1.6) in single or bilayered structures (Fig. 1.6) (Cover et 
al., 1997). Acidic or alkaline pH promotes dissociation of VacA oligomeric 
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complexes into monomers (Cover et al., 1997), which is likely the form of the 
toxin to bind host cells during infection (Gonzalez-Rivera et al., 2010). 
The mature 88-kDa form of the toxin is sometimes detected as a 
proteolytically-nicked protein, comprising two domains designated p33 (residues 
1-311) and p55 (residues 312-821), that remain non-covalently associated (Fig. 
1.6) (Telford et al., 1994). Proteolytic cleavage into discrete functional domains is 
a characteristic of a number of so-called intracellular-acting AB toxins (Cover and 
Blanke, 2005). While neither p33 nor p55 alone are sufficient to induce vacuole 
biogenesis, the cellular activity of VacA can be reconstituted from two separate 
recombinant proteins added exogenously (Gonzalez-Rivera et al., 2010), or 
expressed ectopically within cultured cells (Willhite and Blanke, 2004, Willhite et 
al., 2003, Ye et al., 1999). All of p33 and approximately the amino-terminal 100 
residues of p55 are apparently required to induce vacuolation, revealed when a 
fragment comprising VacA residues 1-422, but not a fragment comprising 
residues 1-394, induced cellular vacuolation when expressed in transiently 
transfected cells (Ye et al., 1999). 
The association of p33 or p55 with discrete toxin functions remains poorly 
understood. Several lines of evidence suggest that p55 possesses a domain 
important for binding the toxin to the cell surface (Wang and Wang, 2000). 
However, the binding of p55 to cells appears to be considerably weaker than that 
of full-length VacA. Moreover, p33 appears to also contribute to VacA cell 
surface binding (Gonzalez-Rivera et al., 2010). 
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The amino-terminal 34 residues of p33 domain comprise what is predicted to 
be a highly hydrophobic domain, which has been implicated to be critical for the 
capacity of VacA to form ion-conducting channels (McClain et al., 2003, Vinion-
Dubiel et al., 1999). As discussed below, VacA channels are probably the 
biochemical activity most critical for the cellular modulating activity of the toxin. 
However, deletion of part of this region (residues 1-27) resulted in a mutant form 
of VacA that also demonstrated some channel activity in planar lipid bilayers, 
albeit requiring a significantly longer time to for channel formation (Vinion-Dubiel 
et al., 1999), suggesting that the hydrophobic amino-terminus is not absolutely 
required for VacA channel activity. More recently, channel activity in planar lipid 
bilayers was also demonstrated for a mutant form of p33 lacking residues 1-37 
(Domanska et al., 2010). Thus, the molecular basis underlying VacA channel 
formation, at least in artificial lipid bilayers, remains to be clarified. 
 
1.5. VacA diversity and disease 
Although essentially all H. pylori strains carried a vacA gene, the levels of 
vacuolating activity with bacterial culture filtrates were found to be markedly 
different from strain to strain (Leunk et al., 1988, Cover and Blaser, 1992, Cover 
et al., 1993). Several reasons underlying the diversity in vacuolating activity 
among H. pylori strains were discovered. H. pylori isolates were identified that 
carried nonsense mutations, internal duplications, deletions, or 1-bp insertions 
within the vacA gene (Ito et al., 1998). Differences in the transcription of vacA or 
the efficiency in VacA secretion have also been found to influence the levels of 
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vacuolating activity with H. pylori culture filtrates (Forsyth et al., 1998). Perhaps 
the most important reason, however, for differences in vacuolating activity 
between differences in strains is variation discovered in the VacA amino acid 
sequences (Atherton et al., 1995), which subsequently have been associated 
with the observed divergence in cellular vacuolating activity (Fig. 1.6) (Atherton et 
al., 1995). The vacA genotype is recognized as an important determinant of the 
toxin’s cellular activity. 
The maximum amount of sequence diversity is found in several defined 
regions of vacA (Fig. 1.6). The middle of vacA, which was named the “m (for 
middle) region,” encodes an approximately 800-basepair region in the carboxyl-
terminal p55 domain of VacA. Within the m region, the two primary allelic families 
that are differentiated among strains are called m1 and m2 (Atherton et al., 1995, 
Atherton et al., 1997). Sequence diversity within the m-alleles of vacA has been 
functionally associated with differences in cell tropism between VacA proteins 
(Pagliaccia et al., 2000, Wong et al., 2001). There is some evidence to indicate 
that the differences in cell type specificities demonstrated for the s1/m1 and 
s1/m2 forms of VacA may be due to, at least in part to distinct cell binding 
properties (Pagliaccia et al., 2000). 
The amino-terminal end of VacA, designated as the “s region,” also 
demonstrates considerable sequence diversity, which extends from the signal 
sequence that directs secretion across the bacterial inner membrane into the 
amino terminus of the processed mature toxin (Fig. 1.6). The two primary allelic 
groups that have been differentiated among strains are referred to as s1 and s2. 
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Notably, sequence differences between strains carrying the s1 or s2 alleles 
correspond directly to functional differences, as strains carrying the s2 vacA 
allele fail to induce cellular vacuolation (Atherton et al., 1995). Analysis of s2 
forms of vacA revealed that the signal sequences of these proteins are 
processed at a different cite, resulting in a mature form of VacA with a 12 amino 
acid extension that inactivates the toxin (McClain et al., 2001). 
Efforts to evaluate potential roles of VacA in the pathogenesis of human 
gastroduodenal diseases are complicated by the multifactorial nature of H. pylori 
pathophysiology in the human stomach. Nonetheless, epidemiology studies have 
been extremely useful for demonstrating a correlation between particular vacA i-, 
m-, and s-region allelic types and occurrence and severity of disease in H. pylori- 
infected humans. Many studies have provided evidence for a higher association 
of disease in individuals infected with H. pylori strains possessing s1 vacA alleles 
encoding toxin variants with greater cellular activity in vitro than strains with s2 
vacA alleles (Atherton et al., 1995, Atherton et al., 1997). In addition, strains with 
s1 alleles are a higher risk for gastric carcinoma than strains harboring vacA s2 
alleles (Figueiredo et al., 2001). As far as the m region, H. pylori strains 
harboring m1 vacA alleles have been more highly associated with gastric 
carcinoma (Figueiredo et al., 2001), as well as gastric alterations that normally 
precede the onset of gastric  cancer, including  epithelial damage, atrophic 
gastritis, and intestinal metaplasia (Atherton et al., 1997), than are those strains 
with m2 vacA alleles. Strains carrying both the s1 and the m1 allele are strongly 
associated with increased bacterial load and PMN infiltration within human 
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gastric mucosa, duodenal and gastric ulceration and gastric cancer (Yamaoka, 
2010). 
 
1.6.     VacA cellular actions 
Vacuole formation 
The first documented cellular activity of VacA was the capacity to induce the 
biogenesis of large intracellular vacuoles that occupy almost the entire epinuclear 
region (Fig. 1.7) (Leunk et al., 1988). VacA-mediated vacuolar compartments are 
acidic, enriched in the small GTPase Rab7 as well as other late endocytic 
markers, and exclude trypan blue (Leunk et al., 1988), indicating that vacuolation 
per se is not a cytolethal response to VacA intoxication. The capacity of VacA to 
form anion-conducting channels is important for the biogenesis of vacuoles 
(McClain et al., 2003, Vinion-Dubiel et al., 1999, Ye et al., 1999), which then 
swell further in the presence of membrane permeable weak bases (Szabo et al., 
1999, Tombola et al., 1999). 
Despite intensive study into the molecular basis and mechanism underlying 
vacuole biogenesis in VacA intoxicated cells, it remains poorly understood 
whether vacuolation per se directly contributes to H. pylori colonization, 
persistence or disease pathophysiology. Alternatively, vacuolation may represent 






Induction of cell death 
Increased cell death within the epithelial membrane may contribute to H. 
pylori disease pathogenesis in several ways. Increased apoptosis may alter the 
gastric environment to promote H. pylori persistence (Blanke, 2005), while at the 
same time, contribute to gastric disease, including peptic ulcers and gastric 
adenocarcinoma . Although several H. pylori have been implicated as mediators 
of cell death, VacA is per se sufficient to induce cell death (Fig. 1.7) (Cover et al., 
2003). VacA-mediated cell death is apparently complex, involving cellular 
alterations that are consistent with both apoptotic (Cover et al., 2003) and 
necrotic (Radin et al., 2011) cell death programs. 
 
Mitochondrial dysfunction 
One of the most intriguing and highly studied activities associated with VacA 
over the past 10 years, is the capacity of the toxin to target and modulate the 
properties of mitochondria within host cells (Fig. 1.7). In addition to the well-
known role of mitochondria in central metabolism, this organelle has emerged as 
a central hub of regulation for many of the most fundamental cellular processes, 
including programmed cell death, progression of the cell cycle, and innate 
immune sensing. At the same time, it is now clear that a loss of mitochondrial 
function, or dysfunction, has been associated with perhaps hundreds of human 
diseases and disorders. However, the extent to which mitochondrial function is 
altered during infection of host cells with pathogenic microbes as well as the 
possible consequences of pathogen-mediated mitochondrial dysfunction, are 
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both poorly understood. This is a particularly relevant issue because several 
dozen pathogenic bacteria and viruses have been reported to generate protein 
effectors that localize to mitochondria (Blanke, 2005). 
VacA-mediated modulation of mitochondrial function was first reported 
approximately a decade after the toxin was discovered as the factor within H. 
pylori culture filtrates that induces vacuolation within cultured epithelial cell lines 
(Leunk et al., 1988). VacA intoxication of human gastric epithelial AZ-521 cells 
was reported to induce mitochondrial dysfunction (Fig. 2C), as manifested by a 
drop in cellular ATP levels, mitochondrial transmembrane potential (DYm), and 
oxygen consumption (Kimura et al., 1999). Since this first report, VacA-
dependent alterations in mitochondria, and in particular DYm dissipation, have 
been confirmed independently by several groups (Calore et al., 2010, Domanska 
et al., 2010, Foo et al., 2010, Galmiche et al., 2000, Willhite and Blanke, 2004, 
Yamasaki et al., 2006), and are considered as one of the primary consequences 
of toxin activity at mitochondria (Blanke, 2005, Galmiche and Rassow, 2010, 
Rassow, 2011). 
Because of the central importance of mitochondria in cellular metabolism, it 
is perhaps not be surprising that VacA-mediated mitochondrial dysfunction has 
distinct consequence for host cells. In general, mitochondrial health is dependent 
on the functional integrity of the organelle’s inner and outer membranes, which 
have distinct biochemical and functional properties. Increased permeability can 
result in depolarization of the mitochondrial inner membrane, leading to DYm 
dissipation and a loss of metabolism (Fig. 1.7), which as indicated above, occurs 
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characteristically within VacA intoxicated cells (Calore et al., 2010, Domanska et 
al., 2010, Foo et al., 2010, Galmiche et al., 2000, Willhite and Blanke, 2004, 
Yamasaki et al., 2006). Increased outer membrane permeability (MOMP) results 
in the release of pro-apoptotic protein effectors from the inner membrane space 
into the cytosol (Blanke, 2005). Several studies have reported the release of 
mitochondrial cytochrome c within cells intoxicated with VacA (Galmiche et al., 
2000, Willhite and Blanke, 2004, Willhite et al., 2003, Yamasaki et al., 2006), 
resulting in apoptotic cell death, which has been demonstrated to be a 
consequence of VacA intoxication (Cover et al., 2003, Kuck et al., 2001, Smoot 
et al., 1996). 
The issue of why VacA targets mitochondria remains an intriguing question. 
The multiple important roles of mitochondria for cellular function suggest that 
VacA-dependent alterations in mitochondria would have consequences for 
gastric epithelial cells. As discussed above, an increase in apoptotic cells within 
the gastric epithelium is a hallmark of persistent H. pylori infection, and VacA has 
been demonstrated to be essential and sufficient among H. pylori factors for 
inducing cell death. But is VacA action at mitochondria linked to cell death? 
Recent studies have provided new insights into how VacA action at 
mitochondria might be functionally associated with cell death. VacA was 
demonstrated to disrupt mitochondrial dynamics (Fig. 1.7) (Jain et al., 2011), 
which is the cellular balance between mitochondrial fission and fusion, the two 
processes that together control mitochondrial morphology, quality control, and 
energy transduction. VacA-mediated disruption of mitochondrial dynamics 
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required hyperactivation of dynamin-related protein 1 (Drp1), which is a master 
regulator of mitochondrial fission, and Drp1 activation, in turn, was essential for 
activation of Bax, thereby committing VacA intoxicated cells to undergoing 
apoptosis. Thus, the discovery of VacA-mediated activation of Drp1 provides the 
direct molecular link between VacA action at mitochondria and toxin-dependent 
cell death. 
The mechanism by which VacA induces Drp1 is not clear. VacA-mediated 
dissipation of mitochondrial transmembrane potential (DYm) may induce Drp1 
activation indirectly, as mitochondrial depolarization has previously been shown 
in unrelated studies to induce calcineurin-mediated dephosphorylation of Drp1 as 
a mechanism to drive Drp1 translocation to mitochondria (Cereghetti et al., 
2008). On the other hand, the possibility that VacA may act more directly to 
activate Drp1 cannot currently be ruled out.  
 
1.7. VacA – CagA interactions 
Bacterial toxins are most typically studied as purified proteins in order to best 
tease out their specific contributions to modulation of host cell function. While 
often appropriate, these approaches do not take into account possible functional 
interactions that may exist between virulence factors. CagA is an important H. 
pylori virulence factor, and analogous to vacA, specific cagA alleles are highly 
predictive for the incidence and severity of disease associated with H. pylori 
infection. Like VacA, CagA modulates host cell function in several ways, primarily 
by disrupting signal transduction within intoxicated cells.  
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In principle, VacA and CagA are fundamentally different in their contributions 
to modulating the host epithelium. CagA, as a Type IV effector injected directly 
into the eukaryotic cytosol, modulates the functional properties of only those cells 
with which H. pylori have specifically colonized. In contrast, secreted VacA can 
act both proximally at the site of bacterial attachment to the epithelial membrane, 
as well as distally upon uninfected epithelial cells after diffusion from the site of 
adherent bacteria. Thus, infected epithelial cells would be predicted to be subject 
to the modulating effects of both VacA and CagA (Fig. 1.8). There is some 
evidence that some the cellular modulatory effects of VacA and CagA might be 
synergistic. For example, a recent report suggests that VacA and CagA may both 
facilitate iron acquisition of H. pylori colonizing the apical surface of polarized 
epithelial monolayers (Tan et al., 2011), without severely damaging the host 
cells.  
However, most studies to date however indicate that the cellular activities of 
VacA and CagA are primarily antagonistic. VacA and CagA inhibit each other’s 
effects on epithelial cells (Argent et al., 2008), with CagA down-regulating cellular 
vacuolation (Fig. 1.8), and VacA down-regulating the hummingbird phenotype of 
gastric epithelial cells associated with CagA injection. Another report 
demonstrated that whereas CagA activates the NFAT pathway via activation of 
calcineurin, VacA blocks calcineurin activation through decreased calcium influx, 
thereby down-regulating the NFAT pathway (Yokoyama et al., 2005). 
Strikingly, the capacity of VacA to induce the death of epithelial cells is 
blocked by CagA (Fig. 3) (Oldani et al., 2009). The authors demonstrated 
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phosphorylated CagA blocks the ability of VacA to traffic to intracellular 
compartments, whereas unphosphorylated CagA blocks apoptosis in a manner 
that mimics Bcl2 (an anti-apoptotic factor) overexpression. CagA further inhibits 
VacA-dependent apoptosis by blocking the cellular uptake of VacA from the cell 
surface (Akada et al., 2010). 
Increasing evidence suggests that VacA and CagA can functionally interact 
in manner that directly affects disease outcome. This idea is supported by 
epidemiological studies revealing significant 3-way associations between vacA 
alleles, cagA alleles, and the development of gastric diseases, including cancer 
(Yamazaki et al., 2005, Van Doorn et al., 1999, Jones et al., 2011, Jang et al., 
2010).  
How might VacA and CagA function together to promote colonization and 
disease? A recent study of the molecular evolution of vacA indicates that the 
vacA gene and the core H. pylori genome do not share the same evolutionary 
history (Gangwer et al., 2010). The vacA and cagA genes are separated on the 
H. pylori genome by a considerable distance, and several lines of evidence 
suggest that the cag PAI was acquired more recently than vacA (Gressmann et 
al., 2005, Olbermann et al., 2010). This type of evolutionary history might support 
the idea that acquisition of the genes encoding VacA and CagA established the 
pro-/anti-inflammatory and pro-/anti-apoptotic balance necessary to promote 
long-term colonization of the human gastric mucosa. 
Overall, these findings are consistent with the idea that VacA and CagA most 
effectively promote H. pylori persistence by functioning together in manner that 
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remodels the gastric niche occupied by the bacterium, but at the same time limits 
the degree to which the epithelial mucosa is damaged. The capacity to limit 
damage to host cells and tissues during infection is an increasingly recognized 
strategy employed by a number of pathogenic bacteria to fine tune virulence 
while promoting propagation and/or persistence (Shames and Finlay, 2010). 
 
1.8. Gaps in knowledge 
Effective utilization of the intracellular energy and resources are the key to 
maintain the cellular function, which is largely mediated by cellular regulatory 
circuits (Kroemer et al., 2010, Dibble and Manning, 2013). In response to 
extracellular or intracellular metabolic conditions, the metabolic regulatory 
pathways maintain cellular homeostasis, which is important for surviving under 
stress conditions, or, Fighting bacterial infections. Hence, from the standpoints of 
pathogenic bacteria, host metabolism is an attractive target for effectively 
modulating the host cellular functions (Eisenreich et al., 2013), and limit the 
responsiveness towards infection. On the other hand, because infections often 
disrupt host metabolic homeostasis, metabolic stress signals can alert host cells 
of infection and protect cells by triggering innate immune responses (Martin et 
al., 2012). Therefore, the role of host metabolism during infection may vary 
depending on the particular context of infection. 
Recently, several studies suggest that host metabolism is implicated in H. 
pylori infection. Metabolic disorders including iron deficiency anemia (DuBois and 
Kearney, 2005), or type II diabetes (Zhou et al., 2013) were reported in patients 
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infected with H. pylori. At the cellular level, H. pylori directly targets host’s 
mitochondria by secreting a mitochondrial targeting exotoxin VacA (Kim and 
Blanke, 2012), and impairs host capability of producing the cellular energy, as 
manifested by the decrease in the cellular ATP level (Kimura et al., 1999). 
However, the extent to which the localized mitochondrial damage impacts the 
overall host cellular metabolism was not well understood. In addition, the 
mechanism by which host cells sense and respond to the VacA-triggered cellular 
stress were together the gaps in knowledge addressed in this study.  
 
1.9. Significance of this study 
The overall objective of this study was to evaluate the hypothesis that H. 
pylori modulates the host metabolism to remodel the harsh gastric condition for 
colonization. There is a substantial body of research that indicates that host 
metabolism is a highly effective target of pathogenic bacteria for manipulating the 
host cellular system (Eisenreich et al., 2013). However, the mechanism by which 
pathogens disrupt the host metabolism, as well as the resulting outcomes, still 
remain poorly understood, and represented a new exciting field of study. 
Therefore, completion of this study contributed to establishing a new paradigm 
for the role of host metabolism during host-pathogen interactions. 
The results from this study demonstrated that the metabolic stress that was 
resulted from the VacA-dependent mitochondrial dysfunction altered the overall 
cellular metabolism, which was sensed by the mammalian target of Rapamycin 
complex 1 (mTORC1), a central metabolic regulator in mammalian cells (Dibble 
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and Manning, 2013). mTORC1 directly regulates both the catabolic and anabolic 
processes in response to the availability of nutrients (Manifava et al., 2016), 
energy (Inoki et al., 2012), and growth signals (Dibble and Manning, 2013), or 
additionally, to intracellular stress signals including reactive oxygen species 
(ROS), or dysregulation of the intracellular calcium reservoir (Hay and 
Sonenberg, 2004). This study demonstrated that mTORC1 was inhibited by H. 
pylori in a VacA-dependent manner, which clearly indicates that metabolic stress 
is induced by VacA cellular actions and sensed within the host cells. Moreover, 
this study also revealed that intracellular amino acid levels were decreased in a 
manner dependent on the VacA impairment of mitochondrial function, which was 
responsible for the inhibition of mTORC1 activity. This study demonstrated that 
H. pylori targets and manipulates host metabolism, which is consistent with a 
growing number of evidence that host metabolism is at the central hub of host-
pathogen interaction (Mohr and Sonenberg, 2012). 
Furthermore, this study investigated several modalities of host responses 
that could be triggered by the VacA-induced metabolic stress. Under favorable 
conditions, mammalian cells actively promote biosynthetic processes to support 
cellular proliferation (Hay and Sonenberg, 2004). In contrast, under cellular 
stress, mTORC1 becomes inhibited, and a series of cellular changes were 
employed in order for securing the intracellular resources. The two common 
strategies are by activating intracellular recycling mechanism (Hay and 
Sonenberg, 2004, Dibble and Manning, 2013), or, by limiting consumption of 
resources that occurs during biosynthetic processes (Dibble and Manning, 2013). 
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Several recent studies reported that H. pylori activates autophagy (Terebiznik et 
al., 2009, Raju et al., 2012b, Tsugawa et al., 2012), a catabolic recycling 
mechanism that breaks down the intracellular compartments for generating 
energy and building blocks to maintain cell viability under stress condition. 
However, the molecular mechanism that underlies the autophagy induction has 
not been well understood. The studies in this dissertation revealed that the 
induction of autophagy is casually and mechanistically linked to the inhibition of 
mTORC1 activity, indicating that mTORC1 mediated sensing of VacA-dependent 
cellular stress is required for cells to fully respond through autophagy. In addition, 
autophagy may represent cellular innate immune response during H. pylori 
infection, because during autophagic recycling process, intracellular bacteria or 
internalized bacterial effectors are also targeted and can be eliminated (Deretic 
and Levine, 2009). On the other hand, autophagic compartments can be hijacked 
by several pathogens and exploited as an intracellular replicative niche (Deretic 
and Levine, 2009, Tattoli et al., 2012). In H. pylori infection, the exact role of 
autophagy remains largely unexplored and is beyond the scope of this study. 
However, the studies here elucidated the mechanism by which autophagy is 
induced during H. pylori infection, broadening our understanding of autophagy in 
bacterial infection. The studies also provide insights for future research for 
evaluating the role of autophagy in H. pylori infection. 
Given that mammalian cells often halt the biosynthetic process to secure 
building blocks and energy, this study further investigated whether the host 
biosynthetic processes, in particular, biosynthesis of proteins were also altered 
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by VacA intracellular actions. This study evaluated possible alterations in the 
protein synthesis within cells infected with H. pylori, and revealed that H. pylori 
infection severely inhibited host protein synthesis in a VacA-dependent manner. 
The mass spectrometric analysis revealed that the majority of host proteins 
were inhibited by VacA at the translational level, which could possibly resulted 
from critical metabolic changes that could impact the overall translational 
capabilities, supported by the observation that cellular amino acids, the building 
blocks for de novo protein synthesis are reduced in a VacA-dependent manner. 
Furthermore, the studies revealed that VacA-dependent amino acid deficiency 
resulted from VacA-dependent impairment of mitochondrial energy production. 
In conclusion, this study demonstrated that overall host metabolism is 
targeted by H. pylori VacA, which extended current understanding of the role of 
VacA in H. pylori infection. Furthermore, the studies here revealed that VacA 
induced cellular stress resulted in a global shift in host metabolism, from a highly 
biosynthetic state where cells actively produce new cellular components, to a 
catabolic state where cells break down their own cellular compartments for cell 
survival under stress conditions. Finally, this study provided the premise for 









Figure 1.1. H. pylori in a gastric pit. Photomicrograph of a section of a biopsy 
taken from a 35-year-old man and stained with Genta stain, shows a gastric pit 
filled with H. pylori.  


























Figure 1.2. H. pylori colonization and persistence factors. During initial 
infection of the stomach lumen, urease-dependent ammonia production locally 
raises the pH, which promotes bacterial survival and solubilizes the mucus gel to 
facilitate bacterial motility. Chemotaxis (driven by pH and possibly other 
gradients) and helical rod shape promote flagellar-based motility away from the 
acidic lumen to H. pylori's preferred niche, on and adjacent to gastric epithelial 
cells. SabA, BabA and other variably expressed adhesins may shift the balance 
to cell-associated bacteria. Inset: cell-associated bacteria alter gastric epithelial 
cell behavior through VacA, CagA and CagL which all have multiple cellular 
targets. This includes CagA and VacA dependent disruption of cell polarity that 
can promote iron acquisition or cell extrusion, CagA and CagL dependent 
induction of chemokines and/or the gastric hormone gastrin, CagL dependent 
inhibition of acid secretion by the H+/K+ ATPase, and affects on proliferation, 
apoptosis and differentiation mediated by all three effectors. As noted in the main 
text, in addition to CagL (depicted), CagA and CagY have also been shown to 
bind α5β1 integrins although the precise interaction surface remains to be 
determined. fla, flagella; che, chemotaxis; ure, urease; T4SS, Cag Type IV 
secretion system; PS, phosphatidylserine; α5β1 and αvβ5, indicated integrin 







Figure 1.3. Helicobacter pylori (H. pylori). Electron micrograph of Helicobacter 
pylori depicting its spiral shape and flagella.  
(Source: Lucinda J. Thompson, Department of Microbiology and Immunology, 











Figure 1.4. H. pylori liquifies stomach mucin to cross over to the epithelial 
cells. H.pylori migration of human gastric mucosal layer is dependent on pH. 











Figure 1.5. The pathogenesis of CagA-related signaling. In the early steps of 
CagA recognition, CagF binds CagA, CagL, CagY and probably CagI utilize host 
integrin β1 as a cell-surface receptor, which triggers delivery of CagA into target 
cells Injected CagA can then undergo tyrosine phosphorylation by Src and Abl 
family kinases at the EPIYA motifs located near the C-terminal end (in EPIYA-A 
[A], EPIYA-B [B], EPIYA-C [C] or EPIYA-D [D] segments). CagA binds to and 
activates or inactivates multiple signaling proteins in both a phosphorylation-
dependent and phosphorylation-independent manner. There are currently 20 
known cellular binding partners of CagA, 10 of which form phosphorylation-
dependent interactions with CagA CagA itself forms dimers in a phosphorylation-
independent manner, via the CagA multimerization (CM) sequence (also known 
as MKI or CRPIA). CM sequence is also essential for formation of the CagA–Par 
and CagA–c-Met complexes. The proposed functions of complexes formed by 
CagA with Grb7, SHP1, Ras-GAP, PI3K, α-Pix and integrin β1 are unknown. 
Experimental data obtained via natural infection versus transfection of CagA are 
conflicting—PI3K, Grb2 and Crk did not interact with CagA in transfection 




Figure 1.6. VacA structure and the function of each domain. (A) Schematic 
VacA structure. Each domain is denoted in different color and approximate 
location is indicated by the number of the amino acid residue. The name of each 
domain is denoted in bold, and its function is briefly described nearby. (s: signal 
peptide, i: intermediate domain, m: mid-region, AT: autotransporter domain, HP: 
hydrophobic region, PF: pore forming region, RB: receptor binding region). (B) 
The proposed role of each domain in the processing and endosomal trafficking of 
VacA. The secretion of VacA is known to follow Type V secretion system, 
suggesting that precursor VacA molecule becomes mature through secretion 
processing. For the translocation to periplasmic space, the signal peptide is 
thought to be recognized by secretion (Sec) complex. AT domain initially 
interacts with outer membrane and forms a b-barrel autotransporter channel, 
through which the 1-822 amino acid portion that constitutes mature VacA is 
translocated. Depending on the pH, mature VacA molecules in extracellular 
space can assemble into larger oligomeric structures or be disassociated into 
monomers in a reversible manner. Sphingomyelin in lipid rafts of host cell 
membrane serves as the receptor of VacA. Although RB and p55 domain are 
both associated with receptor binding, p33 with RB is known to be sufficient to 
bind to receptor and exert subsequent intracellular cytotoxic effects. The 
hydrophobicity of HP region favors initial insertion of VacA into plasma 
membrane. VacA molecules are thought to congregate in lipid rafts and form a 
pore complex. In consequence, VacA molecules are internalized in endosome 
with orientation in which VacA is protected from cytosolic proteolytic activity. Hp  
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Figure 1.6. (cont.) 
is known to be recognized by translocase of outer mitochondrial membranes 20 
kDa (TOM20) complex, a mitochondrial import complex, supporting the recent 
study that HP is essential and sufficient for mitochondrial targeting of VacA. VacA 
translocated through TOM20 complex are thought to reassemble in inter-
membrane space and forms a pore within the mitochondrial inner membrane. 

























Figure 1.7. Modulation of host cell functions by VacA. (A) VacA binds to 
sphingomyelin (SM) in lipid rafts, or alternatively, receptor-type protein-tyrosine 
phosphatase-β (RPTP-β). Subsequently, VacA is pinocytosed into 
glycosylphosphatidylinisotol (GPI)-enriched early endosomal compartments  
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Figure 1.7. (cont.) 
(GEECs) and is transported early and late endosomal trafficking compartments 
(EE and LE), by a mechanism dependent on filamentous actin (F-actin). The late 
endosomes fuse with lysosomes (L), and anion-selective channel activity of the 
VacA pore inflates the endosomes, leading to visually the most apparent VacA 
effect, vacuolation. VacA was recently reported to induce autophagy in gastric 
epithelial cells. Both H. pylori and VacA are recognized by autophagosomes (AP) 
and engulfed within. AP further fuses with lysosome, and forms autolysosome 
(AL), where the engulfed targets are degraded. (B) VacA induces apoptosis 
through the modulation of mitochondria, which serves as the platform of 
triggering apoptosis. VacA in both EE and LE targets mitochondria, driven by 
Bax/Bak. VacA pore localized in inner membrane triggers mitochondrial inner 
membrane permeabilization (MIMP), leading to the intensive fragmentation of 
mitochondria. Mitochondrial fragments recruit Bax, through which diffuses out is 
Cytochrome c (Cyt c), which constitutes apoptosome, leading to activation of 
caspase 3, poly adenosine diphosphate (ADP)-ribose polymerase (PARP), and 
finally apoptosis. In parallel, VacA inhibits the activation of anti-apoptotic B-cell 
lymphoma 2 (Bcl-2) family proteins, such as Bcl-2 and Bcl extra-large (Bcl-xL), 
additively promoting apoptosis-inducing effect of VacA. (C) VacA modulation of 
signaling related to cellular proliferation. VacA has been reported to activate 
ERK1/2 that up-regulates superoxide dismutase-1 (SOD-1), and p38, are both 
activated by VacA, They are thought to prevent from radical oxygen species 
(ROS)-induced apoptosis. The VacA-activated p38 also activates activating 
transcription factor-2 (ATF-2), which is a transcription factor that increases the 
production of prostaglandin E2 (PGE2), presumably promoting proliferation. 
Moreover, VacA might promote proliferation by activating β-catenin though the 
deregulation of phosphorylation of glycogen synthase kinase 3 (GSK3β) and Akt, 
initiated by the activation of phosphoinositide 3-kinase (PI3K). VacA might 
promote proliferation by facilitating the internalization of lipopolysaccharide 
(LPS)-enriched outer membrane vesicles (OMV), a potent inflammatory stimulant 
shed by H. pylori. The histamine secretion stimulated by VacA inhibits the HCO3- 
secretion, disarming the protection against acid and pepsin. (D) To protect itself 
from acid, H. pylori employ VacA to alleviate the acidity by deregulating acid 
production mechanism in parietal cells. The right half of the parietal cell 
represents the proper regulation of acid secretion. Upon stimulation signal, H+/K+ 
anti-porter containing-small tubulovesicles fuse with the apical membrane. The 
fusion with tubule-vesicle membrane not only provides the acid-pumps to the 
apical surface but also provides the large extension of membrane surface area 
by “roll down” the pre-existing F-actin structure to prompt efficient acid secretion. 
Ezrin, an actin-binding protein, plays an essential role in this process by linking 
actin structure and membrane throughout the rapid morphological change. VacA 
induces the influx of Ca2+, which activates calpain 1, a protease that degrades 
ezrin, eventually deregulating acid secretion machinery. (E) In stomach, an  
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Figure 1.7. (cont.) 
extremely high concentration of proton is pumped out of parietal cells, 
accompanied with the exchange with HCO3- that is taken up and secreted by 
nearby mucus epithelial cells to protect from the digestive action by H+ and 
pepsin. About 80% of H. pylori in stomach are found in the mucus layer, and the 
rest as micro-colonies specifically localized onto the cell junctions of the apical 
epithelial surface. The extremely low pH establishes a semi-aseptic environment 
and to survive in such a harsh condition, and parietal cell function is attenuated 
during infection in a VacA-dependent manner. (F, G) VacA pore formed in apical 
surface permeabilizes the membrane, providing extracellular H. pylori with 
utilizable nutrients such as amino acids, sugar and metal ions. The urea, diffused 
out by permeabilization action of VacA pore is further converted by H. pylori 
urease to NH3+ that neutralizes acid, and as a consequence, inhibits activation of 
pepsinogen to pepsin, eventually causing dyspepsia. VacA modulates immune 
cells associated with either innate and/or adaptive immunity. (H) VacA induces 
tissue inflammation by stimulating the secretion of mast cell via the oscillation of 
intracellular Ca2+ level. VacA induces cytokine secretion in a variety of immune 
cells; VacA stimulates cytokine secretion of (i) mast cell, (ii) monocyte by 
activating transcription factors such as ATF-2, cAMP response element-binding 
(CREB) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-
κB), via p38 activation through the modulation of intracellular Ca2+ level, (iii) 
eosinophil by deregulating ROS intermediate (ROI) and intracellular Ca2+ level, 
followed by the activation of NF-κB. VacA suppresses adaptive immunity 
response by inhibiting proliferation of B and T cells. In addition in B cells, VacA 
disrupts antigen presentation of major histocompatibility complex II (MHC II). (I) 
In T cells, VacA recognized by CD18, blocks Ca2+ influx, subsequently the 
activation of calcineurin, and nuclear factor of activated T-cells (NFAT) a 
transcription factor required for the expression of both interleukin-2 (IL-2) and its 
receptor, finally suppressing the proliferation signal. In addition, VacA recognized 
by lymphocyte function-associated antigen 1 (LFA-1) receptor activates mitogen-
activated protein kinase kinase 3/6 (MKK3/6), leading to the activation of p38 and 















Figure 1.8. Molecular cross-talk between VacA and CagA. (A) CagA blocks 
VacA effect (i) by blocking the maturation of VacA-harboring GEEC to 
endosomes (E/L E: early/late endosomes), thereby inhibiting both vacuolation 
and mitochondrial targeting, (ii) by antagonizing mitochondria-associated pro-
apoptotic action, possibly via the activation of Bcl-2 followed by the activation of a 
transcription factor, NFkB. (B) In reverse, VacA blocks CagA effect (i) by 
inactivating epidermal growth factor receptor (EGFR) which is involved in the 
activation of ERK1/2 and the hummingbird-like morphological change in the 
downstream consequences, and (ii) by counteracting on Calcineurin that is 
activated by CagA-activated Phospholipase C-γ (PLC-γ), through blockage of 
Ca2+ influx, resulting in the inactivation of NFAT and presumably alleviation of the 
cell cycle retardation effect of CagA. On the other hand, VacA and CagA 
cooperate with each other. (C) CagA disrupts tight junction (TG) of host 
epithelium, so VacA diffuses over the epithelial barrier and modulate underlying 
immune cells. (D) VacA pair-plays with CagA in the H. pylori modulation of iron  
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Figure 1.8. (cont.) 
acquisition response. CagA stimulates the expression of transferrin receptor (Tfr) 
in cytosol, and VacA action facilitates Tfr presentation to apical surface. In 
parallel, VacA provides Fe3+ ion by permeabilizing the plasma membrane of 
nearby cells so H. pylori can usurp Fe3+ from the cells in direct contact. 
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CHAPTER 2: Helicobacter pylori Modulation of Host Metabolism through 
VacA-dependent Inhibition of mTORC1 
  
2.1. Introduction 
 Helicobacter pylori (Hp) is a human gastric pathogen that chronically infects 
approximately half the world’s population (Suerbaum and Josenhans, 2007), 
resulting in an increased risk for the development of gastric ulcer disease and 
adenocarcinoma (Polk and Peek, 2010). Colonization of the human gastric 
epithelium requires that Hp survive the harsh conditions of the stomach, as well 
as a robust host inflammatory response to infection (Salama et al., 2013). 
Success in establishing chronic infection largely depends on Hp-mediated 
remodeling of the gastric environment into a suitable niche for colonization and 
long-term survival (Salama et al., 2013). There is increasing evidence that 
pathogenic microbes often target host cell metabolism in order to remodel host 
epithelial barriers (Eisenreich et al., 2013). 
 Most strains of Hp secrete vacuolating cytotoxin (VacA), an intracellular-
acting, channel-forming toxin (Kim and Blanke, 2012, Cover and Blanke, 2005). 
The gene encoding VacA is characterized by allelic mosaicism, and several 
alleles are associated with an elevated risk for gastric disease (Atherton et al., 
1995). Intoxication of epithelial cells with VacA results in several well-
characterized alterations in cellular physiology, including cytosolic vacuole 
biogenesis (Leunk et al., 1988), and, the induction of autophagy (Terebiznik et 
al., 2009, Raju et al., 2012a).  
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 VacA is one of the most well studied members of a growing class of microbial 
effectors that target mitochondria within host cells (Blanke, 2005, Arnoult et al., 
2009). Subsequent to cellular internalization, VacA localizes to mitochondria 
(Galmiche et al., 2000, Calore et al., 2010), and induces organelle dysfunction 
(Willhite et al., 2003), as manifested by the dissipation of mitochondrial 
transmembrane potential (DYm) (Kimura et al., 1999, Willhite and Blanke, 2004), 
increased mitochondrial fragmentation (Jain et al., 2011), and depletion of ATP 
(Kimura et al., 1999). However, the full extent to which VacA-dependent 
mitochondrial perturbations affect overall cellular metabolism is poorly 
understood. 
 Here, I describe studies demonstrating that Hp infection of gastric cells results 
in VacA-dependent inhibition of the mammalian target of rapamycin (mTOR) 
complex 1 (mTORC1). In response to nutrient or energy stress, mTORC1 
coordinates cellular responses with the goal of re-establishing metabolic 
homeostasis (Deretic and Levine, 2009, Kroemer et al., 2010, Levine et al., 
2011). Within VacA intoxicated cells, I demonstrated that inhibition of mTORC1 
signaling positively regulates autophagy, which has been previously linked to 
VacA (Terebiznik et al., 2009, Raju et al., 2012a). Finally, our studies indicated 
that disruption of amino acid homeostasis within VacA intoxicated cells is 
causally linked to mTORC1 inhibition. Collectively, these studies indicate that Hp 





2.2. Materials and Methods 
Mammalian cell lines 
 Mammalian cells were maintained within a humidified environment and under 
5% CO2 at 37 °C. HEK293T (human embryonic kidney, fetus), NCI-N87 (human 
gastric epithelial, male), AGS (human gastric epithelial, female), AZ521 cells 
(human duodenal epithelial, male) were maintained in Dulbecco’s Modification of 
Eagle’s Medium (DMEM) supplemented with FBS (10%; Sigma-Aldrich) and 
penicillin/streptomycin (1%; Sigma-Aldrich). AZ521 cells were maintained in 
Minimum Essential Medium Eagle (MEM) (Cellgro) supplemented with FBS 
(10%) and penicillin/streptomycin (1%). Cells were seeded in 24 well plates or in 
chamber microscopy slides (Thermo Fisher) at an appropriate cell confluency not 
exceeding 90% (3 x 104 cells/well). To enhance cellular attachment for HEK293T 
cells, plates and slides were pre-coated with Rat tail-purified collagen I (50 
µg/mL; Gibco), as described by the manufacturer. 
H. pylori infection studies 
 H. pylori (Hp) 60190 strain (cag PAI+, vacA s1m1, ATCC 49503), VM022 (a 
strain that is isogenic to 60190, except for deletion of vacA) (Vinion-Dubiel et al., 
1999), VM084 (VM022 complemented by the reintroduction of vacA) (McClain et 
al., 2001), 26695 (cag PAI+, vacA s1m1), J198 (cag PAI+, vacA s1m2), or, Tx30a 
(cag PAI-, vacA s2m2) were inoculated as a suspension in 4 mL bisulfite/sulfite-
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free Brucella (BSFB) broth (0.1% dextrose, 0.2% β -cyclodextrin, 0.5% NaCl (all 
from Sigma-Aldrich), and, 1% tryptone, 1% peptone, and 0.2% yeast extract (all 
from BD Bacto), and incubated at 37 °C and with humidification on top of 2% 
agar plates made of Ham’s F-12 media (Sigma-Aldrich) supplemented with 5% 
fetal bovine serum (FBS) (Sigma-Aldrich), in a microaerophilic environment (10% 
O2, 5% CO2). After 2 days, the bacterial cells were harvested by centrifugation at 
5000 xg for 1 min, and the bacterial pellets were suspended in the infection 
medium (Dulbecco’s Modification of Eagle’s Medium (DMEM) (Cellgro) 
supplemented with 10% FBS. The concentration of motile, curved bacilli, which 
are highly associated with CFU, was determined by hemocytometer counting 
using phase contrast microscopy. HEK293T cells were infected with Hp bacteria 
(MOI of 100) at 37 °C, with 5% CO2 in a humidified environment. After 3.5 h, 
fresh infection medium containing 1% penicillin/streptomycin (Sigma-Aldrich) (4 
times the volume of the initial infection volume) was added to the infections (to 
supplement nutrients that may have been depleted by Hp bacteria). In the 
absence of Hp, inhibition of cellular mTORC1 signaling activity in mammalian 
cells was not detected after 4 h incubation under the conditions described above. 
Housing conditions for experimental animals 
 All experiments involving the use of live vertebrate animals were conducted 
under the approval of the University of Illinois at Urbana-Champaign Institutional 
Animal Care and Use Committee (IACUC) (protocol number: 15238). Animal 
populations were composed of 9 male and 9 female C57BL\6J mice (Jackson 
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Laboratory), aged 6 to 19 weeks. Animals were group housed within humidified 
environment (50%) with a mean temperature of 22.1 °C, under a 12 h light-dark 
cycle, and provided food and water ad libitum. Mice were randomly selected for 
experiment without gender preference, with both male and female mice included 
in experiments. Influence of gender between male and female was not observed 
in this study, hence not further investigated. 
Preparation of primary gastric epithelial cells from mice 
 Cultures of primary mouse gastric epithelial cells were established as 
previously described (Smoot et al., 2000), with modifications. Whole stomach 
specimens were collected by necropsy following euthanasia by CO2 inhalation. 
The fore stomach was removed by gross dissection, and the remaining gastric 
tissue was opened along the greater curvature. The mucosal surface was rinsed 
thoroughly with ice cold PBS (pH 7.4). The tissue was minced using scissors, 
and incubated for 1 h at 37 °C and under 5% CO2 within a humidified 
environment, in the cell dissociation medium, which was comprised of 
DMEM/Ham’s F-12 (Fisher Scientific) supplemented with 125 U/mL collagenase 
type IV (Gibco), 2.5% FBS, 2 U/mL dispase II, 5 mM CaCl2, 2 mM MgCl2, 2 mM 
N-acetyl-L-cysteine (NAC) (all purchased from Sigma-Aldrich), and 10 nM Y-
27632 dihydrochloride (Selleck Chemicals). After 1 h, the larger chunks of the 
tissue debris were removed by use of a 100 µm cell strainer (Corning). The 
collagenase and dispase activities within the filtrate containing the dissociated 
cells were neutralized by adding PBS (pH 7.4) that contains 5 mM EDTA (pH 8.0; 
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Invitrogen). The dissociated cells within the filtrate were pelleted by centrifugation 
at 100 xg for 7 min at 4 °C, and resuspended in ice cold, EDTA-free PBS (pH 
7.4). The epithelial cells within the cell suspension were enriched using a 70 µm 
cell strainer (Corning). The epithelial cells within the filtrates that passed through 
the strainer were pelleted by centrifugation at 100 xg for 7 min at 4 °C, and then 
resuspended in the culture medium consisting of DMEM/Ham’s F-12 
supplemented with 2.5% FBS, 125 mg/mL amphotericin B, 1% 
penicillin/streptomycin, and 2 mM NAC (all purchased from Sigma-Aldrich), plus 
1% Insulin-Transferrin-Selenium (ITS) cocktail and 10 µg/mL mouse derived 
epidermal growth factor (EGF) (both purchased from Gemini Bio-Products), 10 
nM Y-27632 dichloride (Selleck Chemicals), and then seeded in 24-well plates (2 
x 104 cells/mL) that were pre-coated with 2% Matrigel (prepared as indicated 
within the manufacturer’s instruction manual; Corning Life Sciences). Using 
immunofluorescence microscopy, epithelial cells were identified by positive 
staining for ZO-1 (tight junction marker, Thermo Fisher Scientific), E-cadherin 
(adherins junctions, Sigma-Aldrich), cytokeratin 18 (Santa Cruz Biotechnology), 
as well as negative staining for both Vimentin (mesenchymal marker, Santa Cruz 
Biotechnology), and Smooth Muscle Actin (endothelial/fibroblast marker, Santa 
Cruz Biotechnology).  
Preparation of stomach sections from mice 
 Stomachs from 6-19 weeks old mice (C57BL/6J) were collected by necropsy 
and prepared for sectioning as described above in “Preparation of primary gastric 
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epithelial cells from mice”. After cutting the stomach along the lesser curvature, 
the tissue was further cut into a rectangular shape by trimming the lesser 
curvature side. The remaining stomach tissue was rinsed thoroughly with ice cold 
PBS (pH 7.4), and transferred into mounting agarose (6% low gelling 
temperature agarose, Sigma-Aldrich), supplemented with 40% glycerol, and pre-
cooled to 37 °C. Immediately after embedding, the stomachs were maintained at 
4 °C until ready for sectioning. 350 μm tissue cross-sections were prepared using 
a vibratome (VT 1000S, frequency unit: 10, feed unit: 400, speed unit: 3.5, 
Leica), and each section was placed onto a transwell membrane insert (MilliCell, 
pore size, 0.4 μm, Thermo Fisher) in a 6-well plate with each well containing 1 
mL culture medium consisting of DMEM/Ham’s F-12 supplemented with 2.5% 
FBS, 125 mg/mL amphotericin B, 1% penicillin/streptomycin, and 2 mM NAC (all 
purchased from Sigma-Aldrich), plus 1% Insulin-Transferrin-Selenium (ITS) 
cocktail and 10 µg/mL mouse derived epidermal growth factor (EGF) (both 
purchased from Gemini Bio-Products), 10 nM Y-27632 dichloride (Selleck 
Chemicals). The sections were maintained at 37 °C and under an oxygen-
enriched condition (95% O2, 5% CO2) for 30 min prior to each experiment. Tissue 
sections prepared in this manner were evaluated using fluorescence microscopy 
for viability and metabolic activities. Tissue sections were consistently confirmed 
to be negative for cell death markers (TUNEL staining, and, ethidium homodimer-
1 staining, both purchased from Thermo Fisher Scientific), positive for viability 
markers (CellTracker green staining, and, calcein-AM staining, both purchased 
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from Thermo Fisher Scientific), and, positive for metabolic activity (MTS assay, 
Promega). 
Immunoblot analyses 
 Cell lysates were prepared by incubating monolayers at 4 °C in lysis buffer 
(20 mM Tris pH 7.5, 100 uM Na3VO4, 25 mM NAF, 25 mM β-glycerolphosphate, 
2 mM EGTA, 2 mM EDTA, 0.3% Triton X-100, all purchased from Sigma-Aldrich) 
that was supplemented with complete Mini EDTA-free, protease inhibitor cocktail 
tablets (1 tablet/25 mL, Roche Diagnostics). After 10 min, the lysates were 
transferred to fresh tubes and mixed with an equivalent volume of 2x sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) buffer (100 mM, 
SDS Tris, pH 6.8, 4%, bromophenol blue, 0.2% glycerol, 20% 2-
mercaptoethanol, all purchased from Sigma-Aldrich), and then incubated at 
100 °C for 10 min. After SDS-PAGE, the gel proteins were electro-transferred to 
a polyvinylidene fluoride (PVDF) membrane (Millipore). Transfer membranes 
were incubated overnight at 4 °C with primary antibodies diluted in blocking 
buffer (Tris-buffered (pH 7.4) saline with 0.1% Tween 20 (TBS-T, Sigma-Aldrich) 
supplemented with 5% skim milk (Lab Scientific). The blots were briefly washed 
with TBS-T for 5 min, and then incubated for 1 h at room temperature with HRP-
conjugated secondary antibodies (1:5000 dilution, Cell Signaling) diluted in the 
blocking buffer. After washing 4 times with TBS-T for 5 min each, the blots were 
incubated with HRP substrates (SuperSignal West, Pico and Femto mixed at 1:1 
ratio; Thermo Fisher Scientific). The luminescent signals from the blots were 
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imaged using a ChemiDoc XRS+ imaging system (Bio-Rad), and, analyzed using 
Image Lab software (Version 4.1; Bio-Rad) to quantify the relative band 
intensities. 
Measurement of mTOR activities 
 The relative mTORC1 activity within whole cell lysates was determined by 
immunoblot analysis using p-S6K (T389) antibodies (1:3000 dilution, Cell 
Signaling), or S6K antibodies (1:2000 dilution, Cell Signaling), calculated by the 
intensity of the immuno-specific signal corresponding to p-S6K divided by the 
intensity of the band corresponding to total S6K. The relative mTORC2 activity 
was measured by immunoblot analysis using antibodies specific for protein B 
kinase (Akt) phosphorylated at Serine 473 or p-Akt (1:10000 dilution, Cell 
Signaling), or total Akt (1:10000 dilution, Cell Signaling), calculated by dividing 
the intensity of the immuno-specific signal corresponding to p-Akt by the intensity 
of the band corresponding to total Akt. 
Preparation of Hp culture filtrate 
 Hp culture filtrate (HPCF) was prepared from cultivation of Hp 60190 as 
previously described (Jain et al., 2011). Briefly, Hp were inoculated in 4 mL 
BSFB broth onto the surface of 2% agar plates made of Ham’s F-12 media 
supplemented with 5% FBS. The biphasic cultures were incubated at 37 °C 
within a humidified, microaerophilic environment (10% O2, 5% CO2). After 1-2 
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days, the liquid phase of the biphasic culture was transferred to a fresh BSFB 
liquid culture (300 mL) and incubated with shaking at 37 °C with 5% CO2. After 2 
days, the cultures were centrifuged at 5000 xg for 30 min, and the VacA in the 
supernatant was precipitated out of solution by dissolving ammonium sulfate 
(Fisher Scientific) to 90% saturation (662 g/L) at 4 °C with stirring. After 4 h, the 
precipitated material was collected by centrifugation at 5000 xg at 4 °C. The 
pelleted material was dissolved in wash buffer (10 mM sodium phosphate 
dibasic, pH 7.0; Sigma-Aldrich) and dialyzed at 4 °C for 12 h (with four buffer 
changes) in the wash buffer (100 times the volume of the precipitate solution), 
using 50 kDa molecular weight cutoff (MWCO) dialysis tubing (Spectra/Por 6 RC, 
Spectrum Labs). After pelleting the insoluble fractions by centrifugation at 5000 
xg for 30 min, followed by filtration using a 0.22 μm MWCO filtration funnel 
(Stericup, EMD Millipore), the supernatant was concentrated using a 10 kDa, 
MWCO centrifugal filter (Amicon Ultra, Merck Millipore), and then dialyzed for 12 
h at 4 °C in PBS pH 7.4 with stirring, using a 10 kDa MWCO dialysis cassette 
(Slide-A-Lyzer, Thermo Fisher Scientific). During dialysis, the dialysis buffer 
(PBS pH 7.4, at 100 times the volume of the concentrate) was changed three 
times. The total protein concentration was measured using the BCA assay 
(Thermo Fisher Scientific). The presence of VacA within HPCF was confirmed by 





Inactivation of VacA 
 The VacA within HPCF, or, within purified VacA preparations was heat-
inactivated by boiling at 100 °C for 10 min, or, removed by incubating for 1 h at 
4 °C with Protein A magnetic beads (Cell Signaling), which were pre-incubated 
for overnight at 4 °C with rabbit VacA antiserum (generated at the University of 
Illinois), or rabbit Campylobacter jejuni cytolethal distending toxin A (CdtA) 
antiserum (custom ordered; Rockland Immunochemicals). 
Purification and Acid-activation of VacA 
 After removing the insoluble fractions as described above under “Preparation 
of Hp culture filtrate (HPCF)”, the VacA-containing soluble fraction was loaded 
into a column packed with anion exchange resin (DEAE Sephacel, GE 
Healthcare) that had been pre-equilibrated with wash buffer (10 mM sodium 
phosphate dibasic, pH 7.0). After washing the column with 3 bed volumes of 
wash buffer, VacA was eluted with wash buffer supplemented with 0.2 M NaCl, 
and collected in 1 mL fractions. After evaluating the purity of VacA within the 
fractions by SDS-PAGE gel separation and staining with G-250 Coomassie 
Brilliant Blue (Sigma-Aldrich), the fractions containing VacA with no additional 
visible bands were combined and concentrated using a 10 kDa MWCO 
centrifugal filter (Amicon Ultra, Millipore), and then dialyzed for 12 h at 4 °C in 
PBS pH 7.4 (at 100 times the volume of the concentrate) with stirring using a 10 
kDa MWCO dialysis cassette (Slide-A-Lyzer). The concentration of purified VacA 
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was determined by the Bradford or BCA assay (both from Thermo Fisher 
Scientific). 
 Just prior to addition to cultured host cells or tissue, VacA was activated by 
mixing 10% (v/v) HCl (0.3 M) to purified toxin, and then incubating at 37 °C. After 
30 min, the solution was neutralized by adding NaOH (0.3 M) at an equivalent 
volume as the HCl added. 
Autophagy activation 
 Autophagy activation within whole cell lysates was evaluated by immunoblot 
analysis, using LC3 antibodies (1:10000 dilution, Cell Signaling), or β-actin 
(1:5000 dilution, Cell Signaling), calculated by the intensity of the immuno-
specific signal corresponding to LC3-II normalized by the intensity of the band 
corresponding to β-actin.  
Immunostaining of tissue section specimens 
 After each experiment, the tissue sections were fixed overnight at 4 °C with 
PBS (pH 7.4) buffered formalin (4%), and then incubated in PBS (pH 7.4) 
buffered 30% sucrose until sucrose pervaded the entire tissue section, which 
was indicated when the fixed tissues floating on the buffer surface started to sink 
down in the buffer. The tissues were then mounted in a mold containing Optimum 
Cutting Temperature (OCT) compound (Sakura Finetek USA), and snap-frozen 
by incubating the mold for 3 min in isopentane (Sigma Aldrich) that had been pre-
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chilled with dry ice. The frozen blocks were sectioned into 10 μm sections using a 
cryostat (CM3050S, Leica) and placed on glass slides. 
 For immunostaining, the OCT compound was first removed by washing 
slices once with PBS (pH 7.4) for 5 min with gentle shaking, and then slides were 
incubated overnight at 4 °C with primary antibodies (p-S6K and LC3; 1:200 
dilution, Cell Signaling) (p-GCN2; 1:200 dilution, Abcam) diluted in blocking 
buffer (5% normal goat serum (Cell Signaling) in Tris-buffered (pH 7.4) saline 
with 0.1% Tween 20 (TBS-T). After washing the slides with PBS (pH 7.4) for 5 
min, the slides were incubated overnight at 4 °C with the goat anti-Rabbit Alexa 
488 Fluor-conjugated secondary antibodies (1:400 dilution, Invitrogen) diluted in 
the blocking buffer containing counter staining dyes (1 μM DAPI, 5 μM wheat 
germ agglutinin (WGA), both purchased from Invitrogen). After washing 3 times 
with PBS (pH 7.4), for 10 min each wash, samples were mounted using Prolong 
Gold Antifade Mounting Reagent (Invitrogen). The sections were observed using 
a laser scanning confocal microscope (LSM 700, Carl Zeiss Microscopy) with 
either a 10X objective (EC Plan-Neofluar, NA; 0.3, Carl Zeiss Microscopy) or a 
40X objective (EC Plan-Neofluar, NA; 1.3, Carl Zeiss Microscopy), and imaged 
using a digital microscope camera (Axio Imager Z1, 512x 512 pixels, Carl Zeiss 
Microscopy). The images were processed and analyzed using ZEN 2012 





Overexpression of mTOR constructs 
 Cells overexpressing mTOR constructs were prepared as described 
previously (Ohne et al., 2008). Using Lipofectamine 2000 (Thermo Fisher 
Scientific), cells were transiently transfected, as indicated within the 
manufacturer’s instruction manual, with the pIRES-puro3 plasmid encoding Flag-
wild type mTOR, or, Flag-mTOR SL+LT1, the hyperactive mTOR mutant (Ohne 
et al., 2008). After overnight incubation, the cells that had been transfected were 
selected by incubating at 37 °C and under a humidified environment in the 
presence of 2 μg/mL puromycin (Sigma-Aldrich), which kills cells not transfected 
with pIRES-puro3 plasmid, and therefore not expressing active puromycin-N-
acetyl-transferase. After 24 h, the cells were incubated in the absence of 
puromycin for 4 h before commencing specific experiments. Overexpression of 
the Flag-mTOR constructs was confirmed by immunoblot analysis for the Flag 
motif, using an anti-Flag antibody (1:1000 dilution; Cell Signaling). 
Measurement of mTORC1 mediated phosphorylation of Ulk1 
 The specific mTORC1 activity corresponding to phosphorylation of Ulk1 at 
Ser757 was measured by immunoblot analysis using antibodies specific for Ulk1 
at Serine 757 (p-Ulk1, 1:1000 dilution, Cell Signaling), or total Ulk1 (1:1000 
dilution, Cell Signaling), calculated by the intensity of the band corresponding to 
p-Ulk1 divided by the intensity of the band corresponding to total Ulk1. 
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Inhibition of Ulk1 activities 
 Ulk1 kinase activity was inhibited using the ULK1 specific inhibitor (SBI-
0206965, Cayman Chemical). Cells were pre-incubated in the absence or 
presence of 50 μM SBI-0206965, at 37 °C in DMEM with 5% CO2 in a humidified 
environment for 30 min, and then further incubated at 37 °C in DMEM with 5% 
CO2 in a humidified environment in the absence or presence of VacA (250 nM) 
for 4 h. 
Amino acid deprivation of mammalian cells 
 Cells were briefly washed with PBS pH 7.4 and incubated in pre-warmed 
amino acid depleted medium, which is comprised of the custom formulated 
DMEM, not containing any amino acids (Hyclone), supplemented with dialyzed 
10% FBS (Gibco) and 1% penicillin/streptomycin (Sigma-Aldrich). 
Measurement of co-localization between mTORC1 and lysosomal 
compartments 
 Mammalian cells, that were seeded in 8-well chamber slides (Thermo Fisher 
Scientific), were incubated in the absence or presence of VacA (250 nM) in 
DMEM for 4 h, or in amino acid depleted medium (as defined under “Amino acid 
deprivation of mammalian cells”) for 1 h, at 37 °C with 5% CO2 in a humidified 
environment. After incubation, the cells were prepared for microscopy analysis as 
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described previously (Zoncu et al., 2011). Briefly, the cells were fixed for 20 min 
in PBS (pH 7.4) buffered 4% formaldehyde (Fisher Scientific), and the membrane 
permeability increased by incubating the monolayers for 10 min in PBS (pH 7.4) 
containing 0.1% Triton X-100 (Sigma-Aldrich). Cellular mTOR and LAMP-1 were 
detected using immunofluorescence by incubating the cells at 4 °C with rabbit 
anti-mTOR antibody (1:500 dilution; Cell Signaling) and mouse anti-LAMP-1 
(1:100 dilution; Santa Cruz Biotechnology), both diluted in blocking buffer (PBS 
(pH 7.4) containing 1% BSA (Sigma-Aldrich). After an overnight incubation, the 
monolayers were briefly rinsed with the blocking buffer once and then incubated 
in the dark and at room temperature with goat Alexa Fluor 568-conjugated anti-
rabbit antibody (1:500 dilution, Invitrogen), goat Alexa Fluor 488-conjugated anti-
mouse antibody, (1:500 dilution, Invitrogen) and 50 nM DAPI, all diluted in the 
blocking buffer. After 30 min, the cells were washed 3 times (5 min each) with 
PBS pH 7.4 and were mounted on slides, using a mounting reagent (Prolong 
Gold Antifade, Invitrogen), with a coverslip. The cells were observed using a LSM 
700 laser scanning confocal microscope with a 63X objective (Apochromat, NA; 
1.42, Carl Zeiss Microscopy), and, imaged using an Axio Imager Z1digital 
microscope camera (512 x 512 pixels). The images were processed and 
analyzed using ZEN 2012 software, Version 1.1.2. 
Tethering of mTORC1 to lysosomal membranes 
 Cells were stably transfected with lentiviral particles prepared as described 
previously (Yoon et al., 2015), packaged with either pLJM1 encoding Flag-Raptor 
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(Flag tagged wild type Raptor, Addgene), or, Flag-Raptor-Rheb15 (Flag tagged 
chimeric Raptor fused with the lysosomal transmembrane motif of Rheb, which 
tethers the coupled mTORC1 to lysosomal membranes, Addgene) (Sancak et al., 
2010), both of which were originally deposited at Addgene by Dr. David M. 
Sabatini. After 2 days, the successfully transfected cells were selected by 
incubating in the presence of puromycin (2 μg/mL), which kills cells not 
expressing active puromycin-N-acetyl-transferase, a selection marker that was 
encoded along with the Raptor construct within the pLJM1 vector and packaged 
together within the lentiviral particles. The overexpression of the Flag-Raptor 
constructs was confirmed by immunoblot analysis for the Flag motif within the 
whole cell lysates, using anti-Flag antibody (1:1000 dilution; Cell Signaling). 
Inhibiting de novo protein synthesis 
 Cells were incubated in the presence or absence of VacA (250 nM) in DMEM 
for 3.5 h, or in the amino acid depleted medium (as defined under “Amino acid 
deprivation of mammalian cells”) for 30 min, at 37 °C with 5% CO2 in a humidified 
environment. After each incubation, cells were further incubated in the absence 
or presence of 10 μM cycloheximide (Sigma-Aldrich) at 37 °C with 5% CO2 in a 




Measuring GCN2 dependent cellular sensing of relative intracellular amino 
acid deficiency 
 The GCN2 dependent cellular sensing of relative intracellular amino acid 
levels within whole cell lysates was measured by immunoblot analysis using 
antibodies specific for GCN2 phosphorylated at Thr 898 (p-GCN2, 1:1000 
dilution; Abcam), or, total GCN2 (1:5000 dilution; Cell Signaling), calculated by 
the intensity of the band corresponding to p-GCN2, divided by the intensity of the 
band corresponding to total GCN2. 
Use of L-leucyl-L-leucine methyl ester for inhibiting VacA dependent 
inhibition of mTORC1 signaling activity 
 Cells were incubated in the presence or absence of VacA (250 nM), at 37 °C 
in DMEM for 3.5 h, or in the amino acid depleted medium (as defined under 
“Amino acid deprivation of mammalian cells”) for 30 min, at 37 °C with 5% CO2 in 
a humidified environment. After each incubation, cells were further incubated in 
the absence or presence of L-leucyl-L-leucine methyl ester or LLOMe (0.5 mM; 
Cayman Chemical) at 37 °C with 5% CO2 in a humidified environment in the 





Measurement of relative levels of intracellular amino acids 
 Monolayers of HEK293T cells seeded in 6 cm plates were incubated in a 
humidified environment at 37 °C with 5% CO2 in the absence or presence of 
VacA (250 nM). After 4 h, the cells were immediately chilled on ice, thoroughly 
washed with ice cold PBS pH 7.4 twice, and collected in 300 μL of ice-cold 60 % 
methanol using a cell scraper. The intracellular compartments were further 
disrupted by sonication (Thermo Fisher, 20 % power, 5 repeats of 1 sec pulses, 
using 3 sec intervals). A small fraction of each sample was reserved for 
immunoblot analyses. The cellular debris were removed by centrifuging the cell 
suspension at 12,000 xg at 4 °C for 15 min, yielding a clear supernatant, which 
was transferred to a fresh Eppendorf tube. The samples were kept at – 80 °C 
until submitted to the Metabolomics Center at the Roy J. Carver Biotechnology 
Center (University of Illinois) for gas chromatography-mass spectrometry (GC-
MS) analyses designed for quantitatively measuring amino acids. As a control, 
samples were harvested using the same methodology from cells that were 
incubated for 5 min on ice in PBS (pH 7.4) supplemented with 50 μg/mL digitonin 
(a reagent that selectively permeabilizes plasma membrane at the indicated 
dose, Sigma), and, confirmed to be negative in the amino acid levels. The 
relative levels of intracellular amino acids from different cell samples were 
normalized by the intensity of immune specific-bands corresponding to Histone 




Inhibiting VacA-dependent mitochondrial fragmentation with mdivi-1 
 Cells were pre-incubated at 37 °C in DMEM and under 5% CO2 within a 
humidified environment in the absence or presence of 200 μM mdivi-1 (EMD 
Millipore). After 30 min, and cells were then further incubated at 37 °C in DMEM, 
and under 5% CO2 within a humidified environment, for 4 h in the absence or 
presence of VacA (250 nM). 
Ectopic overexpression of the p34 subunit of VacA 
 Monolayers of cells were transiently co-transfected with plasmids harboring 
the genes encoding p34-GFP (pEGFP-C1::p34) (Galmiche et al., 2000), GFP 
alone (pAc-GFP-N1), or the pCDNA3.1 vector (transfection control for a mock 
overexpression), along with a plasmid harboring the gene encoding Myc-tagged 
S6K1 (pCDNA-Myc-S6K1) (at 4:1 ratio), using Lipofectamine 2000 (Thermo 
Fisher). After 24 h, the relative cellular levels of mTORC1 were determined by 
immunoblot analysis using p-S6K (T389) antibodies (1:3000 dilution, Cell 
Signaling), or Myc antibodies (1:1000 dilution, Cell Signaling), calculated by 
dividing the intensities of the immune-specific signals corresponding to p-Myc-
S6K (distinguishable from p-endogenous S6K by size) by the intensity of the 




Evaluating VacA-dependent cellular vacuolation 
 The VacA dependent cellular vacuolation was evaluated by incubating cells at 
37 °C and under 5% CO2 within a humidified environment in the absence or 
presence of VacA (250 nM) in DMEM and NH4Cl (5 mM). After 4 h, cellular 
vacuolation was visualized using phase contrast microscopy (Thermo Fisher, 
EVOS FL)). Otherwise indicated, all the Hp infection and VacA intoxication 
studies were carried out using culture medium not supplemented with NH4Cl. In 
indicated experiments, the cells were pre-incubated for 30 min at 37 °C and 
under 5% CO2 within a humidified environment in the absence or presence of 
Bafilomycin A1 (10 nM, Sigma-Aldrich), and then further incubated in the 
absence or presence of VacA. 
Quantification and statistical analyses 
 As indicated in the Figure legends, each experiment was performed 
independently at least three times. For each experiment using samples collected 
from mice, a whole experimental set used for different treatments was harvested 
from a single animal. Statistical analyses were conducted using GraphPad Prism 
(ver. 7.0). Error bars indicated standard deviations. P values were calculated 
using either the Students’ t test with paired, two-tailed distribution, or, one-way 
ANOVA, corrected using either the Dunnett’s, or, the Tukey’s test. P values 





H. pylori inhibit mTORC1 signaling by a VacA-dependent mechanism 
 In mammalian cells, mTORC1 senses nutrient and energy stress, and, 
coordinates cellular responses with the goal of re-establishing metabolic 
homeostasis. To evaluate mTORC1 signaling activity in response to H. pylori 
(Hp) infection, monolayers of HEK293T cells, which are extensively employed as 
an in vitro model system for studying mTORC1-mediated regulation (Peterson et 
al., 2009, Hsu et al., 2011), were incubated, at 37 °C and under 5% CO2, in the 
absence or presence of Hp 60190 or Hp 26695 (MOI 100). After 4 h, cell lysates 
were evaluated using immunoblot analysis to determine relative levels of p70 S6 
kinase (S6K) phosphorylated at threonine 389 (p-S6K (T389)), which is a 
commonly used marker for monitoring cellular mTORC1 signaling activity (Hay 
and Sonenberg, 2004). In these studies, lower levels of p-S6K (T389) were 
detected within cells infected with Hp 60190 or Hp 26695 than in mock-infected 
cells (Fig. 2.1A), although total cellular S6K levels were not altered. Moreover, 
lower p-S6K (T389) levels were detected in HEK293T cells exposed to Hp 
60190-derived culture filtrates (HPCF) (150 μg/mL) (Fig. 2.1B), suggesting that 
the inhibitory factor is a secreted factor. Pretreatment of HPCF at 100 °C for 10 
min abolished HPCF-dependent inhibition of mTORC1 signaling activity (Fig. 
2.2A), indicating the involvement of one or more heat-sensitive components. 
Notably, HPCF did not alter the cellular activity of the mTORC2 complex (Fig. 
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2.1B), which regulates cytoskeletal organization and cell proliferation (Laplante 
and Sabatini, 2009).  
 VacA, which is secreted by Hp, induces mitochondrial dysfunction within 
gastric epithelial cells. Because mTORC1 is a cellular sensor of energy stress 
(Inoki et al., 2012), I evaluated whether VacA might be important for HPCF-
dependent mTORC1 inhibition. These studies indicated that the inhibition of 
cellular mTORC1 signaling activity was not detected in HEK293T cells when 
HPCF was pre-incubated with VacA neutralizing antibodies (Fig. 2.2B). In 
addition, inhibition of cellular mTORC1 was not detected in HEK293T cells 
exposed to HPCF prepared from a mutant strain of Hp 60190 lacking the gene 
encoding VacA (Hp (ΔvacA)) (Fig. 2.1C). (Vinion-Dubiel et al., 1999). However, 
inhibition was again detected (Fig. 2.1C) when HEK293T cells were incubated 
with HPCF prepared from a complemented Hp strain (Hp(ΔvacA::vacA)) 
generated by the reintroduction of vacA into Hp (ΔvacA) (McClain et al., 2001). 
Finally, inhibition of cellular mTORC1 was not detected in cells infected at MOI 
100 with Hp (ΔvacA), while, in contrast, cells infected with Hp (ΔvacA::vacA) 
demonstrated inhibition similar to that detected in cells infected with wildtype Hp 
60190 (Fig. 2.1D). Together, these studies indicated that VacA is required for 
HPCF-dependent inhibition of cellular mTORC1 signaling activity. 
Phylogenetic analysis of vacA sequences has revealed several distinct 
groups of vacA alleles (Rudi et al., 1998). Regions of VacA sequence diversity 
include the signal sequence region (s-region) and the middle region (m-region), 
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with the s1m1 form of VacA generally considered to more cytotoxic in cell 
culture-based assays than s2m2 (Atherton et al., 1995). Moreover, 
epidemiological studies have indicated that the risk of gastric disease is higher in 
persons infected with strains containing type s1 or m1 forms of vacA (Rudi et al., 
1998). In our studies, lower levels of p-S6K (T389) were detected within cells 
infected with Hp 60190 or Hp 26695, both of which secrete the highly active 
s1m1 allelic form of VacA, than in mock-infected cells (Fig. 2.1A). Additional 
studies revealed significantly higher levels of p-S6K (T389) within cells infected 
with Hp J198 or Hp Tx30a, which secrete the s1m2 or s2m2 forms of VacA, 
respectively (Fig. 2.2C), than in cells infected with Hp 26695. 
VacA is sufficient for inhibition of cellular mTORC1 signaling activity 
 To evaluate whether VacA alone is sufficient among Hp factors to inhibit 
cellular mTORC1 signaling activity, monolayers of HEK293T cells were 
incubated for 4 h at 37 °C in the absence or presence of purified VacA (Fig. 
2.3A). These studies revealed that mTORC1 activity is inhibited in HEK293T 
cells exposed to purified VacA, but not when toxin was pretreated with VacA-
specific antibodies (Fig. 2.3B). VacA-dependent inhibition of mTORC1 activity is 
not idiosyncratic to HEK293T cells, but is recapitulated within human-derived 
AGS (Raju et al., 2012a, Radin et al., 2011) and NCI-N87 gastric epithelial cells, 
as well as AZ-521 duodenal epithelial cells (Fig. 2.4A), which have been used as 
in vitro models for studying VacA biology (Gupta et al., 2008, Gupta et al., 2010, 
Jain et al., 2011). VacA-dependent inhibition of cellular mTORC1 signaling 
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activity was also detected within primary gastric epithelial cells from C57BL/6J 
mice (Fig. 2.4B). Finally, I observed VacA-dependent inhibition of mTORC1 
signaling activity within an ex vivo gastric tissue slice model derived from the 
stomachs of C57BL/6J mice (Koerfer et al., 2016) (Fig. 2.4C). 
VacA-dependent inhibition of cellular mTORC1 signaling activity is causally 
linked to autophagy induction 
 In response to metabolic stress, inhibition of mTORC1 activates several 
cellular processes in order to re-establish metabolic homeostasis (Kroemer et al., 
2010). Autophagy is a mechanism by which intracellular components are 
engulfed and degraded within specialized autophagic vesicles, called 
autophagosomes, resulting in the recycling and redirecting of biosynthetic 
building blocks to mitochondria for ATP production (Kaur and Debnath, 2015). 
Previous studies reported VacA to be both essential and sufficient for Hp 
activation of autophagy (Terebiznik et al., 2009, Raju et al., 2012a, Tsugawa et 
al., 2012), but did not address the mechanism underlying VacA-dependent 
autophagy induction. In preliminary studies, I confirmed VacA-dependent 
activation of cellular autophagy in HEK293T cells, which had not been previously 
reported, as indicated by toxin-dependent increases in levels of microtubule-
associated protein 1A/1B-light chain (LC3-II) levels (Fig. 2.5). LC3-II is commonly 
used as a surrogate marker for autophagic flux, and previous studies have 
demonstrated that increases in LC3-II within VacA intoxicated cells reflect toxin-
dependent increases in cellular autophagic vesicles (Terebiznik et al., 2009, Raju 
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et al., 2012a, Tsugawa et al., 2012). Additional studies revealed that cellular 
LC3-II levels were significantly greater in HEK293T cells infected at MOI of 100 
with either wildtype Hp 60190 or Hp (ΔvacA::vacA), than with Hp (ΔvacA) (Fig. 
2.6A), supporting the importance of VacA during Hp infection for autophagy 
activation. VacA-dependent autophagy activation was also detected in primary 
murine gastric epithelial cells (Fig. 2.4D), and, in our ex vivo derived gastric 
tissue slice model (Fig. 2.4E). VacA-dependent inhibition of cellular mTORC1 
signaling and activation of autophagy were both detected after 4 h at VacA 
concentrations as low as 35 nM (Fig. 2.5A), and, as soon as 1 h after exposure 
of cells to VacA at 250 nM (Fig. 2.5B).  
 Cellular autophagy can be induced by mTORC1-dependent and -independent 
mechanisms (Sarkar, 2013). To evaluate whether VacA-dependent mTORC1 
inhibition is causally linked to autophagy, I examined VacA intoxication of cells 
expressing a constitutively active form of mTORC1. HEK293T cells were 
transfected with a plasmid harboring the gene encoding an altered form of 
mTORC1, which in the literature has been referred to as “hyperactive mTOR” 
(mTOR SL1+IT) (Ohne et al., 2008). mTOR SL1+IT possesses mutations that 
confer sustained mTORC1 activity, even under conditions of nutrient deprivation 
that normally result in the inhibition of mTORC1. If VacA-dependent autophagy 
induction occurs via an mTORC1-dependent mechanism, I would predict at least 
a partial reduction in autophagy within VacA intoxicated cells expressing 
hyperactive mTOR. To test this prediction, HEK293T cells overexpressing either 
wildtype mTOR or mTOR SL1+IT were incubated for 4 h in the absence or 
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presence of purified VacA (250 nM). Immunoblot analyses confirmed the 
expression of FLAG-mTOR SL+IT or wildtype FLAG-mTOR (Fig. 2.7). These 
studies revealed that, in VacA intoxicated cells overexpressing FLAG-mTOR 
SL+IT, there was both an increase in cellular mTORC1 signaling activity, and, a 
reduction in cellular autophagy, relative to cells overexpressing wildtype FLAG-
mTOR (Fig. 2.7). These results are consistent with a model that cellular 
autophagy within VacA intoxicated cells is induced by an mTORC1-dependent 
mechanism. 
VacA inhibition of mTORC1 activates Ulk1, a positive regulator of 
autophagy 
 To further investigate the mechanistic link between VacA-dependent inhibition 
of cellular mTORC1 activity and increases in cellular autophagy, I evaluated the 
potential involvement of the Unc-51 like autophagy activating kinase 1 (Ulk1) 
complex in mediating mTORC1-dependent regulation of autophagy induction in 
VacA intoxicated cells. When activated, the Ulk1 complex positively regulates 
VPS34 lipid kinase-dependent autophagosome biogenesis (Russell et al., 2013). 
In the absence of cellular metabolic stress, mTORC1 negatively regulates the 
Ulk1 complex through phosphorylation of serine 757 (p-Ulk1 (S757)), resulting in 
suppression of Ulk1 complex activation and autophagy induction (Kim et al., 
2011). Conversely, during cellular stress, inhibition of cellular mTORC1 signaling 
results in the reduction of cellular p-Ulk1 (S757), thereby activating the Ulk1 
protein kinase complex to promote autophagosome biogenesis. Within HEK293T 
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cells, our studies revealed a significant VacA-dependent reduction in cellular p-
Ulk1 (S757) levels (Fig. 2.8A). Additional studies revealed that cellular levels of 
p-Ulk1 (S757) were significantly lower in HEK293T cells infected at MOI of 100 
with either wildtype Hp 60190 or Hp (ΔvacA::vacA), than with Hp (ΔvacA) (Fig. 
2.6B), supporting the importance of VacA during Hp infection for the activation of 
the Ulk1 protein kinase complex. These results are consistent with a model that 
mTORC1-dependent regulation of autophagy induction within VacA intoxicated 
cells is mediated through activation of the Ulk1 protein kinase complex. 
VacA-dependent increases in cellular LC3-II levels require Ulk1 protein 
kinase activity 
 To evaluate a direct role for the Ulk1 protein kinase complex in VacA-
dependent autophagy activation, I examined the effects of inhibiting Ulk1 kinase 
activity on cellular LC3-II levels. HEK293T cells were pre-incubated at 37 °C with 
an Ulk1 inhibitor SBI-0206965 (50 μM) (Egan et al., 2015). After 30 min, the cells 
were further incubated for 4 h in the presence of purified VacA (250 nM). These 
experiments revealed significantly less LC3-II in the presence than absence of 
SBI-0206965 (Fig. 2.8B), indicating that induction of VacA-dependent autophagy 
requires Ulk1 protein kinase activity. Because Ulk1 protein kinase activity is 
directly regulated by mTORC1 signaling, these results further support a model 




mTORC1 dissociates from lysosomal membranes in a VacA-dependent 
manner 
 Our studies thus far have not addressed the mechanism by which VacA 
intoxication ultimately inhibits cellular mTORC1 signaling. Because VacA induces 
mitochondrial dysfunction, I considered the possibility that nutrient stress might 
contribute to the reduction in mTORC1 signaling activity. Under nutrient-rich 
conditions, mTORC1 signaling is activated through direct interactions with a 
lysosomal membrane protein complex called the Ragulator-Rag docking platform 
(Sancak et al., 2010). The mTORC1 docking to Ragulator-Rag stabilizes 
interaction of mTORC1 with the lysosomal membrane protein called “Ras 
homolog enriched in brain” (Rheb), which functions as a direct activator of 
mTORC1 signaling (Laplante and Sabatini, 2009, Sancak et al., 2010). 
Conversely, under conditions of nutrient stress, mTORC1 dissociates from the 
lysosomal Ragulator-Rag docking platform into the cytosol as an inactive 
complex, thereby resulting in a loss of mTORC1-mediated signaling (Sancak et 
al., 2010). To evaluate the possibility that the VacA-dependent reduction in 
cellular mTORC1 activity might involve the dissociation of mTORC1 from 
lysosomal compartments, I investigated whether mTORC1 localization is altered 
within VacA intoxicated cells. Fluorescence microscopy revealed reduced 
mTORC1 localization to lysosomal compartments in cells exposed to VacA, 
compared to cells not exposed to toxin (Fig. 2.9A). Additional studies revealed 
less mTORC1 localization to lysosomal compartments in HEK293T cells infected 
at MOI of 100 with either wildtype Hp 60190 or Hp (ΔvacA::vacA) than with Hp 
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(ΔvacA) (Fig. 2.10). Together, these results support a model that VacA-
dependent inhibition of cellular mTORC1 signaling activity might result from 
inactivation of mTORC1 upon dissociation from lysosomal compartments. 
VacA-dependent mTORC1 dissociation from lysosomal-enriched 
compartments is causal for toxin-dependent reduction in cellular mTORC1 
activity 
 To evaluate whether lysosomal dissociation of mTORC1 is required for VacA-
dependent inhibition of cellular mTORC1, I investigated VacA-dependent 
changes in cellular mTORC1 signaling under conditions where a portion of 
cellular mTORC1 was prevented from dissociating from the surface of lysosomal 
compartments. For these studies, I employed cells overexpressing a chimeric 
protein called Raptor-Rheb15, consisting of Raptor, a component of mTORC1 
that mediates interactions between mTORC1 and the lysosomal Ragulator-Rag 
docking platform (Laplante and Sabatini, 2009), and, the carboxyl-terminal 15 
residues of Rheb comprising the lysosomal targeting motif (Sancak et al., 2010). 
In cells expressing Raptor-Rheb15, mTORC1 is effectively tethered to lysosomal 
membranes in a manner that mTORC1 dissociation cannot occur, even under 
conditions of nutrient stress, thereby resulting in sustained mTORC1 cellular 
signaling. Studies conducted with VacA-intoxicated HEK293T monolayers 
yielded higher levels of p-S6K (T389) within cells overexpressing the Raptor-
Rheb15 chimera than in cells expressing wild type Raptor (Fig. 2.9B). These 
results are consistent with a mechanism of VacA-dependent mTORC1 inhibition 
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requiring mTORC1 dissociation from lysosomal compartments. These results 
also suggest that nutrient stress within VacA intoxicated cells might underlie 
toxin-dependent reduction in mTORC1 signaling activity. 
Inhibition of de novo protein synthesis prevents VacA-dependent inhibition 
of cellular mTORC1 activity 
 Amino acid starvation is a form of nutrient stress that can promote mTORC1 
dissociation from lysosomes (Zoncu et al., 2011). To evaluate the possibility that 
VacA-dependent inhibition of cellular mTORC1 signaling activity might result 
from depletion of available amino acid pools, I examined whether inhibition of 
cellular protein synthesis, which has been employed as a strategy to limit 
deficiencies in cellular amino acid levels (Zoncu et al., 2011), might mitigate 
VacA-dependent inhibition of cellular mTORC1 activity. HEK293T cells were 
incubated at 37 °C in the absence or presence of VacA (250 nM) for 3.5 h, and 
then further incubated for 30 min at 37 °C in the absence or presence of the 
protein synthesis inhibitor cycloheximide (10 μM). In monolayers exposed to 
VacA, these studies revealed higher levels of cellular p-S6K (T389) in the 
presence than absence of cycloheximide (Fig. 2.11A). These results suggest that 
disruption of amino acid homeostasis within VacA intoxicated cells might be 




VacA intoxication leads to depletion of cellular amino acid pools 
 To more directly evaluate the possibility that VacA intoxication might result in 
disruption of cellular amino acid homeostasis, I monitored the phosphorylation 
state of the general control nonderepressible 2 (GCN2) protein, a 
serine/threonine kinase that senses cellular amino acid deficiencies (Dever and 
Hinnebusch, 2005). Specifically, I examined the autophosphorylation state at Thr 
898 of GCN2 (p-GCN2 (T898)), which increases as available pools of amino 
acids are depleted (Dever and Hinnebusch, 2005). These studies revealed a 
VacA-dependent elevation in cellular levels of p-GCN2 (T898) (Fig. 2.11B), 
indicating that intracellular levels of amino acids had been depleted. In support of 
this conclusion, the elevation of cellular p-GCN2 (T898) was not detected in cells 
exposed to both VacA and the protein synthesis inhibitor cycloheximide (Fig. 
2.11B). Additional studies revealed that cellular levels of p-GCN2 (T898) were 
significantly higher in HEK293T cells infected at MOI of 100 with either wildtype 
Hp 60190 or Hp (ΔvacA::vacA), than with Hp (ΔvacA) (Fig. 2.12A). Finally, I 
observed VacA-dependent increases in p-GCN2 (T898) within an ex vivo gastric 
tissue slice model derived from the stomachs of C57BL/6J mice (Fig. 2.12B). 
These results are all consistent with the model that intracellular levels of amino 
acids are depleted in a VacA-dependent manner. Indeed, the levels of 
intracellular amino acids were experimentally determined to be significantly lower 
in HEK293T cells that had been incubated in the presence than absence of VacA 
(Fig. 2.12C). Together, these results further supported the idea that disruption of 
intracellular amino acid homeostasis is a consequence of VacA cellular 
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intoxication that may contribute to toxin-dependent inhibition of mTORC1 
signaling activity and autophagy activation. 
Blocking mTORC1 sensing of VacA-dependent disruption of amino acid 
homeostasis impedes inhibition of cellular mTORC1 activity 
 Amino acids play an important role in regulating mTORC1 signaling by 
promoting the lysosomal localization and activation of mTORC1 (Zoncu et al., 
2011). Leucine is of particular importance because Sestrin2, an intracellular 
leucine sensor, positively regulates the capacity of the lysosomal Ragulator-Rag 
complex to serve as a docking platform and activate mTORC1 (Wolfson et al., 
2016). To more directly evaluate a potential association between a shortage of 
intracellular amino acids and VacA-dependent inhibition of mTORC1 cellular 
signaling, I examined whether VacA-dependent inhibition of cellular mTORC1 
signaling activity could be alleviated in the presence of L-leucyl-L-leucine methyl 
ester (LLOMe), a membrane permeable derivative of leucine that can rapidly 
enter cells in a manner not requiring a transporter-mediated uptake mechanism 
(Manifava et al., 2016). LLOMe has been previously used to rescue mTORC1 
activity under conditions of amino acid starvation (Manifava et al., 2016). Our 
studies revealed that cellular p-S6K (T389) levels were greater in the presence 
than absence of LLOMe (Fig. 2.11C) within VacA intoxicated HEK293T cells, 
providing additional support for a model that VacA-mediated inhibition of cellular 
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mTORC1 signaling activity is a consequence of intracellular amino acid 
depletion. 
VacA disruption of host mitochondrial dynamics is associated with the 
inhibition of cellular mTORC1 activity and autophagy activation 
 To evaluate the causal relationships between VacA-mediated mitochondrial 
perturbations, inhibition of cellular mTORC1 signaling activity, and, autophagy 
activation, HEK293T cells were pre-incubated in the absence or presence of 
mdivi-1 (200 μM), a mitochondrial fission inhibitor that was previously reported to 
block VacA-dependent fragmentation of mitochondria (Jain et al., 2011). These 
studies revealed that in the presence of mdivi-1, VacA-dependent inhibition of 
cellular mTORC1 signaling activity, as well as autophagy activation, was 
effectively blocked (Fig. 2.13A). Moreover, mdivi-1 inhibited VacA-dependent 
phosphorylation of Thr 898 of GCN2 that normally accompanies amino acid 
depletion (Fig. 2.13B). These data suggest that VacA perturbations in 
mitochondrial structure disrupt cellular amino acid homeostasis, which is sensed 
by mTORC1, and, ultimately results in autophagy activation.  
The mitochondrial-targeting, amino-terminal p34 fragment of VacA is 
sufficient for inhibition of cellular mTORC1 activity 
 To further characterize VacA-dependent inhibition of cellular mTORC1 
signaling activity, I ectopically expressed, within the cytosol of HEK293T cells, an 
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amino-terminal fragment of VacA (p34) that, despite lacking the carboxyl-terminal 
domain (p55) required for the cell-surface binding and uptake of full-length VacA, 
is sufficient to target mitochondria and induce mitochondrial dysfunction 
(Galmiche et al., 2000). In our studies, a significant depletion of cellular p-S6K 
(T389) was detected in transiently transfected HEK293T cells ectopically 
expressing p34 (Fig. 2.14A). The sufficiency of the mitochondrial-targeting p34 
fragment of VacA for modulating mTORC1 signaling activity strongly supports the 
importance of VacA-mediated mitochondrial dysfunction for inhibition of cellular 
mTORC1 signaling activity.  
 The cytosol of cells intoxicated with VacA are often vacuolated (Cover and 
Blaser, 1992), but the functional relationship between vacuole biogenesis and 
VacA-dependent mitochondrial dysfunction is poorly understood. In our studies, 
cellular vacuolation was not detected in transiently transfected HEK293T cells 
ectopically expressing p34 (Fig. 2.14B), as previously reported (Ye et al., 1999). 
These results suggest that cellular vacuolation is not causally linked to VacA-
dependent inhibition of mTORC1. In further support of this model, inhibition of the 
vacuolar ATPase with bafilomycin A1 fully blocked vacuolation in HEK293T cells 
intoxicated with full length VacA (Fig. 2.14C), as previously reported (Papini et 
al., 1993). In contrast, bafilomycin A1 did not detectably affect VacA-dependent 
inhibition of cellular mTORC1 signaling activity, or, activation of the Ulk1 protein 






 There is increasing evidence that host metabolism is frequently targeted by 
microbes for modulation (Eisenreich et al., 2013). VacA is an intracellular-acting 
bacterial exotoxin produced by Hp that, subsequent to uptake into gastric cells, 
alters mitochondrial function (Kimura et al., 1999) and dynamics (Jain et al., 
2011). Given the importance of mitochondria for energy production, I predicted 
that, during Hp infection, biosynthetic metabolism within host cells might be 
altered through the action of VacA. Here, our studies revealed that VacA is both 
necessary and sufficient for Hp-mediated inhibition of mTORC1 regulatory 
signaling. (Fig. 2.13C). mTORC1 is an energy and nutrient sensor that integrates 
both intracellular and extracellular signals. Nutritional or energy stress negatively 
regulates mTORC1 (Dibble and Manning, 2013), resulting in a global cellular shift 
to catabolic processes, such as autophagy, which contribute to re-establishing 
metabolic balance (Kroemer et al., 2010). Indeed, our data indicate that VacA-
dependent reduction in cellular amino acid levels leads to the activation of 
cellular autophagy through the inhibition of cellular mTORC1 signaling. 
 Several previous studies reported Hp-mediated changes within infected cells 
that involve mTORC1-mediated signaling. Hp-mediated activation of 
hemeoxygenase-1 (HO-1), an inflammatory regulator of adaptive immune 
responses, requires mTORC1 positive regulation (Ko et al., 2016). mTORC1 
signaling also mediates hypoxia inducible factor-1a (HIF-1a) driven G0/G1 cell 
cycle arrest during Hp infection (Canales et al., 2017). Most recently, Hp strains 
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lacking active VacA were demonstrated to negatively regulate autophagy through 
c-Met-PI3K/Akt-mTOR, by a mechanism involving the Hp type IV secretion 
effector, cytotoxin-associated gene A (CagA) (Li et al., 2017). In these same 
studies, infection with Hp strains expressing active VacA, but lacking active 
CagA, was reported to upregulate cellular autophagy (Li et al., 2017). These 
results imply that VacA and CagA affect host cell mTOR signaling in distinct 
ways and, as previously suggested, these two virulence factors may function 
antagonistically during Hp infection (Oldani et al., 2009, Yokoyama et al., 2005). I 
did not investigate potential antagonistic interactions between CagA and VacA in 
these studies, but our results here extend earlier work by demonstrating that 
VacA, both alone and in the context of Hp infection, is both necessary and 
sufficient to modulate mTORC1 signaling leading to autophagy activation. 
 Our studies revealed that inhibition of cellular mTORC1 is associated with 
VacA-dependent amino acid starvation. Amino acid homeostasis in cells is tightly 
controlled through the balance of amino acid synthesis, uptake, and utilization. 
While the exact mechanism underlying disruption of cellular amino acid 
homeostasis within VacA intoxicated cells is currently unknown, several cell 
surface pore-forming toxins including Streptoccocal α-toxin, Streptolysin O, and, 
Vibrio cholerae cytolysin are thought to induce amino acid starvation in host cells 
(Kloft et al., 2010) by disrupting the electrochemical ion gradients across the 
plasma membrane required for amino acid transport uptake systems (Hyde et al., 
2003). In the case of Hp, I speculate that VacA-dependent perturbations in 
mitochondrial structure may be important, as inhibition of toxin mediated 
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mitochondrial fragmentation prevented amino acid depletion (Fig. 2.13B), as well 
as mTORC1 inhibition and autophagy activation (Fig. 2.13A). Although a 
mechanistic association between mitochondrial dynamics and mTORC1 has not 
been explored in depth, it is noteworthy that a potential link was recently reported 
between mitochondrial fission and mTORC1-mediated regulation of autophagy in 
cells exposed to ionizing radiation-induced stress (Wu et al., 2017). 
 Evidence is emerging that mTORC1 functions as a center of host cell signaling 
during bacterial infections (Mohr and Sonenberg, 2012, Jaramillo et al., 2011, Lu 
et al., 2015, Tattoli et al., 2012). For example, within a Drosophila infection 
model, the intracellular action of monalysin, a pore-forming toxin of 
Pseudomonas entomophila, impairs mTOR-dependent host innate immune 
responses and repair programs (Chakrabarti et al., 2012). A second example is 
the enhancement of mTORC1 signaling activity by the Shigella type-III effector 
OspB in a manner that depends on IQGAP1, thereby promoting proliferation of 
host cells as a replicative niche during intracellular infection (Lu et al., 2015). As 
a third example, during Legionella pneumophila infection, two distinct families of 
the bacterial effectors can positively or negatively impact mTORC1 signaling 
activity within host cells as a means of regulating the availability of amino acid 
pools for the auxotrophic intracellular bacterium (De Leon et al., 2017). As these 
examples illustrate, mTORC1, as a central sensor and regulator of host cell 
nutrient availability, would be expected to be an attractive target of pathogens 
attempting to establish an intracellular niche.  
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 In addition, because of the importance of mTORC1 in regulating protein 
translation, microbial modulation of mTORC1 activity might also be expected to 
affect the capacity of host cells to synthesize the components necessary to 
mount an effective antimicrobial response. Indeed, I speculate that VacA-
dependent inhibition of mTORC1 signaling downregulates biosynthetic 
metabolism in a manner that might impede the production of immune effectors at 
the gastric barrier required to clear Hp infection. Although this idea remains to 
evaluated experimentally, the results described here provide the framework for 
ongoing studies to understand how mitochondrial alterations induced by VacA 















Figure 2.1. H. pylori (Hp) inhibits cellular mTORC1 signaling activity in a 
VacA dependent manner. HEK293T cells were infected (MOI of 100) at 37 °C 
for 4 h in the absence or presence of Hp 26695 strain (A), Hp 60190 (A, D), Hp 
(ΔvacA) (D), or Hp (ΔvacA::vacA) (D). Alternatively, HEK293T cells were 
incubated at 37 °C with HPCF prepared from Hp 60190 (B, C), Hp (ΔvacA) (C), 
or Hp (ΔvacA::vacA) (C). After 4 h, the monolayers were lysed and evaluated by 
immunoblot analyses for total p70 S6K (total S6K) (A - D), p70 S6K 
phosphorylated at Thr 389 (p-S6K) (A - D), total Akt (B), Akt phosphorylated at 
Ser 473 (p-Akt) (B), or, β-actin (A - D). The absence or presence of VacA was 
confirmed by immunoblot analyses using rabbit VacA antiserum (A, C, D). 
Immunoblots representative of those collected from 3 independent experiments 
are shown. For quantification purposes, longer development times for each blot 
revealed the presence of visible bands in each lane corresponding to p-S6K, 
which were quantified by densitometry. The data were combined from the 3 
independent experiments (represented as mean ± SD). Statistical significance (α 
= 0.05) was calculated using the two-tailed Student’s t test (B), or, one-way 




Figure 2.2. VacA is required for H. pylori (Hp) inhibition of cellular mTORC1 
signaling activity. (A, B) HEK293T cells were incubated at 37 °C in the absence 
or presence of Hp culture filtrate (HPCF; 150 μg/mL) prepared from Hp 60190, 
that had been pre-incubated in the absence or presence of heat (100 °C, 10 min) 
(A), or, at 4 °C for 1 h with beads pre-coated with VacA antibodies (αVacA) or 
unrelated antibodies raised against the Campylobacter jejuni cytolethal 
distending toxin subunit A (αCdtA) (B). (C) HEK293T cells were infected (MOI of 
100) at 37 °C with Hp 26695 (s1m1 vacA), Hp J198 (s1m2 vacA), or Hp Tx30a 
(s2m2 vacA). (A - C) After 4 h, the monolayers were lysed and evaluated using 
immunoblot analyses for total p70 S6K (total S6K), p70 S6K phosphorylated at 
Thr 389 (p-S6K), or, β-actin. The absence or presence of VacA was confirmed by 
immunoblot analyses using rabbit VacA antiserum (B, C). Immunoblots 
representative of those collected from 3 independent experiments are shown. 
The data were quantified by combining the densitometric analyses of the 
immune-specific bands from the 3 independent experiments (represented as 
mean ± SD). The results were rendered as bar graphs, with the height of the bars 
representing the relative mTORC1 activity (determined by dividing the intensities 
of immune-specific bands corresponding to p-S6K by the intensities of immune-
specific bands corresponding to total S6K) within the cells incubated in the  
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Figure 2.2. (cont.) 
presence (filled bars), or, absence of Hp or HPCF (empty bars), which were 
normalized to 1.0. Statistical significance (α = 0.05) was calculated using the two-
tailed Student’s t test (A) or one-way ANOVA (corrected using the Tukey’s test) 




























Figure 2.3. VacA is sufficient to mediate the inhibition of cellular mTORC1 
activity. (A) SDS-PAGE analysis of VacA purified from culture filtrates of H. 
pylori 60190, as visualized after Coomassie Brilliant Blue staining. (B, C) 
HEK293T cells were incubated at 37 °C in the absence or presence of VacA that 
had been pre-incubated in the absence or presence of beads pre-coated with 
VacA antibodies (αVacA), or unrelated Cj-CdtA antibodies (αCdtA). After 4 h, the 
cells were lysed and evaluated by immunoblot analyses for total p70 S6K (total 
S6K), p70 S6K phosphorylated at Thr 389 (p-S6K), or, β-actin. The absence or 
presence of VacA after antibody pre-incubation was confirmed by immunoblot 
analyses using rabbit VacA antiserum. Immunoblots representative of those 
collected from 3 independent experiments are shown. The data were quantified 
by combining the densitometric analyses of the immune-specific bands from the 
3 independent experiments (represented as mean ± SD). The results were 
rendered as bar graphs, with the height of the bars representing the relative 
mTORC1 activity (determined by dividing the intensities of immune-specific 
bands corresponding to p-S6K by the intensities of immune-specific bands 
corresponding to total S6K) within the cells incubated in the presence (filled 
bars), or, absence of purified VacA (empty bar), which was normalized to 1.0. 
Statistical significance (α = 0.05) was calculated for the differences in the 
mTORC1 activity among cells incubated in presence of the purified VacA 
fraction, using one-way ANOVA (corrected using the Tukey’s test). P < 0.05 









Figure 2.4. VacA is sufficient to modulate cellular mTORC1 signaling and 
autophagic activities. HEK293T, AGS, NCI-N87, AZ-521 (A), or, primary gastric 
epithelial cells (B, D) and gastric tissue slices (C, E) isolated from C57BL/6J mice 
were incubated for 4 h with VacA (250 nM), or, rapamycin (1 μM) (C, E), followed 
by immunoblot analyses for total S6K (A, B), p-S6K (Thr 389) (A, B), LC3-II (D), 
or, β-actin (A, B, D). The tissue slices were fixed and evaluated by fluorescence 
microscopy analyses for relative p-S6K (C) or the presence of LC3-enriched 
puncta (E). Immunoblots representative of those collected from 3 independent 
experiments are shown in A. For each cell line, the data were combined from the 
3 independent experiments (represented as mean ± SD). Statistical significance 
(α = 0.05) in A was calculated using the two-tailed Student’s t test. Immunoblots 
shown in B and D were generated using primary cells collected on 3 separate 
days from 3 different mice differing in age and gender as indicated. Fluorescence 
images shown in C and E are representative of those using tissue collected from 





Figure 2.5. VacA dependent inhibition of cellular mTORC1 activity, and, 
autophagy activation as a function of toxin concentration and time. 
HEK293T cells were incubated at 37 °C in the absence or presence of purified 
VacA (10, 35, 100, 250, or 500 nM (A), or, 250 nM (B)). After 4 h (A), or, 0 (no 
VacA), 1, 2, 4, 8, 12 h (B), the cells were lysed and evaluated by immunoblot 
analyses for total p70 S6K (total S6K), p70 S6K phosphorylated at Thr 389 (p-
S6K), LC3-II, or, β-actin. Immunoblots representative of those collected from 3 














Figure 2.6. VacA is important for H. pylori (Hp)-mediated autophagy 
activation and activation of the Ulk1 protein kinase complex. HEK293T cells 
were infected (MOI of 100) at 37 °C with Hp 60190 (Hp (wildtype)), Hp (ΔvacA) 
(a strain that is isogenic to Hp 60190 except for deletion of vacA), or, Hp 
(ΔvacA::vacA) (the complemented strain in which vacA was reintroduced into Hp 
(ΔvacA). After 4 h, the monolayers were lysed and evaluated by immunoblot 
analyses for total LC3-II (A), Ulk1 (B), Ulk1 phosphorylated at Ser 757 (p-Ulk1) 
(B), or, β-actin (A, B). The absence or presence of VacA was confirmed by 
immunoblot analyses using rabbit VacA antiserum. Immunoblots representative 
of those collected from 3 independent experiments are shown. The data were 
quantified by combining the densitometric analyses of the immune-specific bands 
from the 3 independent experiments (represented as mean ± SD). The results 
were rendered as bar graphs, with the height of the bars representing the relative 
autophagic activity (A) or relative mTORC1 activity corresponding to p-Ulk1 (B). 
For quantification purposes, longer development times for each blot revealed the 
presence of visible bands in each lane corresponding to LC3-II (A), which were 
quantified by densitometry. The data were combined from the 3 independent 
experiments (represented as mean ± SD). Statistical significance (α = 0.05) was 
calculated using one-way ANOVA (corrected using the Tukey’s test). P < 0.05 









Figure 2.7. VacA-dependent inhibition of cellular mTORC1 signaling activity 
is causally linked to autophagy induction. Transiently transfected HEK293T 
cells overexpressing Flag-mTOR, Flag-mTOR SL1+IT, or, the vector only, were 
incubated at 37 ° C for 4 h with VacA (250 nM), followed by immunoblot analyses 
for total S6K, p-S6K (Thr 389), LC3-II, β-actin, or, the Flag-tagged mTOR 
constructs. The data were combined from 3 independent experiments 
(represented as mean ± SD). Statistical significance (α = 0.05) was calculated 


















Figure 2.8. VacA inhibition of cellular mTORC1 signaling activity is 
associated with decreased Ulk1-mediated repression of autophagosome 
biogenesis. HEK293T cells were pre-incubated at 37 °C for 30 min without (A) 
or with (A, B) SBI-0206965 (50 μM), and then incubated for 4 h with VacA (250 
nM), and then analyzed for total Ulk1 (A), p-Ulk1 (S757) (A), LC3-II (B), or, β-
actin (A, B). Data were combined from 3 independent experiments (represented 
as mean ± SD). Statistical significance (α = 0.05) was calculated using the two-











Figure 2.9. VacA-dependent mTORC1 dissociation from lysosomal-
enriched compartments is causal for toxin-dependent reduction in cellular 
mTORC1 activity. (A) Monolayers of HEK293T cells were incubated at 37 °C for 
4 h with VacA (250 nM), or, for 1 h in amino acid depleted medium before 
imaging with confocal fluorescence microscopy. Red puncta indicate mTORC1; 
green puncta indicate LAMP1; yellow puncta indicate mTORC1 co-localized with 
LAMP1; blue staining indicates nuclei; white bars indicate 10 μm. The white 
dashed boxes were digitally enlarged and shown in the other quadrants. The 
relative pixel signals for mTORC1 and LAMP1 (normalized to maximum pixel 
intensity) along the white dashed arrows (bottom right quadrants) were rendered 
as intensity profile graphs. The degree of overlay for the two-dimensional pixel 
intensity plots corresponds to the relative level of co-localization of mTORC1 with 
LAMP1. (B) Stably transfected HEK293T cells overexpressing Flag-Raptor, or, 
Flag-Raptor-Rheb15 were incubated at 37 ° for 4 h without or with VacA (250 
nM), or, for 1 h in amino acid depleted medium. After incubation, the cells were 
evaluated by immunoblot analyses for total S6K, p-S6K, and, β-actin. Data were  
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Figure 2.9. (cont.) 
combined from the 3 independent experiments (represented as mean ± SD). 






















Figure 2.10. H. pylori (Hp) induces mTORC1 dissociation from lysosomal 
compartments in a VacA dependent manner. Monolayers of HEK293T cells 
were infected (MOI of 100) at 37 °C with Hp 60190 (Hp (wildtype)), Hp (ΔvacA) 
(a strain that is isogenic to Hp 60190 except for deletion of vacA), or, Hp 
(ΔvacA::vacA) (the complemented strain in which vacA was reintroduced into Hp 
(ΔvacA)). After 4 h, the cells were fixed and evaluated by confocal fluorescence 
microscopy imaging. Cell images representative of those collected from 3 
independent experiments are shown. As labeled, red puncta or red signal 
indicate mTORC1; green puncta indicate LAMP1; yellow puncta indicate 
mTORC1 colocalized with LAMP1; blue staining indicates the nucleus; white bars 
indicate 10 μm. For each condition, the area within the white dashed box was 
digitally enlarged and shown in the upper right (mTORC1), bottom left (LAMP1), 
and bottom right (merged; both mTORC1 and LAMP1) quadrants. The relative 
pixel signals for mTORC1 and LAMP1 (normalized to maximum pixel intensity) 
along the white dashed arrows (bottom right quadrants) were rendered as 
intensity profile graphs. The degree of overlay for the two-dimensional pixel 





Figure 2.11. Cellular amino acid deficiency is detected within VacA 
intoxicated cells, which is causally associated with the inhibition of cellular 
mTORC1 activity. HEK293T cells were incubated for 3.5 h in the absence or 
presence of purified VacA (250 nM), or, for 30 min in amino acid depleted 
medium, and then for 30 min in the absence or presence of cycloheximide (10 
μM) (A, B), or LLOMe (0.5 mM) (C). The cells were evaluated for total S6K (A, 
C), p-S6K (A,C), total GCN2 (B), p-GCN2 (B), or, β-actin (A - C). Statistical 
significance (α = 0.05) was calculated using the two-tailed Student’s t test for 





Figure 2.12. VacA-dependent depletion of cellular amino acids. (A) 
Monolayers of HEK293T cells were infected (MOI of 100) at 37 °C with Hp 60190 
(Hp (wildtype)), Hp (ΔvacA) (a strain that is isogenic to Hp 60190 except for 
deletion of vacA), or, Hp (ΔvacA::vacA) (the complemented strain in which vacA 
was reintroduced into Hp (ΔvacA)). After 4 h, the monolayers were lysed and 
evaluated by immunoblot analyses for total GCN2, GCN2 phosphorylated at Thr 
898 (p-GCN2), or, β-actin. The absence or presence of VacA was confirmed by 
immunoblot analyses using rabbit VacA antiserum. Immunoblots representative 
of those collected from 3 independent experiments are shown. The data were 
quantified by combining the densitometric analyses of the immune-specific bands 
from the 3 independent experiments (represented as mean ± SD). Statistical 
significance (α = 0.05) was calculated using one-way ANOVA (corrected using 
the Tukey’s test). (B) Gastric tissue slices isolated from C57BL/6J mice were 
incubated at 37 °C for 4 h in the absence or presence of VacA (250 nM), or, in 
amino acid depleted medium (amino acid deprivation). After incubation, the 
tissue slices were fixed and evaluated by fluorescence microcopy for relative 
green fluorescence, which corresponded to p-GCN2. Fluorescence images 
shown are representative of those using tissue collected from stomachs of 3 
different mice. Green signals indicate p-GCN2, blue signals indicate nuclei, and 
red signals indicate cellular membranes. White bars indicate 200 μm. (C) 
HEK293T cells were incubated at 37 °C in the absence or presence of VacA (250 
nM). After 4 h, the cells were lysed, and cellular levels of 18 of the 20 amino 
acids were quantified using GC-MS analysis. Arg and Cys were not quantified \ 
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Figure 2.12. (cont.) 
because preparation of the samples for analysis converts arginine to citrulline, 
and cysteine to cystine. The levels of each amino acid within cells exposed to 
VacA were compared to the levels or each amino acid within cells incubated in 
the absence of VacA, which for each amino acid, was normalized to 1.0. The 
data were combined from the 3 independent experiments (represented as mean 
± SD). Statistical significance (α = 0.05) was calculated for the difference in 
relative level of individual amino acid levels between cells incubated in the 
absence (white bars) or presence (filled bars) of VacA, using the two-tailed 









Figure 2.13. VacA disruption of host mitochondrial dynamics is associated 
with the inhibition of cellular mTORC1 activity and autophagy activation. 
(A, B) HEK293T cells were pre-incubated at 37 °C with mdivi-1 (200 μM), and 
then further incubated with 37 °C with purified VacA (250 nM) in 3 independent 
experiments (represented as mean ± SD). After 4 h, the cells were evaluated for 
total S6K (A), p-S6K (A), total GCN2 (B), p-GCN2 (B), LC3-II (A) or, β-actin (A, 
B). Statistical significance (α = 0.05) was calculated using the two-tailed 
Student’s t test. (C) Proposed model for the mechanism of VacA-dependent 
inhibition of cellular mTORC1 signaling and autophagy induction. 
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Figure 2.14. Cellular mTORC1 signaling activity is inhibited in cells 
ectopically expressing the amino terminal p34 fragment of VacA, in a 
manner independent of toxin-mediated cellular vacuolation. (A) HEK293T 
cells were transiently co-transfected with expression plasmids harboring either 
the gene encoding the amino-terminal fragment of VacA fused to GFP (p34-
GFP), the gene encoding GFP alone (GFP), or, no genes (empty vector), along 
with (or without) an expression plasmid harboring the gene encoding S6K1 fused 
at the amino terminus with the Myc epitope tag (Myc-S6K). After 24 h, the cells  
were lysed and evaluated by immunoblot analyses for p70 S6K phosphorylated 
at Thr 389 (p-S6K), Myc, GFP, or, β-actin. Immune-specific signals 
corresponding to p-Myc-S6K (distinguishable from endogenous p-S6K by size), 
or, Myc were quantified by densitometry and rendered as bar graphs 
(represented as mean ± SD). Data were combined from the 3 independent 
experiments. Statistical significance (α = 0.05) was calculated for the differences 
measured in cellular p-Myc-S6K levels between cells overexpressing Myc-S6K 
(filled bars), using  the two-tailed Student’s t test. P < 0.05 indicates statistical 
significance. (B) HEK293T cells were transiently transfected with an expression 
plasmid harboring the gene encoding p34-GFP. After 24, the cells (in the 
presence of 5 mM ammonium chloride, which is used to swell vacuoles for ease 
of viewing) (top image) were visually inspected using phase 
contrast/fluorescence microscopy (white bars indicate 20 μm), for the presence 
of intracellular vacuoles, alongside non-transfected cells that had been incubated  
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Figure 2.14. (cont.) 
for 4 h at 37 °C in the presence of purified full length VacA (250 nM; also, with 
ammonium chloride) (bottom image). (C) HEK293T cells were incubated in the 
absence or presence of the vacuolar ATPase inhibitor bafilomycin A1 (Baf A1, 10 
nM). After 30 min, the monolayers were further incubated in the absence or 
presence of VacA (250 nM) and ammonium chloride (5 mM). After 4 h, the cells 
were evaluated by visual inspection, using phase contrast microscopy, for the 
presence of intracellular vacuoles. White bars indicate 20 μm. (D) HEK293T cells 
were incubated in the absence or presence of bafilomycin A1 (Baf A1, 10 nM). 
After 30 min, the monolayers were further incubated in the absence or presence 
of VacA (250 nM) and ammonium chloride (5 mM). After 4 h, the cells were 
lysed, and the lysates analyzed for relative levels of total p70 S6K (total S6K), 
p70 S6K phosphorylated at Thr 389 (p-S6K), total Ulk1, Ulk1 phosphorylated at 
Ser 757 (p-Ulk1) or, β-actin. Immunoblots representative of those collected from 
3 independent experiments are shown. The data were quantified by combining 
the densitometric analyses of the immune-specific bands from the 3 independent 
experiments (represented as mean ± SD). The results were rendered as bar 
graphs, with the height of the bars representing the relative mTORC1 activity 
(determined by dividing the intensities of immune-specific bands corresponding 
to p-S6K by the intensities of immune-specific bands corresponding to total S6K) 
within the cells incubated in the presence (filled bars), or, absence of purified 
VacA (empty bar), which was normalized to 1.0. Statistical significance (α = 0.05) 
was calculated for the difference in relative mTORC1 activity between cells 
incubated with VacA in the absence or presence Baf A1 (middle and right filled 













CHAPTER 3: VacA-dependent Inhibition of Protein Translation during 
Helicobacter pylori Infection 
  
3.1. Introduction 
 Chronic infection with Helicobacter pylori (Hp) in the stomachs of humans is a 
risk factor for the development of gastric ulcer disease or cancer (Polk and Peek, 
2010). Subsequent to initial transmission, which often occurs during early 
childhood (Salama et al., 2013), Hp colonization of the gastric epithelium can 
persist over the entire life-time of an individual (Salama et al., 2013). Most 
infected individuals remain clinically asymptomatic and unaware of their Hp 
colonization status, in part, because gastric disease, if it occurs, generally 
emerges later in life. As a result, the natural history of chronic Hp infection in 
humans, including Hp-dependent alterations in gastric mucosa physiology and 
function, remains poorly understood. 
 During infection, Hp secrete the vacuolating cytotoxin A (VacA). 
Epidemiological studies in humans have revealed sequence diversity in the gene 
encoding VacA (vacA), which segregates into several allelic forms of the toxin 
that differ in cytotoxic activity towards cultured cells (Rudi et al., 1998). Strains of 
Hp harboring vacA encoding the more active forms of the toxin have been 
associated with increased risk for developing gastric disease (Rudi et al., 1998). 
Although these human studies suggest an important role for VacA in the 
development of Hp-mediated gastric disease, the exact contributions of VacA 
towards chronic Hp infection have not been experimentally revealed. 
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 Subsequent to Hp secretion, VacA modulates the properties of gastric 
epithelial cells in several ways, including the induction of mitochondrial 
dysfunction, resulting in the dissipation of the mitochondrial transmembrane 
potential (Kimura et al., 1999, Willhite and Blanke, 2004), reduction in the 
available cellular energy level (Kimura et al., 1999), and fragmentation of the 
organelle structure (Jain et al., 2011). Recent studies revealed that VacA-
dependent mitochondrial energy stress results in the inhibition of the mammalian 
target or rapamycin complex 1 (mTORC1) (Kim et al., 2018), a central sensor 
and regulator of cellular metabolism (Laplante and Sabatini, 2009), indicating that 
localized VacA-dependent alterations in mitochondrial function are sensed 
globally within intoxicated cells. However, the full extent to which acA-dependent 
metabolic dysfunction impacts Hp infection microenvironment is not completely 
understood.   
 Here, we report that VacA dependent mitochondrial dysfunction impedes 
overall protein synthesis within gastric epithelial cells and tissue during Hp 
infection. Our studies indicated that VacA-dependent inhibition of protein 
biosynthesis does not occur through modulation of upstream regulation of 
translation. Instead, the loss of energy production due to toxin mediated 
mitochondrial dysfunction, which triggers the depletion of amino acids. Using 
human gastric organoids, exposure to VacA alone was sufficient to result in 
significant reduction in gastric mucus, which requires nearly constant 
biosynthesis of mucins by mucus-producing neck cells located near the top of 
gastric pits. The findings here provide the framework to better understand how 
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cellular metabolism within the gastric mucosa is impacted by VacA-dependent 
mitochondrial dysfunction, which we speculate may impede gastric barrier 
function. 
 
3.2. Materials and Methods 
Visual measurement of HPG incorporation signals 
 Mammalian cells, that were seeded in 8-well chamber slides (Thermo Fisher 
Scientific), were incubated in the absence or presence of VacA (250 nM) for 30 
min, or in amino acid depleted medium (as defined under “Amino acid deprivation 
of mammalian cells”) for 1 h, at 37 °C with 5% CO2 in a humidified environment. 
After 30 min, the cells were further incubated in the presence of 50 uM HPG, and 
then were prepared for microscopy analysis. Briefly, the cells were fixed for 20 
min in PBS (pH 7.4) buffered 4% formaldehyde (Fisher Scientific), and the 
membrane permeability increased by incubating the monolayers in Saponin-
based permeabilization buffer (Invitrogen). After 15 min, the monolayers were 
incubated in the presence of HPG labeling mixture supplemented with 50 nM 
DAPI at room temperature in dark. After 30 min, the cells were briefly washed 
with PBS buffered 1% BSA (Sigma), and then mounted on slides, using a 
mounting reagent (Prolong Gold Antifade, Invitrogen), with a coverslip. The cells 
were observed using a LSM 700 laser scanning confocal microscope with a 63X 
objective (Apochromat, NA; 1.42, Carl Zeiss Microscopy), and, imaged using an 
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Axio Imager Z1digital microscope camera (512 x 512 pixels). The images were 
processed and analyzed using ZEN 2012 software, Version 1.1.2. 
Quantitative analyses of HPG incorporation signals using flow cytometry 
 After treatment, cells were further incubated in the presence of 50 uM HPG, 
and then were prepared for microscopy analysis. Briefly, the cells were collected 
by trypsinization for less than 5 min at 37 °C, the detached cells were collected in 
microcentrifuge tubes and fixed for 20 min in PBS (pH 7.4) buffered 4% 
formaldehyde (Fisher Scientific). After 20 min, the membrane permeability 
increased by incubating the monolayers in Saponin-based permeabilization 
buffer (Invitrogen). After 15 min, the monolayers were incubated in the presence 
of HPG labeling mixture at room temperature in dark. After 30 min, the cells were 
centrifuged at 800 xg and then briefly washed with PBS buffered 1% BSA 
(Sigma). The cells were analyzed for fluorescence signal corresponding to 
incorporated HPG using flow cytometry. All experiments decribed were run in 
technical duplicates and a total of 10, 000 cells were counted for each incubation 
condition.  The cells were observed using a LSM 700 laser scanning confocal 
microscope with a 63X objective (Apochromat, NA; 1.42, Carl Zeiss Microscopy), 
and, imaged using an Axio Imager Z1digital microscope camera (512 x 512 






 Cell lysates were prepared by incubating monolayers at 4 °C in lysis buffer 
(20 mM Tris pH 7.5, 100 uM Na3VO4, 25 mM NAF, 25 mM β-glycerolphosphate, 
2 mM EGTA, 2 mM EDTA, 0.3% Triton X-100, all purchased from Sigma-Aldrich) 
that was supplemented with complete Mini EDTA-free, protease inhibitor cocktail 
tablets (1 tablet/25 mL, Roche Diagnostics). After 10 min, the lysates were 
transferred to fresh tubes and mixed with an equivalent volume of 2x sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) buffer (100 mM, 
SDS Tris, pH 6.8, 4%, bromophenol blue, 0.2% glycerol, 20% 2-
mercaptoethanol, all purchased from Sigma-Aldrich), and then incubated at 
100 °C for 10 min. After SDS-PAGE, the gel proteins were electro-transferred to 
a polyvinylidene fluoride (PVDF) membrane (Millipore). Transfer membranes 
were incubated overnight at 4 °C with primary antibodies diluted in blocking 
buffer (Tris-buffered (pH 7.4) saline with 0.1% Tween 20 (TBS-T, Sigma-Aldrich) 
supplemented with 5% skim milk (Lab Scientific). The blots were briefly washed 
with TBS-T for 5 min, and then incubated for 1 h at room temperature with HRP-
conjugated secondary antibodies (1:5000 dilution, Cell Signaling) diluted in the 
blocking buffer. After washing 4 times with TBS-T for 5 min each, the blots were 
incubated with HRP substrates (SuperSignal West, Pico and Femto mixed at 1:1 
ratio; Thermo Fisher Scientific). The luminescent signals from the blots were 
imaged using a ChemiDoc XRS+ imaging system (Bio-Rad), and, analyzed using 




Measurement of mTORC1 activity 
 The relative mTORC1 activity within whole cell lysates was determined by 
immunoblot analysis using p-S6K (T389) antibodies (1:3000 dilution, Cell 
Signaling), or S6K antibodies (1:2000 dilution, Cell Signaling), calculated by the 
intensity of the immuno-specific signal corresponding to p-S6K divided by the 
intensity of the band corresponding to total S6K. 
Purification and Acid-activation of VacA 
 Hp culture filtrate (HPCF) was prepared from cultivation of Hp 60190 as 
previously described (Jain et al., 2011). Briefly, Hp were inoculated in 4 mL 
BSFB broth onto the surface of 2% agar plates made of Ham’s F-12 media 
supplemented with 5% FBS. The biphasic cultures were incubated at 37 °C 
within a humidified, microaerophilic environment (10% O2, 5% CO2). After 1-2 
days, the liquid phase of the biphasic culture was transferred to a fresh BSFB 
liquid culture (300 mL) and incubated with shaking at 37 °C with 5% CO2. After 2 
days, the cultures were centrifuged at 5000 xg for 30 min, and the VacA in the 
supernatant was precipitated out of solution by dissolving ammonium sulfate 
(Fisher Scientific) to 90% saturation (662 g/L) at 4 °C with stirring. After 4 h, the 
precipitated material was collected by centrifugation at 5000 xg at 4 °C. The 
pelleted material was dissolved in wash buffer (10 mM sodium phosphate 
dibasic, pH 7.0; Sigma-Aldrich) and dialyzed at 4 °C for 12 h (with four buffer 
changes) in the wash buffer (100 times the volume of the precipitate solution), 
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using 50 kDa molecular weight cutoff (MWCO) dialysis tubing (Spectra/Por 6 RC, 
Spectrum Labs). After pelleting the insoluble fractions by centrifugation at 5000 
xg for 30 min, followed by filtration using a 0.22 μm MWCO filtration funnel 
(Stericup, EMD Millipore), the VacA-containing soluble fraction was loaded into a 
column packed with anion exchange resin (DEAE Sephacel, GE Healthcare) that 
had been pre-equilibrated with wash buffer (10 mM sodium phosphate dibasic, 
pH 7.0). After washing the column with 3 bed volumes of wash buffer, VacA was 
eluted with wash buffer supplemented with 0.2 M NaCl, and collected in 1 mL 
fractions. After evaluating the purity of VacA within the fractions by SDS-PAGE 
gel separation and staining with G-250 Coomassie Brilliant Blue (Sigma-Aldrich), 
the fractions containing VacA with no additional visible bands were combined 
and concentrated using a 10 kDa MWCO centrifugal filter (Amicon Ultra, 
Millipore), and then dialyzed for 12 h at 4 °C in PBS pH 7.4 (at 100 times the 
volume of the concentrate) with stirring using a 10 kDa MWCO dialysis cassette 
(Slide-A-Lyzer). The concentration of purified VacA was determined by the 
Bradford or BCA assay (both from Thermo Fisher Scientific). 
 Just prior to addition to cultured host cells or tissue, VacA was activated by 
mixing 10% (v/v) HCl (0.3 M) to purified toxin, and then incubating at 37 °C. After 
30 min, the solution was neutralized by adding NaOH (0.3 M) at an equivalent 




Antibody neutralization of VacA 
 Purified VacA preparations was removed by incubating for 1 h at 4 °C with 
Protein A magnetic beads (Cell Signaling), which were pre-incubated for 
overnight at 4 °C with rabbit VacA antiserum (generated at the University of 
Illinois), or rabbit Campylobacter jejuni cytolethal distending toxin A (CdtA) 
antiserum (custom ordered; Rockland Immunochemicals). 
Autophagy activation 
 Autophagy activation within whole cell lysates was evaluated by immunoblot 
analysis, using LC3 antibodies (1:10000 dilution, Cell Signaling), or β-actin (1:5000 
dilution, Cell Signaling).  
Immunostaining of tissue section specimens 
 After each experiment, the tissue sections were fixed overnight at 4 °C with 
PBS (pH 7.4) buffered formalin (4%), and then incubated in PBS (pH 7.4) 
buffered 30% sucrose until sucrose pervaded the entire tissue section, which 
was indicated when the fixed tissues floating on the buffer surface started to sink 
down in the buffer. The tissues were then mounted in a mold containing Optimum 
Cutting Temperature (OCT) compound (Sakura Finetek USA), and snap-frozen 
by incubating the mold for 3 min in isopentane (Sigma Aldrich) that had been pre-
chilled with dry ice. The frozen blocks were sectioned into 10 μm sections using a 
cryostat (CM3050S, Leica) and placed on glass slides. 
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 For immunostaining, the OCT compound was first removed by washing 
slices once with PBS (pH 7.4) for 5 min with gentle shaking, and then slides were 
incubated overnight at 4 °C with primary antibodies (p-S6K and LC3; 1:200 
dilution, Cell Signaling) (p-GCN2; 1:200 dilution, Abcam) diluted in blocking 
buffer (5% normal goat serum (Cell Signaling) in Tris-buffered (pH 7.4) saline 
with 0.1% Tween 20 (TBS-T). After washing the slides with PBS (pH 7.4) for 5 
min, the slides were incubated overnight at 4 °C with the goat anti-Rabbit Alexa 
488 Fluor-conjugated secondary antibodies (1:400 dilution, Invitrogen) diluted in 
the blocking buffer containing counter staining dyes (1 μM DAPI, 5 μM wheat 
germ agglutinin (WGA), both purchased from Invitrogen). After washing 3 times 
with PBS (pH 7.4), for 10 min each wash, samples were mounted using Prolong 
Gold Antifade Mounting Reagent (Invitrogen). The sections were observed using 
a laser scanning confocal microscope (LSM 700, Carl Zeiss Microscopy) with 
either a 10X objective (EC Plan-Neofluar, NA; 0.3, Carl Zeiss Microscopy) or a 
40X objective (EC Plan-Neofluar, NA; 1.3, Carl Zeiss Microscopy), and imaged 
using a digital microscope camera (Axio Imager Z1, 512x 512 pixels, Carl Zeiss 
Microscopy). The images were processed and analyzed using ZEN 2012 
software (Version 1.1.2., Carl Zeiss Microscopy). 
Overexpression of mTORC1 activating constructs 
 Using Lipofectamine 2000 (Thermo Fisher Scientific), cells were transiently 
transfected, as indicated within the manufacturer’s instruction manual, with the 
pCDNA3 plasmid encoding myc-S6K, along with pRK7 plasmid encoding Flag-
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wild type Rheb, or, Flag-Rheb R60K mutant. After overnight incubation, the cells 
were incubated in the absence or presence of VacA (250 nM). After 1 h, the cells 
were lysed for immunoblot analyses for Flag, myc, p-S6K, or, b-actin, or, fixed 
and evaluated for incorporated HPG, of puromycin for 4 h before commencing 
specific experiments. Overexpression of the Flag-mTOR constructs was 
confirmed by immunoblot analysis for the Flag motif, using an anti-Flag antibody 
(1:1000 dilution; Cell Signaling). 
 For evaluating protein synthesis, the cells that had been prepared by 
transfecting with the pRK7 plasmids encolding Flag-Rheb constructs were 
incubated in the absence or presence of VacA (250 nM). After 30 min, the cells 
were further incubated in the presence of HPG. After 30 min, the cells were fixed 
and immunostained using a Flag motif antibody (Cell Signaling). 
Measurement of GCN2 activity 
 The GCN2 dependent cellular sensing of relative intracellular amino acid 
levels within whole cell lysates was measured by immunoblot analysis using 
antibodies specific for GCN2 phosphorylated at Thr 898 (p-GCN2, 1:1000 
dilution; Abcam), or, total GCN2 (1:5000 dilution; Cell Signaling), calculated by 
the intensity of the band corresponding to p-GCN2, divided by the intensity of the 




Measurement of GCN2 mediated phosphorylation of eIF2a 
 The cells incubated in the absence or presence of VacA (250 nM), or, 10 uM 
Thapsigargin (ER stress inducer used as a positive control for p-eIF2a) were 
evaluated for GCN2 kinase corresponding to phosphorylation of eIF2a at Ser51 
by immunoblot analysis using antibodies specific for eIF2a at Serine 51 (p-eIF2a, 
1:1000 dilution, Cell Signaling), or total eIF2a (1:1000 dilution, Cell Signaling), 
calculated by the intensity of the band corresponding to p-eIF2a divided by the 
intensity of the band corresponding to total eIF2a. 
Amino acid deprivation of gastric sections 
 Gastric slices were briefly washed with PBS pH 7.4 and incubated in pre-
warmed amino acid depleted medium, which is comprised of the custom 
formulated DMEM, not containing any amino acids (Hyclone), supplemented with 
dialyzed 10% FBS (Gibco) and 1% penicillin/streptomycin (Sigma-Aldrich). 
Measurement of relative levels of intracellular amino acids 
 Monolayers of AZ-521 cells seeded in 6 cm plates were incubated in a 
humidified environment at 37 °C with 5% CO2 in the absence or presence of 
VacA (250 nM). After 1 h, the cells were immediately chilled on ice, thoroughly 
washed with ice cold PBS pH 7.4 twice, and collected in 300 μL of ice-cold 60 % 
methanol using a cell scraper. The intracellular compartments were further 
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disrupted by sonication (Thermo Fisher, 20 % power, 5 repeats of 1 sec pulses, 
using 3 sec intervals). A small fraction of each sample was reserved for 
immunoblot analyses. The cellular debris were removed by centrifuging the cell 
suspension at 12,000 xg at 4 °C for 15 min, yielding a clear supernatant, which 
was transferred to a fresh Eppendorf tube. The samples were kept at – 80 °C 
until submitted to the Metabolomics Center at the Roy J. Carver Biotechnology 
Center (University of Illinois) for gas chromatography-tandem mass spectrometry 
(GC-MS) analyses designed for quantitatively measuring amino acids. As a 
control, samples were harvested using the same methodology from cells that 
were incubated for 5 min on ice in PBS (pH 7.4) supplemented with 50 μg/mL 
digitonin (a reagent that selectively permeabilizes plasma membrane at the 
indicated dose, Sigma), and, confirmed to be negative in the amino acid levels. 
The relative levels of intracellular amino acids from different cell samples were 
normalized by the intensity of immune specific-bands corresponding to Histone 
H3 (1: 1000 dilution, Cell Signaling). 
Inhibiting VacA impairment of mitochondrial energy production 
 Cells were pre-incubated at 37 °C in DMEM and under 5% CO2 within a 
humidified environment in the absence or presence of 100 μM Rotenone 
(Sigma). After 30 min, and cells were then further incubated at 37 °C in DMEM, 
and under 5% CO2 within a humidified environment, for 1 h in the absence or 
presence of VacA (250 nM). 
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Quantification and statistical analyses 
 As indicated in the Figure legends, each experiment was performed 
independently at least three times. For each experiment using samples collected 
from mice, a whole experimental set used for different treatments was harvested 
from a single animal. Statistical analyses were conducted using GraphPad Prism 
(ver. 7.0). Error bars indicated standard deviations. P values were calculated 
using either the Students’ t test with paired, two-tailed distribution, or, one-way 
ANOVA, corrected using either the Dunnett’s, or, the Tukey’s test. P values 
smaller than 0.05 were considered statistically significant (a = 0.05). 
 
3.3. Results 
Intracellular levels of de novo synthesized proteins in host cells are 
decreased during Helicobacter pylori infection 
 Maintaining biosynthetic capacity is critical for the host immune function to 
respond effectively to pathogen infections (Martin et al., 2012). I recently reported 
Hp-dependent inhibition of mTORC1 (Kim et al., 2018), a central metabolic 
regulator (Laplante and Sabatini, 2009), suggesting that infection results in a 
global shift in host metabolism to a catabolic state (Laplante and Sabatini, 2009). 
However, this previous study did not address the extent to which host cell 
biosynthesis is altered during Hp infection. To evaluate whether the host 
biosynthetic capability is altered by Hp infection, I incubated AZ-521 cells, a 
human duodenal derived cell line that has been extensively employed as a host 
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cell model to study Hp pathogenesis (Jain et al., 2011, Kimura et al., 1999), at 
37 °C and under 5% CO2 in cell culture medium (Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with fetal bovine serum (FBS)), in the presence 
of Hp 60190 strain (MOI 100). After 1.5 h, the cells were further incubated at 
37 °C and under 5% CO2 in the presence of 50 μM L-homopropargylglycine 
(HPG), a methionine analog with a modification that allows subsequent 
fluorescent labeling for quantitative measurement (Moses and Moorhouse, 
2007). After 30 min, cells were fixed and evaluated for the amount of HPG 
incorporated into host cells, which corresponds to the amount of proteins newly 
synthesized during the final 30 min of the total incubation period. The studies 
revealed that cellular fluorescence the green fluorescence, corresponding to 
HPG incorporation into newly synthesized proteins, was visibly (Fig. 3.1A) and 
quantitatively (Fig. 3.1B and C) lower within cells incubated in the presence than 
absence of Hp. The results indicated that less HPG had been incorporated into 
cells incubated in the presence than absence of Hp, suggesting that intracellular 
levels of newly synthesized proteins within host cells were reduced during Hp 
infection. 
 To evaluate whether Hp-dependent reduction of HPG incorporation within AZ-
521 cells is idiosyncratic to Hp 60190, AZ-521 cells were incubated in the 
absence or presence of, Hp 26695 (MOI 100), an alternative clinical isolate that 
has been widely used for studying Hp infection biology (Fischer et al., 2001b), at 
37 °C and under 5% CO2 in cell culture medium. After 1.5 h, the cells were 
further incubated at 37 °C and under 5% CO2 in the presence of HPG. After 30 
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min, cells were fixed and evaluated for the amount of HPG incorporated into host 
cells, corresponding to proteins newly synthesized during the final 30 min of the 
total incubation period. The studies revealed that cellular fluorescence the green 
fluorescence, corresponding to HPG incorporation into newly synthesized 
proteins, was lower within cells incubated in the presence than absence of Hp 
(Fig. 3.2A) indicating that intracellular levels of newly synthesized proteins were 
reduced by Hp 26695 infection. The studies suggested that Hp dependent 
reduction of newly synthesized proteins is recapitulated across Hp strains. 
 The results described immediately above suggested that Hp dependent 
reduction of newly synthesized proteins is recapitulated across Hp strains. 
However, these studies did not rule out the possibility that the reduction of HPG 
incorporation was not directly due to Hp modulation of host cell protein synthesis 
during infection but, alternatively, was a consequence of the rapid consumption 
of nutrients in the culture medium by Hp bacteria. To evaluate this possibility, I 
examined the rate of HPG incorporation during infection with a smaller bacterial 
load. AZ-521 cells were incubated in the absence or presence of Hp 60190 at a 
range of different MOIs (1, 3, 10, 35, 100) at 37 °C and under 5% CO2 in cell 
culture medium. After 1.5 h, the cells were further incubated at 37 °C and under 
5% CO2 in the presence of HPG. After 30 min, cells were fixed and evaluated for 
the amount of HPG incorporated into host cells, which corresponds to the 
amount of proteins synthesized during the final 30 min of the total incubation 
period. The studies revealed that cellular fluorescence the green fluorescence, 
corresponding to HPG incorporation into newly synthesized proteins, was lower 
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within cells incubated in the presence than absence of Hp at an MOI as low as 3 
(Fig. 3.2B). These data indicated that the level of newly synthesized proteins was 
lower in cells incubated in the presence of Hp, even at low MOI, than absence of 
Hp. These results support the idea that the decrease in newly synthesized 
proteins during Hp infection is not likely due solely to the rapid bacterial 
consumption of medium nutrients. These studies also further support the finding 
that intracellular levels of newly synthesized proteins were reduced by Hp 
infection, consistent with the hypothesis that the host protein synthesis is 
targeted by Hp during infection. However, these studies did not address the 
identity of the Hp factor or factors required for the Hp-dependent reduction of the 
intracellular levels of newly synthesized proteins within host cells. 
VacA is required for the Hp-dependent reduction of the intracellular levels 
of newly synthesized proteins in host cells 
 The results described immediately above indicated that Hp infection resulted 
in the reduction of newly synthesized proteins within cultured cells. However, 
these studies did not address the identity of the Hp factor or factors involved in 
infection-dependent decreases in newly synthesized proteins. VacA is an 
exotoxin secreted by Hp that, subsequent to cellular uptake, induces metabolic 
stress within host cells, as manifested by depletion of amino acid pools (Kim et 
al., 2018), the building blocks for de novo biosynthesis of proteins, suggesting 
the possibility that reduction of the intracellular levels of newly synthesized 
proteins during Hp infection is dependent on the presence of VacA. To evaluate 
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whether VacA is required for Hp dependent reduction in the intracellular levels of 
newly synthesized proteins, AZ-521 cells were incubated at 37 °C and under 5% 
CO2 in the absence or presence Hp 60190 (DvacA) (MOI 100), an isogenic 
mutant strain of Hp 60190 with an inactivating disruption in vacA (Vinion-Dubiel 
et al., 1999), or, with Hp 60190 (DvacA:: vacA) (MOI 100), a strain in which vacA 
was reintroduced into Hp 60190 (DvacA) (McClain et al., 2001). After 1.5 h, the 
cells were further incubated at 37 °C and under 5% CO2 in the presence of HPG. 
After 30 min, the cells were fixed and evaluated for the amount of incorporated 
HPG within cells, which corresponds to the amount of protein newly synthesized 
during the final 30 min of the total incubation period. These experiments revealed 
that cellular fluorescence, corresponding to HPG incorporation into newly 
synthesized proteins, was greater within cells incubated in the presence of Hp 
60190 (DvacA) than in cells incubated in the presence of Hp 60190 (Fig. 3.1D). 
These data indicated that levels of newly synthesized proteins were less in cells 
infected Hp expressing VacA than in cells infected with Hp not infecting VacA. In 
addition, cellular fluorescence, corresponding to HPG incorporation into newly 
synthesized proteins, was lower within cells incubated in the presence of Hp 
60190 (DvacA:: vacA) than in cells incubated in the presence of Hp 60190 
(DvacA) (Fig. 3.1D). These data further validated that levels of newly synthesized 
proteins were less in cells infected Hp expressing VacA than in cells infected with 
Hp not infecting VacA. Taken together, these results suggest that VacA is 
casually associated with the reduction in newly synthesized within cultured cells 
infected with Hp. 
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 The results described immediately above indicated the importance of VacA for 
Hp-dependent reduction in cellular levels of newly synthesized proteins within 
cultured monolayers. However, these studies did not address the association 
between VacA-associated reduction in cellular levels of newly synthesized 
proteins and toxin cellular activity. Several distinct allelic forms of vacA have 
been identified (Rudi et al., 1998), which express toxins with different levels of 
cytotoxic activity towards cultured cells (Atherton et al., 1995). The signal 
sequence region (s-region) and the middle region (m-region) are of particular 
importance, with the s1 or m1 forms of VacA generally considered more potent 
than the s2 or m2 forms of the toxin (Atherton et al., 1995). Moreover, several 
epidemiological studies demonstrated that individuals infected with Hp strains 
containing s1m1 forms of vacA are more at risk for gastric disease than 
individuals infected with Hp strains harboring the gene encoding the s2m2 form 
of vacA (Rudi et al., 1998). To investigate whether vacA dependent reduction of 
newly synthesize proteins in host cells during Hp infection is dependent on the 
vacA cytotoxicity, AZ-521 cells were incubated at 37 °C and under 5% CO2 in the 
presence of several different Hp strains (MOI of 100) from distinct vacA allelic 
forms. After 1.5 h, the cells were further incubated at 37 °C and under 5% CO2 in 
the presence of HPG. After 30 min, the cells were fixed and evaluated for the 
amount of incorporated HPG, which corresponds to the amount of proteins newly 
synthesized during the final 30 min of the total incubation period. These 
experiments revealed that cellular fluorescence, corresponding to HPG 
incorporation into newly synthesized proteins, was greater within cells incubated 
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in the presence of Hp 60190 (DvacA) than in cells incubated in the presence of 
Hp 60190, which secrete the highly active s1m1 form of VacA (Fig. 3.2C), than in 
cells incubated in the presence of Hp J198 or Hp Tx30a, which secrete the less 
cytotoxic forms of s1m2 or s2m2 VacA, respectively (Fig. 3.2C). These data 
indicate that the levels of newly synthesized proteins within cells infected with Hp 
that possess the s1m1 form of vacA are relatively lower than within cells infected 
with Hp that generate the s1m2 or s2m2 forms of vacA, suggesting that reduction 
of the newly synthesized proteins within host cells is more highly associated with 
Hp secreting the s1m1 form of VacA. Taken together, these results are 
consistent with a conclusion that VacA cytotoxicity is associated with Hp-
dependent reduction in the intracellular levels of newly synthesized proteins 
during infection. 
Intracellular levels of newly synthesized proteins are reduced in cells 
incubated in the presence of purified VacA 
 The results described immediately above revealed that vacA is important for 
Hp-dependent reduction of intracellular levels of newly synthesized proteins. 
However, these studies did not address whether additional Hp factors are 
involved in the reduction of newly synthesized proteins within host cells during 
Hp infection. To evaluate whether incubation with VacA alone is sufficient to 
result in reduction of newly synthesized proteins, AZ-521 cells were incubated at 
37 °C and under 5% CO2 in the absence or presence of VacA (250 nM) purified 
from Hp 60190 (Fig. 3.2D). After 30 min, the cells were further incubated at 37 °C 
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and under 5% CO2 in the presence of HPG. After 30 min, the cells were fixed 
and analyzed for incorporated HPG within cells, which corresponds to the 
amount of proteins newly synthesized during the final 30 min of the total 
incubation period. The studies revealed lower levels of HPG incorporated within 
cells incubated in the presence of VacA than in the absence of VacA (Fig. 3.1E), 
indicating that intracellular levels of newly synthesized proteins were reduced in 
the presence of VacA alone. In addition, reduction of incorporated HPG was 
detected within cells incubated in the presence of purified VacA that had been 
pre-incubated in the presence of beads coated with cytolethal distending toxin B 
specific antibodies (αCdtB) (Fig. 3.2E), but not in the presence of VacA that had 
been pre-incubated in the presence of beads coated with VacA specific 
antibodies (αVacA) (Fig. 3.2E). These results are consistent with the idea that 
VacA is sufficient for Hp dependent reduction of intracellular levels of newly 
synthesized proteins, in a manner not requiring Hp bacteria or other Hp factors. 
VacA dependent inhibition of protein synthesis is recapitulated across 
different in vitro cell line models 
 The results described immediately above revealed that, among Hp factors, 
VacA is sufficient for inducing a reduction in newly synthesized intracellular 
proteins. However, the studies did not address whether the phenomenon is 
idiosyncratic to AZ-521 cells. To evaluate whether VacA-dependent reduction in 
newly synthesize proteins extends to different in vitro cell line models, human 
embryonic HEK293T cells, which have been extensively used to study cellular 
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metabolism (Peterson et al., 2009, Hsu et al., 2011), or, human gastric derived 
AGS, MKN7, or MKN45 cells, which have been extensively used to study Hp 
infection biology (Raju et al., 2012a, Radin et al., 2011), were incubated at 37 °C 
and under 5% CO2 in the absence or presence of VacA (250 nM). After 3.5 h, the 
cells were further incubated at 37 °C and under 5% CO2 in the presence of HPG. 
After 30 min, the cells were fixed and analyzed for incorporated HPG, which 
corresponds to proteins newly synthesized during the final 30 min of the total 
incubation period. The studies revealed a significant reduction in incorporated 
HPG within cells incubated in the presence of VacA relative to cells incubated in 
the absence of VacA (Fig. 3.2F). These studies indicated that VacA dependent 
inhibition of host protein synthesis is not limited to one cell line, but can be 
recapitulated across several immortalized host cell models. 
VacA dependent inhibition of protein synthesis is recapitulated across 
different models directly derived from the stomach 
 The results described immediately above indicated VacA dependent inhibition 
of protein synthesis in several different immortalized cell models. However, 
metabolism in highly proliferative immortalized cell lines may not directly 
represent metabolism of gastric epithelial barriers during Hp infection. For 
example, the Warburg effect (Vander Heiden et al., 2009), which comprises 
metabolic conditions that generate carbon sources and energy generation 
through simple aerobic glycolysis faster than full-fledged oxidative respiration, is 
more predominant in highly proliferative tissue or cancer cells, than fully 
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differentiated cells within stomach tissue. To evaluate VacA dependent inhibition 
of host protein synthesis in host models that are directly derived from the healthy 
stomach, monolayers of the murine primary gastric epithelial cells freshly isolated 
from C57J/BL mouse were incubated at 37 °C and under 5% CO2 in the absence 
or presence of VacA (250 nM). After 3.5 h, the monolayers were further 
incubated at 37 °C and under 5% CO2 in the presence of HPG. After 30 min, the 
monolayers were fixed and analyzed for the incorporated HPG, which 
corresponds to the amount of proteins newly synthesized during the final 30 min 
of the total incubation period. The studies revealed that the green fluorescence 
signal, which is indicative of incorporated HPG, was visibly lower within 
monolayers (Fig. 3.2G) incubated in the presence of VacA than monolayers 
incubated in absence of VacA, indicating VacA-dependent inhibition of host 
protein synthesis within epithelial cells that are directly derived from healthy 
stomach tissue. 
 To further extend our finding of VacA-dependent inhibition of host protein 
synthesis in a whole tissue section model, gastric tissue slices (200 µm 
thickness) freshly prepared from C57J/BL mouse were incubated at 37 °C and 
under 5% CO2 at air-liquid interface using Transwell inserts in the absence or 
presence of VacA (250 nM). After 3.5 h, the tissue slices were further incubated 
at 37 °C and under 5% CO2 at air-liquid interface in the presence of HPG. After 
30 min, the slices were fixed and sectioned at 20 µm for analyzing the 
incorporated HPG, which corresponds to the amount of proteins newly 
synthesized during the final 30 min of the total incubation period. The studies 
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revealed that the green fluorescence signal, which is indicative of incorporated 
HPG, was visibly lower within slices incubated in the presence of VacA than 
slices incubated in absence of VacA (Fig. 3.1F). Together, these studies 
indicated VacA dependent inhibition of protein synthesis in the models that are 
representative of the normal gastric tissue, suggesting that VacA dependent 
inhibition of host protein synthesis is relevant to actual host metabolism during 
Hp infection. Furthermore, these studies validated use of AZ-521 cells as a host 
model to further characterize VacA dependent inhibition of host protein synthesis. 
VacA dependent reduction of newly synthesized proteins within host cells 
is not associated with cell death 
 The results described immediately above indicated VacA dependent inhibition 
of host protein synthesis in several different intoxication models. However, these 
studies didn’t address the underlying molecular mechanism associated with the 
reduction in newly synthesized intracellular proteins. Cellular metabolism is often 
arrested while cells are undergoing programmed cell death (Garland and 
Halestrap, 1997). Prolonged exposure to higher concentrations of VacA, triggers 
release of mitochondrial cytochrome c (Cyt c) into the cytosol (Galmiche et al., 
2000, Willhite and Blanke, 2004, Willhite et al., 2003, Yamasaki et al., 2006), 
thereby committing host cells to cell death (Fig. 3.3A) (Cover et al., 2003, Kuck et 
al., 2001, Smoot et al., 1996). To evaluate whether VacA-dependent reduction in 
newly synthesized proteins is associated with cell death, AZ-521 cells were 
incubated at 37 °C and under 5% CO2 in the absence or presence of VacA (1, 3, 
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10, 35, 100, 250 nM). After 0.5, 11.5, or 23.5 h, cells were further incubated at 
37 °C and under 5% CO2 in the presence of HPG. After 30 min, the cells were 
fixed and analyzed for HPG incorporated, which corresponds to proteins newly 
synthesized during the final 30 min of the total incubation period. For evaluating 
cell death, cells, incubated in the absence or presence of VacA (1, 3, 10, 35, 100, 
250 nM) for 1, 12, and 24 h, were further incubated in the presence of DAPI (0.1 
µg/ml, a nuclear-membrane impermeable DNA dye that selectively stains dead 
cells) and Calcein AM (0.2 µM, a cytosolic dye that is retained within the plasma 
membrane barrier of live cells). After 10 min, cells were evaluated for intracellular 
retention of both the dyes using flow cytometry. The studies revealed reduction of 
incorporated HPG within cells incubated for 1 h in the presence of VacA at a 
toxin concentration as low as 35 nM (Fig. 3.3B). On the other hand, an increase 
in the percentage of viable cells, as manifested by positive Calcein AM and 
negative DAPI signals, was not detected in AZ-521 cells incubated in the 
presence of VacA (250 nM) for 1 h. At a higher concentration of VacA (250 nM), 
an increase in negative Calcein AM and positive DAPI signals were first detected 
at 12 h (but not at 1 h), (Fig. 3.3A). The data indicated that the VacA-dependent 
reduction in newly synthesized proteins, which was observed at 1 h, precedes 
cell death, and, occurs at a VacA concentration (35 nM) where cell death was not 
observed. These results are consistent with a conclusion that programmed cell 
death were not observed under conditions which synthesis of newly synthesized 
proteins was inhibited, supporting a model that VacA-dependent reduction in 
newly synthesized proteins within host cells is not a consequence of cell death. 
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VacA dependent reduction of newly synthesized proteins is detected even 
when intracellular turnover is inhibited 
 The results described immediately above suggested that VacA dependent 
reduction of newly synthesized proteins is not a consequence of toxin dependent 
cell death. Intracellular protein abundance is generally determined by the balance 
of synthesis and turnover (Kaur and Debnath, 2015). To evaluate whether VacA 
dependent reduction in newly synthesized proteins results from rapid cellular 
turnover of newly synthesized proteins, monolayers of AZ-521 cells were 
incubated at 37 °C and under 5% CO2 in the absence or presence of VacA (250 
nM), along with the proteasome inhibitor MG-132 (10 µM) (Fig. 3.3C and D). 
After 30 min, the cells were further incubated at 37 °C and under 5% CO2 in the 
presence of HPG and MG-132. After 30 min, the cells were fixed and analyzed 
for the incorporation of HPG, which corresponds to the amount of proteins newly 
synthesized during the final 30 min of the total incubation period. These 
experiments revealed that cellular fluorescence, corresponding to HPG 
incorporation into newly synthesized proteins, was similar between cells 
incubated without, or with VacA in the presence of MG-132 (Fig. 3.3D), 
suggesting that increased proteasome degradation of cytosolic proteins is not 
causal for VacA-dependent reduction in cellular levels of newly synthesized 
proteins. 
 A second major means by which cells sustain proteostasis within the cytosol is 
autophagy, a cellular recycling mechanism through which intracellular proteins 
are targeted for degradation in specialized vesicles called autophagolysosomes 
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(Kroemer et al., 2010). VacA-dependent activation of cellular autophagy has 
been reported during Hp infection (Terebiznik et al., 2009, Raju et al., 2012a, 
Tsugawa et al., 2012). To evaluate whether VacA-dependent induction of 
autophagy is important for the reduction in newly synthesized proteins during Hp 
infection, monolayers of AZ-521 cells were pre-incubated at 37 °C and under 5% 
CO2 in the absence or presence of E64d (10 µg/mL) and Pepstatin A (10 µg/mL), 
which inhibit protein degradation within autophagolysosomes. After 30 min, the 
monolayers were further incubated at 37 °C and under 5% CO2 in the absence or 
presence of VacA (250 nM), After 30 min, the cells were further incubated at 
37 °C and under 5% CO2 after the addition of HPG. After 30 min, the cells were 
fixed, and the effectiveness of E64d and Pepstatin A for inhibiting proteolysis by 
E64d and Pepstatin A within autophagolysosomes was validated using 
immunoblot analysis by examining cellular levels of microtubule-associated 
protein 1A/1B light chain 3B-II (LC3-II), which is degraded in 
autophagolysosomes during normal autophagic flux as well as during conditions 
of autophagy induction. These studies revealed visibly higher immuno-specific 
densities corresponding to LC3-II within lysates of monolayers incubated in the 
presence than absence of E64d and Pepstatin A (Fig. 3.3.E), consistent with the 
interpretation that E64d and Pepstatin A were effective for inhibiting proteolysis 
within degradative autophagic compartments. 
 The fixed cells were then analyzed using flow cytometry for the incorporation 
of HPG, which corresponds to the amount of proteins newly synthesized during 
the final 30 min of the total incubation period. The studies revealed that cellular 
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fluorescence, corresponding to HPG incorporation into newly synthesized 
proteins, was similar between cells incubated with VacA, or VacA in the presence 
of E64d and Pepstatin A (Fig. 3.3F), suggesting that VacA-dependent reduction 
in cellular levels of newly synthesized proteins is not associated with increased 
autophagy-mediated degradation of cytosolic proteins. Together, these studies 
suggested that VacA-dependent reduction in newly synthesized proteins is not 
likely due to toxin-dependent increases in protein turnover. However, these 
studies did not immediately suggest alternative mechanisms for VacA-dependent 
reduction in newly synthesized proteins. 
Downregulation of protein translation is associated with VacA-dependent 
reduction of the intracellular levels of newly synthesized proteins 
 The results described immediately above suggested that VacA dependent 
reduction in newly synthesized proteins are not highly associated with 
intracellular turnover. However, these studies did not address the involvement of 
protein biosynthesis as a possible mechanism underlying VacA-dependent 
reduction in cellular levels of newly synthesized proteins. To evaluate a possible 
role for alterations in host translation activity, I examined ribosomal occupancy 
associated with mRNA transcripts. Robustness in translation is often manifested 
by enrichment of ribosomes along a single mRNA strand (Ceman et al., 2003), 
which allows for high-throughput translation off a single mRNA transcript. 
Conversely, down-regulated translation leads to reduced ribosomal occupancy 
on a single transcript, resulting in reduction in synthesis of nascent protein 
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peptides. To evaluate ribosome associations with mRNAs, AZ-521 cells were 
incubated at 37 °C and under 5% CO2 in the absence or presence of VacA. After 
1 h, the cells were lysed in a manner that preserves ribosome-mRNA 
interactions. The cell lysates were resolved by sucrose density gradient 
centrifugation at 39,000 xg. After 1.5 h, the gradients were evaluated for relative 
levels of ribosomes across the gradients, using spectrometry to identify RNA, 
and, immunoblot analysis to identify the ribosomal protein S6. The experiments 
revealed that, within cells incubated in the absence of VacA, rRNA (Fig. 3.4A) 
and S6 (Fig. 3.4B and C) were detected predominantly in fractions # 5 - 13, 
which correspond to ribosome enriched mRNA. In contrast, within cells incubated 
in the presence of VacA, the rRNA and S6 proteins were predominantly detected 
in fractions # 2 – 4, which correspond to a single ribosome per transcript, or, 
ribosomes that are not associated with mRNA transcripts (Fig. 3.4). These data 
indicated that the number of ribosomes per transcript was decreased in a VacA 
dependent manner. These resulted are consistent with the idea that VacA-
dependent reduction in cellular levels of newly synthesized proteins results from 
inhibition of protein synthesis at the translational level. 
VacA-dependent inhibition of host protein synthesis results in non-
discriminative reduction of cellular proteins 
 The results immediately above indicated that VacA-dependent reduction in 
cellular levels of newly synthesized proteins occurs at the translational level. 
However, the studies did not address the molecular mechanism underlying the 
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inhibition of host protein synthesis. The maintenance of cellular homeostasis in 
mammalian cells requires the regulation of protein synthesis by several different 
regulatory pathways (Darnell et al., 2018). Mechanisms exist at the translational 
levels to selectively promote expression of stress-related proteins, while 
effectively limiting expression of other sets of proteins (Vasudevan et al., 2017) . 
VacA-dependent induction of several distinct cellular stresses during Hp-infected 
cells, including reduction in cellular ATP (Kimura et al., 1999), accumulation of 
reactive oxygen species (ROS) (Tsugawa et al., 2012), and amino acid 
deficiency (Kim et al., 2018), suggest the possibility that proteins are differentially 
regulated at the translational level in response to VacA-dependent induction of 
cellular stress. To assess the molecular mechanism underlying the VacA 
dependent inhibition of host protein synthesis, I conducted studies to identify and 
characterize host cellular proteins that were directly impacted by VacA at the 
translational level. 
 To identify the proteins whose synthesis is altered by VacA, I employed Click-
Stable Isotope Labeling using Amino acids in Cell culture (SILAC) technology, 
which selectively enriches for newly synthesized proteins (using a modified 
methionine) for comparing relative abundance of each newly synthesized protein 
between cells under two different sets of environmental conditions (using isotope 
labeled arginine and lysine) (Eichelbaum et al., 2012). AZ-521 cells were pre-
conditioned for amino acid labeling by incubating at 37 °C and under 5% CO2 in 
culture medium lacking methionine, lysine, and arginine. After 30 min, 
monolayers of cells were incubated at 37 °C and under 5% CO2 in the absence of 
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VacA in culture medium containing L-Azidohomoalanine (AHA), a methionine 
analog with an alkyne moiety that allows selective enrichment of newly 
synthesized proteins using azide-coated agarose beads, along with “heavy 
labeled” 13C6 15N4 arginine and 13C6 15N2 lysine. As a counterpart, monolayers of 
cells were incubated with VacA (250 nM) in culture medium containing AHA, 
along with “intermediate labeled” 13C6 arginine and d4 lysine. After 4 h, the 
cultured media were collected for evaluating proteins that were newly 
synthesized and secreted during the 4 h incubation period, and, the cells, which 
were lysed immediately after collection of cultured media, were collected for 
evaluating cell-associated proteins newly synthesized during the 4 h incubation 
period. To avoid possible experimental bias that might result from inconsistency 
during sample preparation, experimental sets of each “intermediate”, or, “heavy” 
isotope incorporated samples, which were collected separately between cells 
incubated in the absence or presence of VacA, were combined in a single tube 
immediately after sample collection. The “intermediate”, or, “heavy” isotope 
incorporated proteins in the single tube were then selectively captured using 
azide-coated agarose beads through covalent bonds with the incorporated AHA 
within the newly synthesized proteins, and fragmented with trypsin for 
quantitative analyses using liquid chromatography tandem mass spectrometry 
(LC-MS) (Fig. 3.5).  
 Using LC-MS analyses, 396 cell-associated- and 19 secreted proteins newly 
synthesized during the 4 h period were identified (Tab. 3.1, Fig. 3.6A), which 
were quantitatively analyzed by calculating the ratios between the fragments that 
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incorporated “intermediate” arginine/lysine (collected from cells incubated in the 
presence of VacA) versus the corresponding fragments that incorporated “heavy” 
arginine/lysine (collected from cells incubated in the absence of VacA) (Fig. 3.6C; 
replicate #1). The studies revealed a VacA-dependent inhibition of protein 
synthesis in 99.3 % of total proteins detected (in 396 proteins), as manifested by 
the ratios smaller than 1. The only two exceptions that were detected to be more 
abundant within VacA intoxicated cells were ectoderm-neural cortex protein 1 
(ENC1) (ratio: 1.08) (Accession number: NP_003624.1), and connective tissue 
growth factor (CTGF) (ratio: 2.76) (Accession number: NP_001892.1). ENC1 is 
aregulator that inhibits translation of mRNAs that encode nuclear factor erythroid 
2–related factor (Nrf2) (Wang and Zhang, 2009), although the mechanism is 
poorly understood. CTGF is a secreted growth factor (Lipson et al., 2012) that 
was also detected in the cultured media at the ratio of 0.82. Furthermore, the 
overall results were consistent in the technical replicates (replicate #2, Fig. 3.6C), 
where the labeling media each containing “heavy”-, or, “intermediate”-arginine/ 
lysine were swapped between cells incubated in the absence or presence of 
VacA, as manifested by symmetric distributions of identified proteins across the 
replicate #1 and #2 (Fig. 3.6C). Finally, among 267 proteins identified, in silico 
analyses through PANTHER database (Mi et al., 2017) annotated a large 
number of proteins that were involved in translational control (Tab. 3.2., Fig. 
3.6B). Together, these studies indicated a VacA-dependent inhibition of protein 
synthesis in almost all proteins identified by LC-MS, which resulted presumably 
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by cellular mechanisms or changes that can lead to general inhibition of protein 
synthesis. 
VacA dependent inhibition of host protein synthesis is not causally 
associated with mTORC1 regulatory pathways in AZ-521 cells 
 The results described immediately above indicated that biosynthesis of a 
subset of cellular proteins was inhibited in monolayers that had been exposed to 
VacA. However, these studies did not address the mechanism by which protein 
synthesis of these proteins had been altered. To evaluate the molecular 
mechanism underlying VacA-dependent inhibition of host protein synthesis, I 
investigated several major cellular mechanisms that are important for general 
host protein synthesis. The mammalian target of Rapamycin complex I 
(mTORC1) regulates protein synthesis. Under nutrient rich conditions, active 
mTORC1 promotes protein synthesis through direct regulation of several 
translation factors, including eukaryotic initiation factor 4E (eIF4E) binding protein 
1 (4E-BP1) (which facilitates translation initiation) and S6K (which facilitates 
elongation) (Laplante and Sabatini, 2009). Conversely, under nutrient deficient 
conditions, mTORC1 activity is inhibited, which can lead to suppression of host 
protein synthesis. A recent study revealed VacA-dependent inhibition of 
mTORC1 activity during H. pylori infection (Fig. 3.7A) (Kim et al., 2018), 
suggesting the possibility that mTORC1 is associated with VacA-dependent 
inhibition of host protein synthesis. To evaluate a potential temporal association 
between the inhibition of mTORC1 activity and the inhibition of host protein 
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synthesis, AZ-521 cells were incubated at 37 °C and under 5% CO2 in the 
absence or presence of VacA (250 nM). After 0.5, 1, 2, 4, or, 8 h, cells were 
lysed and evaluated by immunoblot analyses for relative levels of S6 Kinase 
(S6K) phosphorylated at Threonine 389 (p-S6K), a cellular marker widely used to 
evaluate the overall mTORC1 kinase activity (Hay and Sonenberg, 2004).  For 
evaluating protein synthesis, AZ-521 cells, which were incubated at 37 °C and 
under 5% CO2 in the absence or presence of VacA (250 nM) for 0.5, 1.5, 3.5, or, 
7.5 h, were further incubated at 37 °C and under 5% CO2 in the presence of 
HPG. After 30 min, the cells were fixed and analyzed for HPG incorporation, 
which corresponds to proteins newly synthesized during the final 30 min of the 
total incubation period. These studies revealed a significant reduction in both 
cellular levels of p-S6K and incorporated HPG within cells that were incubated in 
the presence of VacA for 30 min (Fig. 3.7A -3.7C), consistent with the idea that 
mTORC1 is associated with VacA-dependent inhibition of host protein synthesis. 
 To more directly evaluate the causal association of mTORC1 with VacA-
dependent inhibition of host protein synthesis, I employed Ras homolog enriched 
in brain (Rheb), the direct activator of mTORC1 (Laplante and Sabatini, 2009). 
Overexpression of Rheb has been extensively used as an effective tool to 
sustain mTORC1 activity even under mTORC1 inhibitory conditions (Sun et al., 
2008). To first validate the efficacy of Rheb overexpression in preventing VacA-
dependent inhibition of mTORC1 activity, AZ-521 cells were transiently co-
transfected at 37 °C and under 5% CO2 with a plasmid that harbored the gene 
encoding S6K fused with a myc motif (S6K-myc), a mTORC1 activity marker for 
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cells overexpressing the Rheb constructs, and additionally, with either a plasmid 
that harbored the gene encoding for Rheb fused with a Flag motif (Rheb 
wildtype-Flag), a plasmid that harbored the gene encoding for an inactive Rheb 
kinase mutant fused with a Flag motif (Rheb D60K-Flag), or, the plasmid only. 
After overnight incubation, the cells were incubated at 37 °C and under 5% CO2 
in the absence or presence of VacA (250 nM). After 1 h, cells were lysed and 
evaluated by immunoblot analyses for relative levels of S6K-myc phosphorylated 
at Threonine 389 (p-S6K-myc), which corresponds to relative mTORC1 activity 
within cells overexpressing the Rheb constructs. The studies revealed that in 
cells incubated in the presence of VacA, there was both visibly and quantitatively 
lower immunoblot-specific signal densities corresponding to p-S6K-myc within 
lysates prepared from monolayers that that had been transfected with a plasmid 
that harbored the gene encoding for an inactive Rheb kinase mutant fused with a 
Flag motif (Rheb D60K-Flag), or, the plasmid only, then transfected cells 
incubated in the absence of VacA (Fig, 3.7C). These data indicated that lower 
levels of p-S6K were detected in cells incubated in the presence than absence of 
VacA. These results are consistent with the interpretation that cellular mTORC1 
activity is inbited whtin cells exposed to VacA, as previously reported (Kim et al., 
2018). In contrast, within lysates prepared from cells that had been transfected 
with transfected with Rheb wildtype-Flag, immunoblot-specific signal densities 
corresponding to p-S6K-myc were similar in monolayers that had been incubated 
in either the absence or presence of VacA (Fig. 3.7C). These data indicated that 
similar levels of p-S6K were detected in cells overexpressing wild type Rheb, 
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independent of whether the monolayers had been incubated in the presence or 
absence of VacA. These results are consistent with the interpretation that 
overexpression of Rheb was sufficient to rescue VacA-dependent inhibition of 
mTORC1-mediated phosphorylation of cellular S6K, thereby supporting the 
model of VacA-dependent inhibition of cellular mTORC1 kinase activity, as 
previously reported (Kim et al., 2018). 
 The results described immediately above confirmed our earlier work reporting 
VacA-dependent inhibition of cellular mTORC1 kinase activity. However, these 
studies did not address a possible causal association between VacA-dependent 
inhibition of cellular mTORC1 kinase activity and inhibition of protein 
biosynthesis. AZ-521 cells were transiently transfected at 37 °C and under 5% 
CO2 with a plasmid that harbors a gene encoding Rheb wildtype-Flag, which our 
work above validated is sufficient to sustain cellular mTORC1 activity even in 
cells exposed to VacA. Next day, the cells were incubated at 37 °C and under 
5% CO2 in the absence or presence of VacA (250 nM). After 30 min, the cells 
were further incubated at 37 °C and under 5% CO2 in the presence of HPG. After 
30 min, the cells were fixed and immunostained with a Flag motif antibody. The 
cells were analyzed using flow cytometry for incorporation of HPG, which 
corresponds to proteins newly synthesized during the final 30 min of the total 
incubation period, and, fluorescence associated with detection of intracellular 
immunostaining of the Flag motif signals, which corresponds to overexpression 
of Rheb within individual cells (Fig. 3.7D). These studies revealed, as expected, 
a VacA-dependent reduction in cellular fluorescence, corresponding to the 
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incorporation of HPG, within cells transfected with a Rheb wildtype-Flag plasmid, 
but not expressing Rheb wildtype-Flag  (Fig. 3.7D and 3.7E). In cells that had 
been transfected with a plasmid harboring the gene encoding wild type Rheb and 
overexpressing Rheb wildtype-Flag, cellular fluorescence, corresponding to the 
incorporation of HPG, also was reduced in a VacA-dependent manner (Fig.  
3.7E). These data indicated that VacA-dependent reduction in cellular levels of 
newly synthesized proteins was reduced in both the presence of overexpressed 
wild type Rheb, consistent with the interpretation that although overexpressed 
Rheb rescued VacA dependent inhibition of cellular mTORC1 activity, 
overexpression of Rheb was not sufficient to rescue toxin-dependent reduction in 
cellular levels of newly synthesized proteins. These results support a model that 
host protein synthesis in AZ-521 cells is inhibited by VacA by a mechanism that 
is mTORC1-independent.  
The GCN2 dependent regulation of protein synthesis is not associated with 
the VacA dependent inhibition of protein synthesis 
 The results described immediately above indicated VacA dependent inhibition 
of protein synthesis in a manner not requiring mTORC1-mediated protein 
synthesis regulation. However, these studies did not address possible alternative 
mechanisms of protein synthesis regulation. Previously, I demonstrated that cells 
exposed to VacA become depleted in intracellular amino acid levels (Kim et al., 
2018). Under nutrient depleted conditions, cellular amino acid deficiency can 
result in suppression of cellular protein synthesis activity in a manner that is 
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directly mediated by general control nonderepressible 2 (GCN2). Upon binding to 
uncharged tRNAs that become enriched under conditions amino acid deficiency, 
GCN2 is activated though autophosphorylation at Threonine 899 (p-GCN2), 
which promotes the overall kinase activity of GCN2 (Dever and Hinnebusch, 
2005). Subsequently, activated GCN2 suppresses translational activity of 
eukaryotic initiation factor (eIF2) through direct phosphorylation of the subunit α 
at Serine 51 (p-eIF2α) (Dever and Hinnebusch, 2005). Recently, I reported that 
GCN2 is activated by VacA during Hp infection (Kim et al., 2018), suggesting the 
possibility that GCN2 mediates VacA-dependent inhibition of host protein 
synthesis. To evaluate a possible temporal association between VacA-dependent 
GCN2 activation and protein synthesis inhibition, AZ-521 cells were incubated at 
37 °C and under 5% CO2 in the absence or presence of VacA (250 nM). After 
0.5, 1, 2, 4, or, 8 h, cells were lysed and evaluated by immunoblot analyses for 
relative levels of p-GCN2. These studies revealed both a visible and quantitative 
increase in the densities of immunospecific bands corresponding to p-GCN2 
within lysates prepared from cells that had been incubated for 0.5 h in the 
presence of VacA relative to lysates prepared from cells that had been incubated 
in the absence of VacA (Fig. 3.7F). These data indicated that cellular levels of p-
GCN2 were significantly increased within 30 min, and in a VacA-dependent 
manner. Notably, VacA-dependent reduction in protein synthesis was also 
observed after cells had been exposed to VacA for 30 min (Fig. 3.7F).  
 The results described immediately above suggested a temporal association 
between VacA-dependent activation of the amino sensor GCN2 kinase activity 
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and inhibition of protein synthesis. However, these studies did not address how 
toxin-dependent phosphorylation of GCN2 might impact host cell translation. 
Because GCN2 suppresses translational activity of eukaryotic initiation factor 
(eIF2) through direct phosphorylation of the subunit α at Serine 51 (p-eIF2α) 
(Dever and Hinnebusch, 2005), I next evaluated the possibility that VacA-
dependent activation of GCN2 kinase activity might result in phosphorylation of 
the subunit α at Serine 51 (p-eIF2α). AZ-521 cells were incubated at 37 °C and 
under 5% CO2 in the absence or presence of VacA (250 nM). As a positive 
control, cells were incubated in the absence or presence of 10 µM Thapsigargin, 
a small molecule that induces phosphorylation of eIF2α (p-eIF2α) by causing ER 
stress (Jiang and Wek, 2005). After 1 h, cells were lysed and evaluated by 
immunoblot analyses for relative cellular levels of p-eIF2α. The studies revealed 
that, as expected, the densities of immuno-specific bands corresponding to p-
eIF2α were greater in cells incubated in the presence than in the absence of 
Thapsigargin (Fig. 3.7G). In contrast, the densities of immuno-specific bands 
corresponding to p-eIF2α were similar in cells incubated either in the presence or 
absence of VacA (Fig. 3.7G). These data indicated that cellular levels of p-eIF2α 
were not significantly altered in cells exposed to VacA. These results are 
consistent with the conclusion that VacA-dependent inhibition of protein 
synthesis is not likely regulated by a mechanism involving GCN2-mediated 




Amino acid deficiency within VacA intoxicated cells 
 The results described immediately above indicated that host protein synthesis 
is inhibited by VacA by a mechanism that is largely independent of mTORC1- 
and GCN2/eIF2-mediated mechanisms. However, these studies did not address 
a possible role for alterations in metabolic homeostasis, rather than translational 
regulatory circuits, as a possible mechanism for regulating VacA-dependent 
inhibition of host protein synthesis. Cellular protein synthesis can be directly 
inhibited when availability of intracellular amino acids, the building blocks for de 
novo protein synthesis, is limited (Mazor et al., 2018). Furthermore, an increase 
in p-GCN2 levels within cells (Fig. 3.8A) incubated in the presence of VacA (250 
nM) is indicative of cellular amino acid deficiency (Dever and Hinnebusch, 2005), 
suggesting the possibility that VacA-dependent inhibition of protein synthesis is 
associated with limited availability of intracellular amino acids. To investigate 
whether intracellular amino acid homeostasis is disrupted in a VacA dependent 
manner, AZ-521 cells were incubated at 37 °C and under 5% CO2 in culture 
medium (DMEM supplemented with 10% dialyzed FBS) in the absence or 
presence of VacA (250 nM). After 1 h, the cells were collected by scraping from 
plates. After completely homogenizing by sonication, the cell lysates were 
analyzed for relative abundance of individual intracellular amino acids using gas 
chromatography-tandem MS (GC-MS). The studies revealed a significant 
reduction in 15 amino acids within cells incubated in the presence of VacA 
relative to cells incubated in the absence of VacA (Fig. 3.8C). Notably, among 18 
amino acids evaluated, glutamine, which is highly available (73.8 %, Fig. 3.8B) 
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as a major carbon and energy source within cells (Yang et al., 2014), was 
detected to be most severely reduced by VacA (72.8 % reduction, Fig. 8C). 
 Furthermore, among amino acids that were reduced in a VacA dependent 
manner, alanine and aspartate are non-essential amino acids in humans. The 
intracellular homeostasis of these amino acids, even with no availability from the 
environment, can be maintained through cataplerosis (mitochondrial biosynthesis 
using TCA cycle intermediates) (Owen et al., 2002). Under the incubation 
conditions described immediately above, cells were provided with neither alanine 
nor aspartate from the culture medium, suggesting that under these culture 
conditions, the cells largely reply on mitochondrial cataplerosis for acquiring 
those amino acids. Therefore, VacA dependent-reduction in these amino acids 
suggests that mitochondrial cataplerotic activity is also inhibited by VacA. 
Together, these results indicated VacA-dependent deficiency in intracellular 
amino acids, the building blocks of cellular proteins during translation, which is 
consistent with the observation that levels of the majority of newly synthesized 
cellular proteins were reduced by VacA in a non-discriminative manner (Fig. 
3.8A). Furthermore, these studies suggested a VacA-dependent reduction in 
mitochondrial cataplerotic activity, which can possibly contribute to overall amino 
acid deficiency, implying a possible link between VacA dependent mitochondrial 




The fluxes between the intracellular pools of available amino acids are 
altered in a VacA-dependent manner  
 To maintain cellular homeostasis and function, amino acids are utilized as 
building blocks for newly replenished cellular proteins, and also metabolized 
through anaplerosis (mitochondrial synthesis of TCA cycle intermediates), a 
mechanism through which cells acquire additional energy and carbon sources for 
maintaining metabolic homeostasis even under metabolic stress. A series of 
cellular responses to restore metabolic balance are induced within VacA 
intoxicated cells (Kim et al., 2018), suggesting the possibility that cells respond to 
VacA-dependent mitochondrial energy stress by utilizing amino acids at 
mitochondria. 
 To investigate a possible utilization of amino acids at mitochondria, we 
evaluated the anaplerotic flux of amino acids into TCA cycle metabolites, in 
particular glutamine, which is highly available (Fig. 3.8B) as a major carbon and 
energy source within cells. AZ-521 cells were incubated at 37 °C and under 5% 
CO2 in glutamine tracer medium (DMEM lacking glutamine supplemented with 
13C5 glutamine and 10% dialyzed FBS) in the absence or presence of VacA (250 
nM). After 5, 15, 30, 60, 120 min, the cells were collected by scraping from 
plates. After completely homogenizing by sonication, the cell lysates were 
analyzed for relative abundance of individual cellular metabolites using GC-MS. 
The studies revealed that within cells that were incubated in the absence of 
VacA, glutamine derived 13C5 carbons began to incorporate into glutamate (Fig. 
3.9A) as early as 15 min, and then fumarate (15 min), malate (15 min), and, 
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citrate (15 min) (m+5 for glutamate, m+4 for malate, fumarate, citrate). In 
contrast, within cells incubated in the presence of VacA, glutamine derived 13C5 
carbons began to incorporate into the corresponding metabolites at a slower rate 
(Fig. 3.9B). These studies indicated that mitochondrial metabolism of cellular 
glutamine is inhibited in a VacA dependent manner, suggesting that VacA-
dependent amino acid deficiency resulted, in part, from limitations in cellular 
ability to acquire exogenous amino acids. In addition, these studies also revealed 
that mitochondrial synthesis of alanine and aspartate through cataplerotic 
reactions were also inhibited by VacA (Fig. Fig.3.9B), which can contribute to 
overall VacA-dependent amino acid deficiency. Together, these studies directly 
demonstrated a VacA-dependent decrease in anaplerosis of cellular glutamine, 
and decrease in cataplerosis of alanine and aspartate, which are consistent with 
the idea that VacA-dependent cellular amino acid deficiency, in part, resulted 
from VacA-dependent alterations in mitochondrial bioenergetics. 
VacA-dependent mitochondrial energy stress is causally associated with 
amino acid deficiency within VacA intoxicated cells  
 The results described immediately above indicated amino acid deficiency 
within VacA intoxicated cells, with the possibility that, as indicated by the 
decrease in mitochondrial cataplerosis, it may have occurred in a manner that is 
dependent on VacA actions at mitochondria. To maintain cellular homeostasis 
and function, amino acids are utilized as building blocks for newly replenished 
cellular proteins, and also metabolized through anaplerosis (mitochondrial 
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synthesis of TCA cycle intermediates), a mechanism through which cells acquire 
additional energy and carbon sources for maintaining metabolic homeostasis 
even under metabolic stress (Owen et al., 2002). A series of cellular responses 
to restore metabolic balance are induced within VacA intoxicated cells 
(Terebiznik et al., 2009), suggesting the possibility that cells respond to VacA-
dependent mitochondrial energy stress by utilizing amino acids at mitochondria. 
 To maintain energy homeostasis, cells respond to energy stress by promoting 
overall productivity of the TCA cycle, in a manner mediated by small respiratory 
factors including NAD or ATP (Berg et al., 2002). These factors, which 
accumulate under energy stress as oxidized (NAD+), or, dephosphorylated 
(ADP/AMP) form, can directly promote the activity of TCA cycle enzymes through 
allosteric binding to the regulatory sites (Berg et al., 2002). I hypothesized that 
VacA-dependent mitochondrial energy stress results in accumulation of these 
factors that could potentially promote enzymatic activity of the TCA cycle. To 
investigate a potential causality of VacA-dependent mitochondrial energy stress 
with VacA-dependent amino acid deficiency, I employed Rotenone, a small 
molecule that can suppress NAD+ generation by inhibiting NADH dehydrogenase 
activity of Complex I in the respiratory electron transport chain (ETC) (Heinz et 
al., 2017). AZ-521 cells were pre-incubated at 37 °C and under 5% CO2 in the 
absence or presence of 100 µM Rotenone. After 30 min, the cells were further 
incubated at 37 °C and under 5% CO2 in the absence or presence of VacA (250 
nM). After 1 h, the cells were lysed and evaluated by immunoblot analyses for 
relative levels of p-GCN2. These studies revealed a significant increase in 
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cellular levels of p-GCN2, as expected, within cells that were incubated in the 
presence of VacA compared to cells incubated in the absence of VacA (Fig. 
3.10A), However, the increase in p-GCN2 levels were significantly attenuated 
within cells incubated in the presence of both Rotenone and VacA (Fig. 3.10A). 
These studies indicated that VacA-dependent increase in p-GCN2 levels was 
effectively suppressed by Rotenone, suggesting that VacA-dependent amino 
acid deficiency resulted from VacA-dependent mitochondrial energy stress. The 
GC-MS analyses for evaluating individual amino acids revealed a Rotenone-
dependent prevention of amino acid deficiency. (Fig. 3.11) 
 Together, these studies indicated that VacA-dependent amino acid deficiency, 
as manifested by an increase in p-GCN2 levels, can be prevented by Rotenone, 
suggesting that VacA-dependent amino acid deficiency is causally associated 
with VacA-dependent induction of mitochondrial energy stress. 
 
3.4. Discussion 
 Host capabilities of producing cellular proteins are critical to effectively 
respond to infection. In order to colonize the harsh gastric environment, Hp 
manipulates the gastric epithelial barrier through several different mechanisms, 
including manipulating host metabolism with secreted VacA (Kim and Blanke, 
2012). VacA is a mitochondrial toxin that results in metabolic stress within host 
cells by impairing mitochondrial function, as manifested by reduction in cellular 
ATP level (Kimura et al., 1999), dysregulation of mitochondrial dynamics (Jain et 
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al., 2011), and, more recently, amino acid deficiency (Kim et al., 2018). As a 
result, mTORC1 signaling pathway, a major biosynthetic regulatory circuit, was 
inhibited (Kim et al., 2018), suggesting the possibility that host biosynthetic 
capabilities would be inhibited in response to VacA metabolic stress. Here, our 
studies indicated that, during Hp infection, host protein synthesis capabilities 
were limited by VacA in a manner resulting in the majority of host cellular 
proteins were inhibited at the translational level. Such the inhibition is consistent 
with the idea that cellular metabolic changes critically impacted the general 
translational mechanism, and our studies revealed that VacA intoxication results 
in deficiency in cellular amino acids, the building blocks for de novo protein 
synthesis. 
 The possibility that energy stress contribute to VacA-dependent inhibition of 
host protein synthesis needs further investigation. During protein synthesis, 
amino acids are polymerized through a series of peptide bonds, which consume 
5 ATP molecules per addition of single amino acid, suggesting the possibility that 
VacA-dependent energy stress, as manifested by reduction in cellular ATP levels 
(Kimura et al., 1999), can directly impede host protein synthesis. Alternatively, 
VacA-dependent reduction in availability of cellular ATP can indirectly impede 
host protein synthesis in a manner dependent on amino acid transport. 
Threonine, tryptophan, leucine, valine, isoleucine, proline, and methionine are 
essential amino acids that human cells are not able to synthesize (Owen et al., 
2002), thus largely imported from the environment. These amino acids were 
detected to be reduced in a VacA dependent manner, suggesting the possibility 
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that amino acid transport was altered in a VacA dependent manner. The 
membrane transporters that is driven by electrochemical gradients across the 
plasma membrane, which is maintained in an ATP dependent manner (Hyde et 
al., 2003). Thus, reduction in these amino acids could indirectly result from VacA-
dependent the energy stress in a manner dependent on possible reductions in 
energy availability to support the function of amino acid transporters. 
 In our proteomic analyses, the majority of host proteins were detected host 
protein synthesis was inhibited by VacA. Although VacA-dependent inhibition of 
host protein synthesis observed within 1 h VacA intoxication appears to be 
largely mTORC1-independent, the possibility that mTORC1 inhibition can 
additionally contribute to VacA-dependent inhibition of overall host protein 
synthesis needs further studies. For example, while pharmaceutical inhibition of 
mTORC1 activity can result in a global inhibition of protein synthesis (Thoreen et 
al., 2012), mTORC1-mediated translational control is preferential to translational 
factors encoded by 5’ terminal oligopyrimidine motif (5’ TOP) mRNAs, which is 
characterized by a cytosine at the penultimate nucleotide position followed by a 
stretch of 4–14 pyrimidines (Thoreen et al., 2012), which is consistent with 
numbers of translational factors identified through our in silico analyses (Fig. 
3.6B). Reduction in cellular replenishment of translational factors can gradually 
decrease the host translational capacity. I speculate that VacA dependent 
inhibition of mTORC1 activity is likely to contribute to prolonged VacA inhibitory 
effects on host protein synthesis. 
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3.5. Figures and Tables  
Figure 3.1. Incorporation of methionine is reduced by H. pylori (Hp) 
infection in a VacA dependent manner. AZ-521 cells (A - E), or, gastric slices 
(F) collected from C57BL/6J mice were incubated at 37 °C in the absence or 
presence of Hp 60190 wildtype strain (Hp (wildtype)) (A - D), a strain that is 
isogenic except for deletion of vacA (Hp (ΔvacA)) (D), the complemented strain 
in which vacA was reintroduced (Hp (ΔvacA::vacA)) (D) (MOI of 100), puromycin 
(10 μg/mL) (A - C, positive control for inhibiting protein synthesis), or VacA toxin 
(250 nM) (E, F) purified from Hp 60190. The absence or presence of VacA was 
confirmed by immunoblot analyses using rabbit VacA antiserum (D). After 1.5 h 
(A -D), or 30 min (E, F), the cells (A- E) or slices (F) were further incubated in 
medium containing 50 μM L-homopropargylglycine (HPG, a methionine analog) 
supplemented without (E, F) or with (A -D) streptomycin (bacterial protein 
synthesis inhibitor used to block HPG incorporation into Hp). After 30 min, the 
cells were fixed and analyzed for the flurorescence-tagged HPG incorporation 
within AZ-521 cells (A - E), or slices (F) using flurorescence microscopy (A, F) or 
flow cytometry (B - E). (D) The presence of VacA was confirmed by immunoblot 
analyses using anti-VacA antibodies. (A, F) Blue signals indicate nuclei (DAPI); 
red signals indicate cellular membrane (WGA); green signals indicate HPG 
incorporated during protein synthesis; white bars indicate 40 μm (A) or 200 μm 
(F). The data were combined from 3 independent experiments (represented as 
mean ± SD). Statistical significance (α = 0.05) was calculated using one-way 
ANOVA (corrected using the Dunnett’s (C) or the Tukey’s test (D)) or Students’ t 
test (E). Images are representative of those collected from the 3 experiments (A 




Figure 3.2. VacA is required and sufficient for H. pylori (Hp)-dependent 
reduction in incorporation of methionine. AZ-521 (A - C, E), human gastric 
ephithelial AGS, MKN7, or MKN45 (F), human kidney embryonic HEK293T (F), 
or, primary gastric epithelial cells collected from C57BL/6J mice (G) were 
incubated at 37 °C in the absence or presence of Hp 60190 wildtype strain (Hp 
(wildtype)) (A - C), Hp 26695 (s1m1 vacA) (A), Hp J198 (s1m2 vacA) (C), Hp 
Tx30a (s2m2 vacA) (C) (at the MOI 100 (A, C)  or, 1, 3, 10, 35, 100 (B)), or, 
VacA prepared from Hp 60190 culture (D) that had not been (E - G) or had been 
(E) pre-incubated at 4 °C for 1 h with beads pre-coated with VacA antibodies 
(αVacA) (E) or unrelated antibodies raised against the Campylobacter jejuni 
cytolethal distending toxin subunit A (αCdtA) (E). After 1.5 h (A - C) or 30 min (E - 
G), the cells were further incubated in medium containing 50 μM L-
homopropargylglycine (HPG, a methionine analog) supplemented without (E - G) 
or with (A - C) streptomycin (bacterial protein synthesis inhibitor used to block 
HPG incorporation into Hp). After 30 min, the cells were fixed and analyzed for 
the flurorescence-tagged HPG incorporation within cells using flurorescence 
microscopy (G) or flow cytometry (A - C, E, F). (E) The presence of VacA was 
confirmed by immunoblot analyses using rabbit VacA antibodies. (F) In insets, 
blue signals indicate nuclei (DAPI); red signals indicate cellular membrane 
(WGA). Green signals indicate HPG incorporated during protein synthesis; white 
bars indicate 40 μm. Images are representative of those collected from 3 
independent experiments. The data were combined from the 3 independent  
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Figure 3.2. (cont.) 
experiments (represented as mean ± SD). Statistical significance (α = 0.05) was 
calculated using one-way ANOVA (corrected using the Dunnett’s (A, B, E) or the 

















Figure 3.3. VacA-dependent reduction in newly synthesized proteins is not 
highly associated with either cell death, or, intracellular protein turnover. 
AZ-521 cells were incubated at 37 °C in the absence or presence of purified 
VacA (A, B: 0, 3, 10, 35, 100, or 250 nM; D - F: 250 nM) without or with 
proteasomal (C, D: MG132, 10 μM), or, lysosomal protease inhibitors (E, F: 
E64d+Pepstatin A (PepA), 10 μg/mL each), (A) along with 5 mM NH4Cl (reagent 
added to promote VacA cytotoxicity). After incubation (A: 1, 12, 24 h; B: 0.5, 
11.5, 23.5 h; C: 8 h; D, F: 0.5, E: 1 h), the cells were further incubated in the 
presence of 50 μM HPG for 30 min (A, D, F), and then fixed for flow cytometry 
analyses for incorporated HPG, which corresponds to proteins newly synthesized 
during the last 30 min period. Alternatively, the cells were incubated with 5 μg/mL 
DAPI (dead cell stain) and 20 μM Calcein AM (live cell stain) for 15 min at room 
temperature (A), and collected for flow cytometry analyses for the percentage of 
subpopulations of viable cells (as manifested by negative DAPI and positive 
Calcein AM signals), or, lysed and evaluated using immuno blot analyses for 
ubiquitinated proteins (ub-proteins) (C), or LC3 (E), an autophagic factor  
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Figure 3.3. (cont.) 
regulated through autophagolysosomal degradation. The data (A,B, D, F) were 
combined from 3 independent experiments and rendered as bar graphs (mean ± 
SD). Statistical significance (α = 0.05) was calculated using using one-way 
ANOVA (corrected using the Dunnett’s (A, B) against cells incubated in the 
absence of VacA at each time point (empty bar), or, Students’ t test (D, F). P < 




























Figure 3.4. VacA dependent reduction in the cellular ribosomal occupancy 
of mRNA transcripts. AZ-521 cells were incubated at 37 °C for 1 h in the 
absence or presence of purified VacA (250 nM). After 1 h, the cells were lysed, 
and the ribosomes within the lysates were separated by ultracentriguation across 
sucrose gradient (10 - 45%). The relative abundance of ribosomes across the 
gradients were investigated by measuring relative density of rRNAs (by 
absorbance at 254 nm) (A), or, a ribosomal protein S6 (by immunoblot for rpS6) 
(B), which was quantified by densitometric analyses from 3 independent 
experiments (mean ± SD) (C). The immunoblots (C) are representative of those 
collected from the 3 independent experiments. The fraction #6 - 13 are 
representive of ribosome-enriched mRNA transcripts (higher density), whereas 
the fractions #2 - 4 are representive of mRNAs associated with a single ribisome 
































Fig.3.5. Experimental procedure for Click-SILAC assay 










Table 3.1. Proteins identified from the Click-SILAC assay. 
 
Cell-associated proteins
detected in both -VacA and +VacA
rep #1 rep #2 rep #1 rep #2 exp #1 exp #2 exp#3 exp #1 exp #2 exp#3
O O O BAB14016.1 unnamed protein product [Homo sapiens] 0.022 0.873 0.853 -0.195450754705528-0.228887491786041X 0.8909 0.8557 X 0.84674 0.85985
O O O EAW61661.1
Ras-GTPase-activating protein SH3-domain-
binding protein, isoform CRA_b [Homo 
sapiens] 
0.038 0.269 0.254 -1.89700600667667-1.97877097876124X 0.2641 0.2729 X 0.24981 0.2576
O O O NP_006078.2
tubulin beta-4A chain isoform 3 [Homo 
sapiens] 
0.038 0.893 0.849 -0.163671866076022-0.235836 645040120.9135 0.872 X X 0.83333 0.86505
O O O ABC40730.1
heat shock 90kDa protein 1, alpha [Homo 
sapiens] 
0.049 0.446 0.422 -1.1658551339368- .244140438514630.474 0.4349 0.4278 0.41322 0.42827 0.42499
O O O NP_003409.1
cellular nucleic acid-binding protein isoform 3 
[Homo sapiens] 
0.055 0.264 0.276 -1.91920591804176-1. 59 6557763755-V 0.2806 0.2482 -V 0.27495 0.27632
O O O CAA25833.1
glyceraldehyde-3-phosphate dehydrogenase 
[Homo sapiens] 
0.058 0.480 0.465 -1.06009643613523-1.10519942983135X 0.503 0.4562 0.49826 0.44843 0.44783
O O O AAC52035.1 beta-tubulin [Homo sapiens] 0.063 0.858 0.825 -0.220278018792928- .2 75772572722060.9363 0.8202 0.8187 0.78309 0.83126 0.86059
O O O NP_001005.1 40S ribosomal protein S10 [Homo sapiens] 0.069 0.793 0.758 -0.333819086332176- .3996627977420490. 697 0.8422 0.7684 0.83472 0.71736 0.72202
O O O NP_076205.1 tubulin beta-2B chain [Mus musculus] 0.073 0.830 0.797 -0.268121651191569-0.3273725911377040.9245 0.7956 0.7711 0.75815 0.8244 0.80841
O O O NP_000282.1 phosphoglycerate kinase 1 [Homo sapiens] 0.074 0.390 0.370 -1.35722142488203-1. 35487464562510.3693 0.4246 0.3771 0.39793 0.369 0.34223
O O O AAD08846.1
similar to 60S ribosomal protein L7; similar to 
P18124 (PID:d133021) [Homo sapiens] 
0.074 0.493 0.452 -1.02092583885455-1.146 41515903910. 052 0.4804 X 0.42248 0.481 X
O O O NP_006280.3 talin-1 [Homo sapiens] 0.075 0.281 0.252 -1.83238515924489- . 8771164096906-V 0.2808 X 0.27027 0.24038 0.24576
O O O BAF82120.1 unnamed protein product [Homo sapiens] 0.076 0.497 0.531 -1.00839199160684-0.91320 036648828X 0.4791 0.5151 X 0.56818 0.49383
O O O NP_004850.1
clathrin heavy chain 1 isoform 1 [Homo 
sapiens] 
0.077 0.448 0.431 -1.15767815454747- .213456552543240.4974 0.4402 0.4071 0.43802 0.42445 X
O O O AAH24038.1 Tubulin, beta 2C [Homo sapiens] 0.078 0.801 0.748 -0.319675643155984-0.4 9252674090772X 0.8619 0.7406 0.72993 0.7657 X
O O O BAC03738.1 unnamed protein product [Homo sapiens] 0.078 0.283 0.260 -1.82316662921551-1. 44 6234503520.277 0.2974 0.2734 X 0.28058 0.23901
O O O CAA04006.1 Glucosidase II (plasmid) [Homo sapiens] 0.082 0.252 0.220 -1.9899363166553-2.1871 429147454X 0.2448 0.2587 -V X 0.21959
O O O WP_047149380.1 hypothetical protein [Escherichia coli] 0.083 0.530 0.486 -0.914983326511286-1.040 7 25548558X 0.5775 0.4832 0.49751 0.4878 0.47348
O O O NP_004387.1
probable ATP-dependent RNA helicase DDX5 
isoform a [Homo sapiens] 
0.084 0.344 0.374 -1.53826191397953-1.41907405433415X 0.3654 0.3232 0.39604 X 0.35186
O O O NP_002800.2
26S proteasome non-ATPase regulatory 
subunit 3 [Homo sapiens] 
0.084 0.242 0.235 -2.0445383960765-2.086 1350795612X 0.2656 0.2192 -V 0.22868 0.24219
O O O NP_031381.2
heat shock protein HSP 90-beta isoform a 
[Homo sapiens] 
0.088 0.479 0.425 -1.06235429309494-1.235963385962320. 126 0.4451 X 0.41632 0.4386 0.41876
O O O NP_003082.1
small nuclear ribonucleoprotein-associated 
proteins B and B' isoform B [Homo sapiens] 
0.092 0.559 0.490 -0.8401125212695-1.0 8641239745350.5252 0.592 X 0.48333 X 0.49702
O O O AAA52651.1 histone H3, partial [Homo sapiens] 0.092 0.529 0.474 -0.917933299310604-1.078237806318010.5236 0.5775 0.4867 X 0.4529 0.49432
O O O CAA34261.1 unnamed protein product [Homo sapiens] 0.092 0.384 0.369 -1.38176134440455-1. 3723402506994X 0.4226 0.3449 X 0.35511 0.38344
O O O NP_006588.1
heat shock cognate 71 kDa protein isoform 1 
[Homo sapiens] 
0.092 0.332 0.311 -1.59016557402977-1.685624302366530.3522 0.309 0.3352 0.35261 0.2805 0.29949
O O O NP_005013.1 profilin-1 [Homo sapiens] 0.094 0.466 0.420 -1.10242395287574-1. 49940458506240.474 0.4775 0.4457 0.45914 0.36443 0.43783
O O O NP_002583.1
proliferating cell nuclear antigen [Homo 
sapiens] 
0.096 0.524 0.544 -0.933646698507352-0. 784813689399430.580 0.452 0.5377 0.56948 X 0.5184
O O O BAD92832.1
DEAD box polypeptide 17 isoform p82 variant, 
partial [Homo sapiens] 
0.097 0.360 0.398 -1.47353049535917-1.328 28461767370.3973 0.3568 0.3262 0.43384 0.3861 0.37425
O O O BAG70074.1 14-3-3 protein beta/alpha [Homo sapiens] 0.097 0.484 0.541 -1.04602709194783- .886450393565226-V 0.4843 X 0.50251 0.57937 X
O O O BAA24447.1 alpha actinin 4 [Homo sapiens] 0.098 0.376 0.372 -1.41055608219141-1.42648 338523380.3346 0.3978 0.3961 0.35039 0.342 0.42373
O O O NP_002098.1 histone H3.3 [Homo sapiens] 0.099 0.493 0.421 -1.01897545997039-1.248587849421130.50 7 0.4983 0.4794 0.44209 0.43573 0.38476
O O O NP_036525.1
phosphoribosylformylglycinamidine synthase 
[Homo sapiens] 
0.100 0.333 0.380 -1.5859727408751-1.39643353125099X 0.3427 0.3235 X 0.407 0.35273
O O O AAI28106.1 HIST2H4B protein, partial [Homo sapiens] 0.101 0.434 0.392 -1.20589610144025- .351374959619270.4241 0.4429 X 0.43271 0.35112 X
O O O AAH20946.1 Tubulin, beta [Homo sapiens] 0.102 0.799 0.696 -0.322950365971759-0. 218271126961940.8755 0.7891 0.7337 0.71685 X 0.67613
O O O NP_009193.2
protein/nucleic acid deglycase DJ-1 [Homo 
sapiens] 
0.104 0.285 0.299 -1.81121930220786-1.74106579612867X 0.2861 0.2838 0.34002 0.30075 0.25667
O O O NP_004437.2
bifunctional glutamate/proline--tRNA ligase 
[Homo sapiens] 
0.105 0.243 0.238 -2.04334854442894-2.07135863298094X -V 0.2426 0.23408 0.27034 0.20938
O O O NP_006487.1
guanine nucleotide-binding protein G(k) 
subunit alpha [Homo sapiens] 
0.107 0.322 0.317 -1.63441943416663-1.65 79685186708X 0.3173 0.3269 X 0.35842 0.27586
O O O NP_000680.2 retinal dehydrogenase 1 [Homo sapiens] 0.107 0.507 0.448 -0.980226930959973-1.158554174431540.5702 0.4883 0.4622 0.47529 0.42017 0.44843
O O O NP_002874.1
ran GTPase-activating protein 1 [Homo 
sapiens] 
0.107 0.340 0.401 -1.55851652041736-1.319053138876250.3609 X 0.3181 X 0.39526 0.40634
O O O BAA31672.2 KIAA0697 protein, partial [Homo sapiens] 0.109 0.291 0.251 -1.78190082562986-1.99405 25289468X -V 0.2908 X 0.26853 0.23354
O O O NP_004930.1
ATP-dependent RNA helicase DDX1 [Homo 
sapiens] 
0.110 0.301 0.360 -1.73264398821611-1.474 9542769255X 0.305 0.2968 X 0.37467 0.34495
O O O NP_001419.1 alpha-enolase isoform 1 [Homo sapiens] 0.111 0.495 0.442 -1.01411101729824-1.17 093815726120. 639 0.4643 0.4572 0.47893 0.4279 0.41806
O O O AAA03427.1 54 kDa protein [Homo sapiens] 0.113 0.461 0.392 -1.11726566434855-1.350 82229298030.4857 0.465 0.4322 0.34698 0.40883 0.42034
O O O AAI07895.1 NME1-NME2 protein [Homo sapiens] 0.114 0.314 0.308 -1.67024491425525-1.69973830663791X 0.3256 0.3028 0.36284 0.27049 0.29019
O O O NP_000678.1
adenosylhomocysteinase isoform 1 [Homo 
sapiens] 
0.114 0.617 0.578 -0.697515215603031-0.7918 5201254780.6 72 0.5758 0.6469 0.68446 0.49925 0.54915
O O O NP_001348.2
ATP-dependent RNA helicase A [Homo 
sapiens] 
0.115 0.341 0.287 -1.5525794954095-1.80 47088958382X 0.3268 0.355 0.31437 0.27617 0.27071
O O O ABB01006.1 heat shock protein 60 [Homo sapiens] 0.115 0.448 0.406 -1.15961062326445-1.298869459518620.461 0.4388 0.4431 0.4686 0.41684 0.33389
O O O NP_003312.3
elongation factor Tu, mitochondrial precursor 
[Homo sapiens] 
0.116 0.454 0.418 -1.14050745460722-1.25968551313565X 0.5091 0.3981 X 0.40883 0.42644
O O O NP_002201.1
integrin alpha-V isoform 1 preproprotein 
[Homo sapiens] 
0.118 0.340 0.294 -1.55724224236523-1.768014334297580.3359 0.3437 X 0.33704 0.27012 0.27367
O O O NP_001531.1 heat shock protein beta-1 [Homo sapiens] 0.119 0.180 0.200 -2.47754244188479-2.32064216083996-V 0.1821 0.177 0.23186 0.18882 0.17986
O O O NP_000025.1
fructose-bisphosphate aldolase A isoform 1 
[Homo sapiens] 
0.119 0.340 0.386 -1.55724224236523-1.372731547322050.31 4 0.3741 0.3329 0.43879 0.35881 0.36088
O O O NP_004095.4 fatty acid synthase [Homo sapiens] 0.119 0.265 0.247 -1.91756990005405-2. 149 603456549X 0.281 0.2484 -V 0.27878 0.21608
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O O O NP_005557.1
L-lactate dehydrogenase A chain isoform 1 
[Homo sapiens] 
0.119 0.408 0.397 -1.29247520910039-1.33297006105004X 0.4071 0.4094 0.43668 0.31939 0.43478
O O O NP_001032726.1
transcription factor BTF3 isoform A [Homo 
sapiens] 
0.120 0.320 0.361 -1.64475815606912- .46803429781853X 0.3311 0.3085 X 0.40016 0.32279
O O O NP_004172.2
ubiquitin carboxyl-terminal hydrolase isozyme 
L1 [Homo sapiens] 
0.121 0.336 0.347 -1.5747555578519-1.52753178210184-V 0.2859 0.3855 0.34868 X 0.34507
O O O NP_004492.2
heterogeneous nuclear ribonucleoprotein U 
isoform b [Homo sapiens] 
0.122 0.409 0.400 -1.28859319955415- .32206650524404X 0.401 0.4177 0.47939 0.36284 0.35765
O O O AAI10390.1 HNRPR protein, partial [Homo sapiens] 0.123 0.216 0.255 -2.20889442958747-1. 7369 682684440.1978 0.2462 0.2049 0.23821 0.27255 0.25304
O O O NP_035784.1 tubulin alpha-1B chain [Mus musculus] 0.123 0.475 0.468 -1.07430433869111-1.094348238496450.5674 0.4426 0.4147 0.50942 0.42481 0.47081
O O O NP_705935.1
tropomyosin alpha-3 chain isoform Tpm3.1cy 
[Homo sapiens] 
0.123 0.314 0.304 -1.67001535024158-1.71927465222479X 0.3602 0.2683 X 0.30084 0.30656
O O O NP_001460.1
X-ray repair cross-complementing protein 6 
isoform 1 [Homo sapiens] 
0.127 0.468 0.416 -1.09490587625685-1.26414829050480.5 12 0.4079 0.4454 0.429 0.39432 0.42571
O O O NP_001814.2 creatine kinase B-type [Homo sapiens] 0.129 0.452 0.429 -1.14603095878661-1.222398907702310.5194 0.4059 0.4303 0.49875 0.37509 0.41186
O O O NP_000995.1
60S acidic ribosomal protein P2 [Homo 
sapiens] 
0.129 0.294 0.237 -1.76415042349244-2.076491932234910. 955 0.3065 0.2812 0.2419 0.2517 0.21768
O O O NP_003371.2 vimentin [Homo sapiens] 0.130 0.289 0.245 -1.79235698731347-2.0278 2663463830.2817 0.3209 0.2635 0.2681 0.25265 0.21492
O O O NP_060502.1
putative RNA-binding protein Luc7-like 1 
isoform a [Homo sapiens] 
0.131 0.386 0.358 -1.37164632865016-1.48364740011562X 0.3774 0.3955 X 0.41305 0.30211
O O O NP_009089.4
cold shock domain-containing protein E1 
isoform 2 [Homo sapiens] 
0.133 0.274 0.309 -1.86722576672367-1. 9329364388574X 0.3129 0.2353 0.32082 X 0.29762
O O O NP_001777.1
cyclin-dependent kinase 1 isoform 1 [Homo 
sapiens] 
0.136 0.305 0.325 -1.7112280327526-1.623 36990827650.3265 0.3192 0.2705 0.25773 0.35945 0.35663
O O O NP_000475.1
amyloid-beta A4 protein isoform a precursor 
[Homo sapiens] 
0.137 0.312 0.271 -1.68038206579984-1.882836686117640.355 0.3097 0.2706 0.23646 0.29265 0.28433
O O O BAD96744.1 tubulin alpha 6 variant, partial [Homo sapiens] 0.140 0.474 0.459 -1.07841133351531-1.12294 859705780.559 X 0.3876 0.4845 0.42481 0.46816
O O O NP_004166.1
small nuclear ribonucleoprotein Sm D3 [Homo 
sapiens] 
0.141 0.588 0.614 -0.766766371699448-0.703065 617854020.6876 0.6174 0.4582 -V 0.61728 0.61125
O O O CAA56074.1 translation initiation factor [Homo sapiens] 0.141 0.579 0.510 -0.787534418568843-0.970 521000720350.59 1 0.5124 0.6285 0.54555 0.57438 0.41068
O O O AAH08633.1 actin, beta, partial [Homo sapiens] 0.142 0.680 0.574 -0.557136103314904-0.800556930777596X 0.7126 0.6467 0.64599 X 0.50226
O O O NP_002296.1 galectin-1 [Homo sapiens] 0.142 0.221 0.274 -2.17984146526984-1.865 20111905710.2262 0.2347 0.2012 0.29248 -V 0.25621
O O O NP_001961.1
eukaryotic translation initiation factor 5A-1 
isoform B [Homo sapiens] 
0.143 0.515 0.472 -0.956795501434832-1.0845 648553070. 804 0.4528 0.5124 0.54113 0.40193 X
O O O AAI03761.1 ALDOC protein, partial [Homo sapiens] 0.143 0.311 0.395 -1.68578687024064-1.3384 3487843220.309 0.3202 0.303 0.38805 0.36928 0.429
O O O NP_002558.1
phosphatidylethanolamine-binding protein 1 
[Homo sapiens] 
0.144 0.160 0.182 -2.6474674433271-2.45894753865608X 0.1806 0.1386 -V 0.16714 0.19662
O O O BAF82705.1 unnamed protein product [Homo sapiens] 0.144 0.307 0.342 -1.70368943929191-1.54 5 040805890.3579 0.282 0.2811 0.373 0.36941 0.28273
O O O AAC03787.1
malate dehydrogenase precursor [Homo 
sapiens] 
0.146 0.301 0.374 -1.73424307399376-1.41708166277210.3214 0.3139 0.2664 0.39683 X 0.35211
O O O NP_066953.1
peptidyl-prolyl cis-trans isomerase A isoform 
1 [Homo sapiens] 
0.147 0.468 0.364 -1.09634466613051-1.457125807343470.4976 0.4705 0.435 0.38491 0.34352 X
O O O AAA63192.1 histone H2B.1, partial [Homo sapiens] 0.149 0.743 0.575 -0.429342779694709-0.7972185626717720.7164 0.774 0.7374 0.60716 0.59701 0.52219
O O O NP_005753.1
transcription intermediary factor 1-beta [Homo 
sapiens] 
0.150 0.400 0.432 -1.32192809488736-1.2106 8653020330. 696 0.4122 0.4182 0.53562 0.36738 0.39324
O O O AEX07732.1
YWHAE/FAM22A fusion protein, partial [Homo 
sapiens] 
0.150 0.416 0.419 -1.26557578617705-1.255028049411140.4955 0.4237 0.3286 0.46232 0.36023 0.4344
O O O NP_006699.2 lactoylglutathione lyase [Homo sapiens] 0.151 0.271 0.346 -1.88496675705376-1.531 2966798007-V 0.2585 0.283 X 0.36232 0.3296
O O O NP_001015.1 40S ribosomal protein S21 [Homo sapiens] 0.151 0.394 0.347 -1.34483138239041-1.5289992793566X 0.4246 0.3628 X 0.29542 0.39761
O O O NP_001422.1
band 4.1-like protein 2 isoform a [Homo 
sapiens] 
0.151 0.255 0.309 -1.97114799415251-1.69242719808971X 0.2281 0.282 -V 0.30941 X
O O O XP_001152516.2 glutathione S-transferase P [Pan troglodytes] 0.153 0.293 0.254 -1.77324487673018-1.9 949366750853X 0.3255 0.2596 X 0.28137 0.22578
O O O AAH00606.1 Ribosomal protein L14 [Homo sapiens] 0.153 0.565 0.442 -0.82316662921551-1.17863722815750.6012 0.5292 X -V 0.43611 0.44743
O O O NP_002005.1
peptidyl-prolyl cis-trans isomerase FKBP4 
[Homo sapiens] 
0.154 0.371 0.376 -1.42960183788195-1.413013528173190.3 69 0.4059 0.3909 0.40437 0.43403 0.28818
O O O NP_001226.2 serpin H1 precursor [Homo sapiens] 0.154 0.413 0.420 -1.2748550916251-1.251461332817330.5098 0.3975 0.3325 X 0.43271 0.40733
O O O NP_001952.1 elongation factor 2 [Homo sapiens] 0.155 0.534 0.470 -0.903828121374311- .089164961460350.6247 0.4916 0.4871 0.55617 0.4075 0.44643
O O O NP_006420.1
T-complex protein 1 subunit eta isoform a 
[Homo sapiens] 
0.156 0.656 0.616 -0.6083055895814-0.6998759483327210.7576 0.6901 0.5202 0.72098 0.56786 0.55804
O O O NP_006382.1 importin-7 [Homo sapiens] 0.157 0.272 0.334 -1.87885194352469-1.5836 2390146320.281 0.2673 0.2674 0.39401 0.30404 0.30285
O O O NP_008996.1 hsp90 co-chaperone Cdc37 [Homo sapiens] 0.160 0.340 0.328 -1.55533293315809-1.609924432343450.377 X 0.3032 0.38081 X 0.27442
O O O NP_001312.1
cysteine and glycine-rich protein 2 [Homo 
sapiens] 
0.160 0.139 0.173 -2.85100083741224-2.53441862774548X +V 0.1386 X 0.15586 0.18936
O O O BAH13327.1 unnamed protein product [Homo sapiens] 0.160 0.648 0.606 -0.625266521968786-0.72375 8291745430.5831 0.7135 X 0.70522 0.50582 X
O O O NP_003510.1 histone H2B type 1-L [Homo sapiens] 0.161 0.667 0.505 -0.584313433981822-0.9855114340463450.6464 0.7213 0.6332 X 0.5339 0.47619
O O O AAH04534.2 SFPQ protein, partial [Homo sapiens] 0.161 0.310 0.307 -1.68764461708933-1. 56 0820218110.3835 0.2316 0.3162 0.32755 0.30303 0.28918
O O O NP_001117.2
adenylosuccinate synthetase isozyme 2 
[Homo sapiens] 
0.162 0.254 0.215 -1.97482942426509-2.21516151135082X 0.2812 0.2276 -V 0.24155 0.18918
O O O NP_001395.1 elongation factor 1-gamma [Homo sapiens] 0.163 0.260 0.222 -1.94119864638381-2.17169387421758-V 0.2959 0.2249 -V 0.20421 0.23969
O O O NP_005338.1
endoplasmic reticulum chaperone BiP 
precursor [Homo sapiens] 
0.166 0.293 0.280 -1.76905922387606-1.834 55021903260.2 92 X 0.2876 0.34329 0.21191 0.28588
O O O BAA23735.1 cytochrome b5, partial [Homo sapiens] 0.166 0.244 0.304 -2.03563833675327-1.71 55244496037X 0.2757 0.2121 X 0.3202 0.28877
O O O NP_000909.2
protein disulfide-isomerase precursor [Homo 
sapiens]
0.167 0.291 0.305 -1.78239702341321-1.71 494906650090.2219 0.3266 0.3236 0.30534 X -V
O O O NP_006358.1
adenylyl cyclase-associated protein 1 isoform 
a [Homo sapiens] 
0.167 0.266 0.222 -1.91068264934171-2.16875 783504780.28 3 0.2796 0.238 0.27412 0.18392 0.20916
O O O NP_009057.1
transitional endoplasmic reticulum ATPase 
isoform 1 [Homo sapiens] 
0.169 0.432 0.398 -1.2095615718148-1.329714881754290.4632 0.4358 0.3982 0.51493 0.35063 0.32798
O O O NP_919223.1
heterogeneous nuclear ribonucleoprotein A3 
isoform a [Homo sapiens] 
0.170 0.337 0.321 -1.5703215538394-1.640453513415750. 708 0.2478 0.3916 0.33047 X 0.31104
O O O Q00341.2
RecName: Full=Vigilin; AltName: Full=High 
density lipoprotein-binding protein; Short=HDL-
binding protein 
0.171 0.286 0.215 -1.80389660228519-2. 149079041988X 0.2845 0.2883 X 0.23068 0.20012
O O O NP_001007.2 40S ribosomal protein S12 [Homo sapiens] 0.171 0.330 0.403 -1.60011798997333-1.31084579403115X 0.2732 0.3865 X 0.40016 0.40601
O O O NP_001960.2
eukaryotic translation initiation factor 5 [Homo 
sapiens] 
0.172 0.058 0.072 -4.10631161781015-3. 922 924782511X 0.05806 -V 0.0841 0.06101 0.07143
O O O NP_006301.3
puromycin-sensitive aminopeptidase isoform 
1 [Homo sapiens] 
0.172 0.284 0.386 -1.8170535054889-1.37427474792715-V X 0.2838 0.37133 0.40016 X
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O O O NP_002810.1 polypyrimidine tract-binding protein 1 isoform a [Homo sapiens] 0.173 0.381 0.371 -1.39062325123669-1.4 912760073680.4162 0.3839 0.3441 0.4562 0.39063 0.26724
O O O NP_002769.1 prosaposin isoform a preproprotein [Homo sapiens] 0.173 0.459 0.361 -1.12202022722934-1.467 95053040330.4602 X 0.4587 0.41442 0.30855 X
O O O NP_035995.1 poly(rC)-binding protein 1 [Mus musculus] 0.176 0.405 0.359 -1.30454061736144-1.478751352180930.3571 X 0.4526 0.43459 0.28994 0.35186
O O O XP_016873759.1 neuroblast differentiation-associated protein AHNAK isoform X1 [Homo sapiens] 0.177 0.327 0.241 -1.61072689651209-2.0 4042891087560.335 0.3504 0.2962 X 0.24857 0.23305
O O O NP_003325.2 ubiquitin-like modifier-activating enzyme 1 [Homo sapiens] 0.178 0.391 0.435 -1.35463650069246-1.202104970604240.5146 0.3517 0.3068 0.44111 0.42248 0.44033
O O O NP_005907.3 DNA replication licensing factor MCM7 isoform 1 [Homo sapiens] 0.178 0.383 0.417 -1.38320319326293- .260 22136277470.4 92 0.3149 0.406 X 0.49261 0.34235
O O O WP_071211971.1 50S ribosomal protein L11 [Acinetobacter baumannii] 0.181 0.131 0.176 -2.93401417050142-2.50581725687442X 0.1271 0.1346 X 0.16493 0.1872
O O O BAG51276.1 unnamed protein product [Homo sapiens] 0.181 0.379 0.381 -1.40023788021928-1.390500118753280.392 0.3278 0.4168 0.47939 0.38314 0.28177
O O O AAV38817.1
tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, theta 
polypeptide [Homo sapiens] 
0.182 0.531 0.412 -0.912944565456624-1.278159729148120.5792 0.483 X 0.45331 0.37133 X
O O O EAX00138.1 spectrin, beta, non-erythrocytic 1, isoform CRA_b [Homo sapiens] 0.182 0.244 0.326 -2.03622996892924-1.615416297262870.2309 -V 0.2567 0.32637 -V X
O O O NP_002124.1 heme oxygenase 1 [Homo sapiens] 0.185 0.276 0.374 -1.85673720696138-1.41909484491455X 0.2995 0.2527 X 0.38226 0.36563
O O O BAA75063.1 apg-1 [Homo sapiens] 0.186 0.403 0.392 -1.31019393492129-1.3519 3400421720.5177 0.3381 0.354 0.44924 0.39777 0.3283
O O O NP_003356.2 cytochrome b-c1 complex subunit 1, mitochondrial precursor [Homo sapiens] 0.186 0.349 0.382 -1.52035552542376-1.38949898031654-V 0.3856 0.3116 0.31566 0.35051 0.47893
O O O XP_011536691.1 nascent polypeptide-associated complex subunit alpha isoform X2 [Homo sapiens] 0.187 0.276 0.204 -1.85970123189607- .290444137201350.2914 0.282 0.2532 X 0.23326 0.17556
O O O NP_002148.1 10 kDa heat shock protein, mitochondrial [Homo sapiens] 0.188 0.288 0.250 -1.79510807516277-1.999381518215130.34 8 X 0.2345 0.26525 X 0.23496
O O O BAD96306.1 minichromosome maintenance protein 3 variant, partial [Homo sapiens] 0.189 0.329 0.358 -1.6034020684251-1.48 645942717220.4003 0.3376 0.2494 0.4075 0.3811 0.2849
O O O NP_004037.1 ATP synthase subunit alpha, mitochondrial isoform a precursor [Homo sapiens] 0.191 0.557 0.573 -0.844337107131225-0.802606733888860.6 93 0.5017 0.4799 0.71633 0.5184 0.4852
O O O NP_002257.1 importin subunit alpha-1 [Homo sapiens] 0.192 0.270 0.218 -1.88754450680371-2.199093860516490.3327 0.2543 0.2238 0.23267 0.20044 0.22022
O O O NP_001892.1 connective tissue growth factor precursor [Homo sapiens] 0.192 2.853 2.667 1.512226886513961.415 2 01711934+V 3.329 2.376 X 3.09023 2.24417
O O O NP_000405.1 peroxisomal multifunctional enzyme type 2 isoform 2 [Homo sapiens] 0.195 0.432 0.330 -1.21156485152694-1.60137728828816X 0.4318 -V X 0.29053 0.3686
O O O NP_004648.1 caveolae-associated protein 2 [Homo sapiens] 0.195 0.337 0.307 -1.56810965171382-1.703663687659-V 0.3617 0.3128 -V 0.23708 0.37693
O O O NP_001062.1 thymidylate synthase [Homo sapiens] 0.196 0.540 0.447 -0.89030513517407- .162694998356860.56 9 0.5589 0.4937 0.5005 0.53419 0.30534
O O O NP_001101.1
disintegrin and metalloproteinase domain-
containing protein 10 isoform 1 preproprotein 
[Homo sapiens] 
0.200 0.347 0.252 -1.52616114710497- .98908252311409X 0.3472 -V -V 0.2661 0.2377
O O O NP_004334.1 calreticulin precursor [Homo sapiens] 0.201 0.245 0.272 -2.02659689409801-1.878670209034830.3285 0.2318 0.176 0.25523 0.28868 0.27189
O O O AAH02488.1 SERPINE1 mRNA binding protein 1 [Homo sapiens] 0.202 0.258 0.255 -1.95530280079376-1.9 07 1288033180.2855 0.2589 0.2292 0.33102 0.17746 0.25687
O O O EAW52998.1 lamin A/C, isoform CRA_c [Homo sapiens] 0.202 0.259 0.219 -1.94814070116475-2. 917041323693X 0.2177 0.3006 X 0.25006 0.18772
O O O NP_032168.1
guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 [Mus 
musculus] 
0.202 0.265 0.228 -1.91702497274223-2.13299085005899X 0.2171 0.3125 X 0.20028 0.25569
O O O BAE06117.1 ACLY variant protein, partial [Homo sapiens] 0.202 0.304 0.276 -1.7159597360459-1.857 7075820451X 0.3685 0.2403 X 0.30157 0.25031
O O O EAX00968.1 hCG23833, isoform CRA_b [Homo sapiens] 0.204 0.438 0.602 -1.19017400390255- .7320 2073300289X 0.4718 0.4047 X -V 0.60205
O O O AAC18044.1 antigen NY-CO-25, partial [Homo sapiens] 0.204 0.350 0.357 -1.51581029885173-1.4 6859447195380.3977 0.3221 0.3293 0.44924 X 0.26434
O O O NP_005498.1 cofilin-1 [Homo sapiens] 0.204 0.351 0.318 -1.51251365065146-1.65351 361534610.4 85 0.2806 0.3124 0.34941 0.33501 0.26918
O O O NP_004035.2 bifunctional purine biosynthesis protein PURH [Homo sapiens] 0.205 0.291 0.285 -1.78041325542668-1.80924 44835133X 0.2969 0.2853 0.3667 0.28835 0.20096
O O O AAK74072.1 heat shock protein gp96 precursor, partial [Homo sapiens] 0.205 0.380 0.304 -1.39504308282008-1.717935461839210.3 15 0.3625 0.3967 0.24534 0.26192 0.40469
O O O NP_003891.1 sequestosome-1 isoform 1 [Homo sapiens] 0.205 0.323 0.296 -1.63247982629068-1.754836788324020.2178 0.4037 0.3461 0.27049 0.31309 0.30534
O O O NP_000996.2 40S ribosomal protein S3 isoform 1 [Homo sapiens] 0.207 0.630 0.620 -0.66611834053191-0.6905785446687140.7915 0.51 0.5891 0.78309 0.5637 0.51203
O O O WP_079866251.1 hypothetical protein [Acinetobacter baumannii] 0.208 0.360 0.346 -1.47573568517916-1. 2943385766647-V 0.3703 0.3488 -V 0.43516 0.25767
O O O NP_002286.2 40S ribosomal protein SA isoform 1 [Homo sapiens] 0.208 0.403 0.299 -1.31258092262811-1.74026398008988X 0.4227 0.3825 -V 0.25189 0.34674
O O O NP_006089.1 receptor of activated protein C kinase 1 [Homo sapiens] 0.209 0.609 0.432 -0.716078227692383-1.212442 19420630.6517 X 0.5658 0.41824 0.44484 X
O O O NP_115834.1 PHD finger protein 6 isoform 1 [Homo sapiens] 0.213 0.375 0.268 -1.41522987144273-1.902 0686423836X 0.3656 0.3843 0.21988 0.29429 0.28843
O O O BAG70050.1 nucleophosmin 1 isoform 1 [Homo sapiens] 0.213 0.423 0.404 -1.24218021876503-1.30 797882355670.3582 0.5173 0.3927 X 0.3124 0.49603
O O O AAH03170.1 Ubiquitin associated protein 2-like [Homo sapiens] 0.214 0.255 0.361 -1.96973455714233-1.46840110299410. 553 -V X 0.39479 X 0.32798
O O O NP_004491.2 heterogeneous nuclear ribonucleoproteins C1/C2 isoform b [Homo sapiens] 0.214 0.480 0.385 -1.05979565534796-1.37662857451606X 0.5154 0.444 0.46948 0.30075 X
O O O NP_004721.1 eukaryotic peptide chain release factor subunit 1 isoform 1 [Homo sapiens] 0.217 0.315 0.251 -1.6688680777828-1.99364425432605-V 0.3121 0.3169 0.21701 0.20572 0.33058
O O O AEE02017.1 NF45 [Homo sapiens] 0.219 0.327 0.385 -1.61058003490043-1.378170510193850.43 7 0.2827 0.26 0.37037 0.39904 X
O O O NP_005304.3 protein disulfide-isomerase A3 precursor [Homo sapiens] 0.220 0.340 0.365 -1.55582769666813-1.452136395158880.4631 0.2512 0.3061 0.35689 0.41894 0.32062
O O O NP_001753.1 T-complex protein 1 subunit zeta isoform a [Homo sapiens] 0.221 0.375 0.358 -1.41414010152598- .480201188729250.504 0.3415 0.2802 0.3937 0.38462 0.297
O O O NP_006422.1 T-complex protein 1 subunit beta isoform 1 [Homo sapiens] 0.221 0.345 0.341 -1.53554083438701-1.554215974080510. 272 0.2627 X 0.41771 0.31656 0.28727
O O O AAH68456.2
Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta 
polypeptide [Homo sapiens] 
0.221 0.461 0.338 -1.1160664382024-1.566956808857960.5041 X 0.4186 0.36075 0.26911 0.3827
O O O AAB00969.1 ribosomal protein, partial [Homo sapiens] 0.222 0.440 0.333 -1.18562731821909-1.58527163135640.5048 0.4465 0.3676 0.25132 0.3827 0.36576
O O O NP_003137.1 FACT complex subunit SSRP1 [Homo sapiens] 0.222 0.263 0.228 -1.92494663539549-2.1 409161943487-V 0.2472 0.2795 0.14848 0.26151 0.27345
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O O O NP_002128.1 heterogeneous nuclear ribonucleoproteins A2/B1 isoform A2 [Homo sapiens] 0.225 0.403 0.352 -1.31102893145427-1.5063 2597091390.5367 0.3741 0.2983 0.38536 0.35461 0.31606
O O O NP_003365.1 voltage-dependent anion-selective channel protein 1 [Homo sapiens] 0.227 0.234 0.193 -2.09357114068631-2.376514744447180.1781 0.2963 0.2285 0.22889 0.16764 0.18119
O O O NP_002725.1 cAMP-dependent protein kinase type I-alpha regulatory subunit isoform a [Homo sapiens] 0.228 0.318 0.325 -1.65214539797931-1.623688908080040.3311 0.2195 0.4039 0.39479 0.25687 0.32185
O O O NP_116126.3 lamin-B2 [Homo sapiens] 0.230 0.245 0.168 -2.02973532098547-2.56939039718339X 0.2397 0.2501 X 0.1895 0.14745
O O O NP_055316.2 ubiquitin-conjugating enzyme E2 S [Homo sapiens] 0.230 0.301 0.295 -1.73424307399376-1.761793003741310. 198 0.3393 0.2426 -V 0.2124 0.37736
O O O AAH16148.1 Integral membrane protein 2B [Homo sapiens] 0.236 0.559 0.426 -0.839337919886656-1.23048946769780.5962 0.6559 0.4246 0.44131 0.34118 0.49603
O O O NP_002565.1 peroxiredoxin-1 [Homo sapiens] 0.237 0.384 0.307 -1.38132280670717-1.703969188689730.4906 0.3631 0.2979 0.2805 0.36657 0.27375
O O O NP_000959.2 60S ribosomal protein L4 [Homo sapiens] 0.237 0.436 0.425 -1.1988137459868-1.23405737293830.56 2 0.3866 0.3571 0.5168 X 0.33344
O O O NP_002283.3 laminin subunit beta-2 precursor [Homo sapiens] 0.239 0.106 0.139 -3.23575576975504-2.8516420667793X 0.09591 0.1164 0.14569 0.16697 0.10295
O O O NP_003065.3 SWI/SNF complex subunit SMARCC1 [Homo sapiens] 0.242 0.179 0.235 -2.48358135836613-2.08 9066225274X 0.1738 0.1838 X 0.189 0.28177
O O O NP_001407.1 eukaryotic initiation factor 4A-I isoform 1 [Homo sapiens] 0.246 0.691 0.551 -0.532755304649928-0.8586704693307070.5698 0.9139 0.59 0.5637 0.62383 0.46685
O O O AAH07392.2 HNRPDL protein, partial [Homo sapiens] 0.248 0.348 0.264 -1.52367016224286- .9 015468470020.4 85 0.3256 0.2693 0.28944 0.26103 0.2401
O O O NP_002620.1 phosphoglycerate mutase 1 isoform 1 [Homo sapiens] 0.248 0.251 0.354 -1.99404915046525- .497939256433580.302 0.198 0.2531 0.41442 0.35075 0.297
O O O NP_003624.1 ectoderm-neural cortex protein 1 isoform 1 [Homo sapiens] 0.249 1.083 1.145 0.114944431653720. 948580567978641.214 1.173 0.8618 1.45455 1.27307 0.70621
O O O NP_035322.1 proteasome activator complex subunit 3 [Mus musculus] 0.251 0.279 0.255 -1.84321509244564-1.9706 0567229770.3 37 0.2851 0.2273 0.33523 0.17504 X
O O O NP_005889.3 caprin-1 isoform 1 [Homo sapiens] 0.254 0.323 0.210 -1.62875712452728-2.2 656601002640.3664 0.3163 0.2874 0.20786 0.19794 0.22371
O O O NP_001527.3 protein arginine N-methyltransferase 1 isoform 1 [Homo sapiens] 0.256 0.402 0.259 -1.31311853956777-1. 48 1563675247X 0.4166 0.3883 -V 0.24337 0.27473
O O O NP_000980.1 60S ribosomal protein L30 [Homo sapiens] 0.256 0.436 0.507 -1.19671784732886-0.9789449240685350. 933 0.4244 0.3911 0.70572 0.3888 0.42753
O O O Q9P2E9.4
RecName: Full=Ribosome-binding protein 1; 
AltName: Full=180 kDa ribosome receptor 
homolog; Short=RRp; AltName: Full=ES/130-
related protein; AltName: Full=Ribosome 
receptor protein 
0.256 0.136 0.135 -2.87461339463419-2.89188501116606X 0.1593 0.1134 -V 0.17044 0.09901
O O O NP_000977.1 60S ribosomal protein L24 [Homo sapiens] 0.258 0.406 0.391 -1.29991545050691-1.3 317281011232X 0.5224 0.2899 -V 0.43898 0.34388
O O O NP_036565.2 splicing factor 3B subunit 1 isoform 1 [Homo sapiens] 0.258 0.254 0.185 -1.97880457548551-2.43421362334155-V 0.245 0.2624 0.23381 0.13624 X
O O O EAW70563.1
X-ray repair complementing defective repair in 
Chinese hamster cells 5 (double-strand-break 
rejoining; Ku autoantigen, 80kDa), isoform 
CRA_b [Homo sapiens] 
0.260 0.552 0.446 -0.857956950410596-1.163644515245010.7459 0.4691 0.4402 0.52826 0.38536 0.42553
O O O NP_000810.1 trifunctional purine biosynthetic protein adenosine-3 isoform 1 [Homo sapiens] 0.262 0.286 0.320 -1.80490442282278-1.64192174601934X 0.3548 0.2176 0.40866 0.31766 0.23496
O O O NP_008950.1 ubiquitin-conjugating enzyme E2 C isoform 1 [Homo sapiens] 0.264 0.407 0.411 -1.29672207601863-1.28 78263947782X 0.4056 0.4085 0.54348 -V 0.2791
O O O NP_002511.1 nucleophosmin isoform 1 [Homo sapiens] 0.272 0.426 0.445 -1.23242994404826-1.16750 419506370.3939 0.5173 0.3656 0.58207 0.25747 0.49603
O O O NP_003079.1 fascin [Homo sapiens] 0.273 0.235 0.216 -2.09172508152094-2.210451630040780.1615 0.3383 0.204 0.21441 0.19019 0.24361
O O O NP_001000.2 40S ribosomal protein S5 [Homo sapiens] 0.275 0.470 0.506 -1.08967667135019-0.984 935999549640.5562 0.4676 0.3858 0.72622 0.37651 0.41391
O O O NP_002902.2 regulator of nonsense transcripts 1 isoform 2 [Homo sapiens] 0.278 0.187 0.271 -2.42159258624638-1.88380453998283X 0.1462 0.2271 X 0.30039 0.24155
O O O NP_002130.2 RNA-binding motif protein, X chromosome isoform 1 [Homo sapiens] 0.279 0.311 0.217 -1.68362251808027-2.2 665810687107-V 0.2905 0.3321 -V 0.1599 0.27337
O O O NP_000886.1 leukotriene A-4 hydrolase isoform 1 [Homo sapiens] 0.281 0.396 0.263 -1.33752102957675-1. 2 29245405628X 0.3325 0.4589 X 0.25543 0.27042
O O O XP_011509878.1 E3 SUMO-protein ligase RanBP2 isoform X6 [Homo sapiens] 0.282 0.229 0.150 -2.12973392960402-2.7353 554015507-V 0.1938 0.2632 0.15017 X -V
O O O AAH00064.1 YBX1 protein, partial [Homo sapiens] 0.282 0.283 0.181 -1.8216359181532-2.467166324959810.282 -V X 0.19497 0.16672 X
O O O NP_001340.2 aspartate--tRNA ligase, cytoplasmic isoform 1 [Homo sapiens] 0.284 0.386 0.227 -1.3737010510082-2. 3815914522947X 0.4099 0.3619 X 0.22717 -V
O O O NP_001740.1 calpain small subunit 1 isoform 1 [Homo sapiens] 0.285 0.273 0.398 -1.87302714374224- . 29666610527310.1859 0.3535 0.2796 0.41964 0.37608 X
O O O BAD92119.1 chaperonin containing TCP1, subunit 3 (gamma) variant, partial [Homo sapiens] 0.285 0.482 0.591 -1.05304461335688-0.759917069063117X 0.5205 0.4434 0.80192 0.56497 0.40469
O O O AAH00608.1 ANP32A protein, partial [Homo sapiens] 0.286 0.301 0.281 -1.73392311501243- .82975 540902770.4418 0.2637 0.1964 0.31027 0.24771 0.28596
O O O AAH66320.1 Ribosomal protein L13 [Homo sapiens] 0.288 0.506 0.381 -0.981650690121108-1.39 3 564656333-V 0.4737 0.5391 -V 0.25634 0.50556
O O O NP_000173.2 trifunctional enzyme subunit alpha, mitochondrial precursor [Homo sapiens] 0.290 0.601 0.908 -0.735403520509118-0.1388 4468902282X 0.501 0.7003 -V 0.90827 -V
O O O AAH16736.1 HNRPF protein [Homo sapiens] 0.290 0.344 0.505 -1.54105810642554-0.9864128759415490.4107 0.2452 0.375 0.4717 0.62073 0.42176
O O O NP_001203.1
complement component 1 Q subcomponent-
binding protein, mitochondrial precursor 
[Homo sapiens] 
0.290 0.291 0.222 -1.78140479844914-2.173753168457010.253 0.3281 -V 0.28885 X 0.15442
O O O NP_001900.1 cathepsin D preproprotein [Homo sapiens] 0.291 0.497 0.317 -1.01013437713371-1.6560 430442774X 0.5038 0.4892 0.36765 0.35817 0.22609
O O O NP_003225.2 transferrin receptor protein 1 isoform 1 [Homo sapiens] 0.293 0.263 0.370 -1.92686529536978-1.4 34 041296473X 0.2841 0.2419 0.4223 0.24944 0.43898
O O O NP_002614.2 prefoldin subunit 4 [Homo sapiens] 0.293 0.191 0.228 -2.39062325123669- . 3047230590743X 0.2034 0.178 -V 0.15924 0.29753
O O O NP_001950.1 elongation factor 1-beta [Homo sapiens] 0.293 0.346 0.212 -1.53129505168233-2.234721556108560.37 4 0.3499 0.3176 0.26371 0.15977 0.2139
O O O AAD34054.1 CGI-59 protein [Homo sapiens] 0.296 0.485 0.333 -1.04483601238305-1.58 09002299637X 0.5818 0.3876 -V 0.36311 0.30211
O O O NP_002778.1 proteasome subunit alpha type-2 [Homo sapiens] 0.298 0.383 0.595 -1.38332863955151-0.7493197245740810. 399 0.2765 0.4336 -V X 0.59488
O O O EAX05489.1
phosphoribosylaminoimidazole carboxylase, 
phosphoribosylaminoimidazole 
succinocarboxamide synthetase, isoform 
CRA_a [Homo sapiens] 
0.299 0.290 0.248 -1.78819864281671-2.01020 294290730.26 6 0.3269 0.2721 0.38358 0.16964 0.1915
O O O NP_004528.1 nucleosome assembly protein 1-like 1 isoform 1 [Homo sapiens] 0.300 0.281 0.285 -1.82998950805125-1. 12950956159330.3965 0.2124 0.2349 0.38358 0.2582 0.21204
O O O AAC02114.1 NACP/alpha-synuclein [Homo sapiens] 0.302 0.403 0.250 -1.31186441154266-1.997144294267030.3692 0.4417 0.3975 0.16351 0.29317 0.29481
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O O O NP_000933.1 peptidyl-prolyl cis-trans isomerase B precursor [Homo sapiens] 0.305 0.542 0.447 -0.882836924534241-1.16219 03263510.4174 0.7629 0.4466 0.3758 X 0.51787
O O O NP_036339.1 heterogeneous nuclear ribonucleoprotein H3 isoform a [Homo sapiens] 0.307 0.366 0.344 -1.44850859145251-1.5 090790108152-V 0.3007 0.4321 0.45851 0.22883 X
O O O NP_003861.1 ras GTPase-activating-like protein IQGAP1 [Homo sapiens] 0.309 0.236 0.298 -2.08069805937192-1.74808 33170791X 0.1913 0.2815 0.41271 0.24728 0.2331
O O O AAH11827.1 MSN protein, partial [Homo sapiens] 0.309 0.398 0.402 -1.32825373313678-1. 5207229560150.4724 0.3241 X 0.5339 0.26983 X
O O O NP_006147.1 NEDD8 precursor [Homo sapiens] 0.310 0.322 0.190 -1.63307635102148-2.39506279951758X 0.3627 0.2821 X 0.19011 -V
O O O NP_001545.2 protein CYR61 precursor [Homo sapiens] 0.313 0.952 0.727 -0.0711938546593736-0. 0761 296308X 1.212 0.6917 X 0.82781 0.62539
O O O 5T0G_I Chain I, Structural Basis For Dynamic Regulation Of The Human 26s Proteasome 0.314 0.281 0.291 -1.82896401692345-1.77990717735260.4 99 0.2069 0.1976 0.31756 0.3046 0.25145
O O O NP_004431.1 ephrin type-A receptor 7 isoform 1 precursor [Homo sapiens] 0.314 0.248 0.315 -2.01042497941909-1.665523596588910.1427 X 0.3537 0.31606 0.36536 0.26427
O O O NP_005234.1 RNA-binding protein EWS isoform 2 [Homo sapiens] 0.315 0.244 0.234 -2.03484987107391-2.092656648327950.2782 0.2715 0.1824 0.3375 0.12558 0.24027
O O O NP_009207.2 chromobox protein homolog 3 [Homo sapiens] 0.315 0.315 0.229 -1.66634728523459- .1 53 8863760670. 859 X 0.2442 X 0.27739 0.181
O O O NP_005724.1 kinesin-like protein KIF20A [Homo sapiens] 0.319 0.193 0.332 -2.37706964907982-1.58984385122736X +V 0.1925 X 0.37439 0.29002
O O O NP_004628.4 ras-related protein Rab-7a [Homo sapiens] 0.322 0.408 0.304 -1.2944201380609- .71884823086550.4758 0.3948 0.3525 0.45331 0.16515 0.29291
O O O AAB02546.1 Gu protein, partial [Homo sapiens] 0.325 0.217 0.274 -2.20356836893431-1. 68316890934550.2876 0.1759 0.1878 0.38462 0.19592 0.24114
O O O 1QGK_A Chain A, Structure Of Importin Beta Bound To The Ibb Domain Of Importin Alpha 0.325 0.383 0.310 -1.38420706912557-1.688 43464173180. 255 0.3407 X 0.47059 0.22158 0.23855
O O O NP_056461.1 ras-related protein Rap-1b isoform 1 precursor [Homo sapiens] 0.325 0.381 0.244 -1.39238955933423-2.0 198430416150.5002 0.341 0.3016 X 0.22732 0.2613
O O O NP_057584.2 protein PBDC1 isoform 1 [Homo sapiens] 0.329 0.114 0.260 -3.13923579737117-1.946 5243503201X 0.1135 -V 0.25 0.27012 0.2584
O O O NP_006256.1 double-strand-break repair protein rad21 homolog [Homo sapiens] 0.330 0.341 0.275 -1.55025376097899-1.86075626243007X 0.4413 0.2416 0.33356 X 0.21711
O O O NP_002779.1 proteasome subunit alpha type-3 isoform 1 [Homo sapiens] 0.339 0.554 0.387 -0.85139122979478-1.36 0593871331X 0.5877 0.5208 X 0.53908 0.23502
O O O CAA35621.1 Nm23 protein, partial [Homo sapiens] 0.345 0.427 0.319 -1.2293823533438-1.650477147557870.2993 X 0.5537 X 0.26532 0.37175
O O O NP_006784.1
thioredoxin-dependent peroxide reductase, 
mitochondrial isoform a precursor [Homo 
sapiens]
0.351 0.248 0.302 -2.01449956969512-1.726407740961590.3 06 0.2017 0.1502 0.30581 0.2986 -V
O O O AAH08906.1 Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial [Homo sapiens] 0.353 0.399 0.501 -1.32397336193508-0.9 64249483480350.62 4 0.2776 0.2963 0.56465 0.43783 X
O O O NP_001173.2
alpha-aminoadipic semialdehyde 
dehydrogenase isoform 1 precursor [Homo 
sapiens]
0.356 0.294 0.441 -1.76635731699119-1.18269229751619X 0.3819 0.206 X 0.44053 -V
O O O NP_003866.1 GMP synthase [glutamine-hydrolyzing] [Homo sapiens] 0.358 0.331 0.175 -1.59378989146843-2.51757039186058X 0.3271 0.3355 -V 0.17331 0.17596
O O O NP_006810.1 stress-induced-phosphoprotein 1 isoform b [Homo sapiens] 0.359 0.428 0.289 -1.22549755489034-1.7 8472446341390.4433 0.412 X 0.4415 0.25329 0.17364
O O O NP_002785.1 proteasome subunit beta type-2 isoform 1 [Homo sapiens] 0.359 0.227 0.408 -2.14146193366346-1.2927 71243224X 0.1827 0.2706 0.44111 X 0.37523
O O O NP_004359.1 calponin-2 isoform a [Homo sapiens] 0.361 0.208 0.457 -2.26673244064524-1.12848708789718-V 0.2078 X 0.54705 0.37951 0.44563
O O O NP_000843.1 glutathione S-transferase P [Homo sapiens] 0.361 0.417 0.300 -1.26239975962773-1.736638854815070.5508 0.2829 X 0.37994 0.28137 0.23889
O O O NP_057085.2 U3 small nucleolar RNA-associated protein 18 homolog [Homo sapiens] 0.363 0.241 0.157 -2.05169818764936-2.67301157657177X 0.2885 0.1939 X 0.20165 0.11194
O O O BAD96188.1 ribosomal protein P0 variant, partial [Homo sapiens] 0.367 0.154 0.144 -2.70121657809501-2.796876401278550.2316 0.09659 0.1331 X 0.11046 0.17734
O O O NP_006517.1 zinc finger protein 217 [Homo sapiens] 0.370 0.545 0.364 -0.874481140424909- .4565198624647X 0.6163 0.4746 X 0.21906 0.50968
O O O AEE02020.1 NF110b [Homo sapiens] 0.372 0.452 0.289 -1.14496710279792- .791 6929862328X 0.4981 0.4063 0.42355 0.27601 0.16689
O O O NP_003133.1 lupus La protein [Homo sapiens] 0.372 0.145 0.237 -2.78936177161985-2.076 3262970073-V 0.1391 0.1502 0.21993 0.32123 0.16989
O O O BAD92238.1 H2A histone family, member V isoform 1 variant, partial [Homo sapiens] 0.374 0.335 0.410 -1.57647561175567-1.286412165893170.2 57 0.2925 0.4277 0.50736 0.53706 0.18549
O O O BAG35238.1 unnamed protein product [Homo sapiens] 0.375 0.547 0.355 -0.871574610971163-1.4 4 59563712840.6898 X 0.4033 X -V 0.35499
O O O NP_004530.1 asparagine--tRNA ligase, cytoplasmic [Homo sapiens] 0.375 0.312 0.270 -1.67968862909296-1.8886 4549509540.202 0.4214 X -V 0.27005 X
O O O NP_005808.3 perilipin-3 isoform 1 [Homo sapiens] 0.378 0.316 0.249 -1.66291692368921-2.0076065276991X 0.3158 -V X 0.15385 0.34352
O O O NP_001530.1 dnaJ homolog subfamily A member 1 isoform 1 [Homo sapiens] 0.381 0.415 0.225 -1.26846916294584-2.15166879844339X 0.4151 -V -V 0.22247 0.22763
O O O AAI42947.1 RCC2 protein, partial [Homo sapiens] 0.381 0.254 0.349 -1.97994234765875-1.51871773229831X 0.2787 0.2283 0.51948 0.2551 0.27241
O O O NP_008835.5 DNA-dependent protein kinase catalytic subunit isoform 1 [Homo sapiens] 0.382 0.298 0.450 -1.74516411721424- .15207649071443X 0.4355 0.1611 X 0.46555 0.4344
O O O NP_002284.3 laminin subunit gamma-1 precursor [Homo sapiens] 0.385 0.283 0.208 -1.82240107067227-2.2 3615379890390.3581 X 0.2074 0.1381 0.2784 X
O O O NP_006746.1 transaldolase [Homo sapiens] 0.386 0.165 0.264 -2.60062835588067-1.92143633080630.24 9 0.1239 0.1298 0.26399 X -V
O O O NP_001895.1 catenin beta-1 isoform 1 [Homo sapiens] 0.386 0.380 0.342 -1.39681481379472-1.548065688185220.6 4 0.2202 0.3007 0.35638 0.38926 0.28027
O O O NP_006182.2 proliferation-associated protein 2G4 [Homo sapiens] 0.389 0.524 0.292 -0.932498951433429-1.77421131795412X 0.4298 0.6181 X 0.24618 0.33852
O O O NP_006836.2 kinesin-like protein KIF2C isoform 1 [Homo sapiens] 0.399 0.391 0.352 -1.3543905588165-1.507 2867959411-V 0.5135 0.2687 0.24131 0.27263 0.54113
O O O NP_009109.3 serine-threonine kinase receptor-associated protein [Homo sapiens] 0.400 0.253 0.173 -1.9847879149315-2.528 47323827840.165 X 0.3403 0.16556 0.18116 -V
O O O NP_001058.2 DNA topoisomerase 2-alpha [Homo sapiens] 0.403 0.518 0.267 -0.948326280666021-1.903981974157810.3982 0.5568 0.5997 0.28193 0.32342 0.19627
O O O NP_003364.1 vinculin isoform VCL [Homo sapiens] 0.411 0.412 0.266 -1.28021784300253-1.911 40137370720.6168 0.3083 0.3101 0.23337 0.26553 0.29869
O O O NP_001896.2 CTP synthase 1 isoform a [Homo sapiens] 0.412 0.345 0.210 -1.53338158009051-2.254 74321633220.4 96 0.2729 0.2939 0.20627 0.12615 0.29647
O O O NP_002464.1 myosin-9 [Homo sapiens] 0.416 0.413 0.202 -1.27520422929652- .304985753922740.4833 0.3185 0.4377 0.26164 X 0.14308
O O O NP_003306.3 dnaJ homolog subfamily C member 7 isoform 1 [Homo sapiens] 0.417 0.238 0.444 -2.07126964038896-1.17056 05679207-V 0.2848 0.1911 -V -V 0.44425
O O O NP_001125409.1 signal recognition particle 14 kDa protein [Pongo abelii] 0.418 0.372 0.192 -1.42856588412349-2.38108558969903-V 0.4396 0.3034 -V 0.18972 0.19421
O O O AAC51317.1 karyopherin beta 3 [Homo sapiens] 0.420 0.401 0.224 -1.31760648893727-2.158 3941668384X 0.45 0.3524 X 0.3124 0.1355
O O O NP_003555.1 transgelin-2 isoform b [Homo sapiens] 0.423 0.446 0.430 -1.16617886220942-1. 17583311061510.5679 0.3233 X 0.65317 0.19279 0.44405
O O O NP_004484.1 3-hydroxyacyl-CoA dehydrogenase type-2 isoform 1 [Homo sapiens] 0.428 0.211 0.293 -2.24810786159569-1.77031198029485+V 0.2105 X 0.43725 0.26896 0.17322
O O O NP_000265.1 ornithine aminotransferase, mitochondrial isoform 1 precursor [Homo sapiens] 0.435 0.255 0.215 -1.96954620345829- .214241670819680.359 0.2428 0.1642 0.26069 0.31085 0.07496
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O O O NP_065174.1 coronin-1B [Homo sapiens] 0.436 0.175 0.389 -2.51210209878991-1.362126539340240.1753 -V X 0.32573 X 0.45228
O O O NP_005906.2 DNA replication licensing factor MCM6 [Homo sapiens] 0.439 0.224 0.189 -2.15778544603906-2.4 2 3409715765X 0.1284 0.3198 X 0.23958 0.13858
O O O NP_001509.3 general transcription factor II-I isoform 4 [Homo sapiens] 0.440 0.322 0.176 -1.63643640620281-2.504543502849650. 02 X 0.3631 0.27093 0.11681 0.14092
O O O NP_006351.2 eukaryotic translation initiation factor 3 subunit M isoform 1 [Homo sapiens] 0.443 0.188 0.375 -2.41234697890768-1.41467678042689X 0.163 0.2127 X -V 0.37509
O O O NP_002473.2 nuclear autoantigenic sperm protein isoform 2 [Homo sapiens] 0.443 0.285 0.269 -1.81096617560998- .891 15738471620.4217 X 0.1483 0.37161 0.27495 0.16179
O O O BAG70161.1 RuvB-like 1, partial [Homo sapiens] 0.455 0.381 0.292 -1.39232643965094-1.7777 8757936520.5558 X 0.2061 X 0.31437 0.26889
O O O NP_036374.1 dickkopf-related protein 1 precursor [Homo sapiens] 0.457 0.571 0.620 -0.807763743571639-0.6905804312473870.8958 0.3321 0.4859 0.90992 0.66269 0.2862
O O O NP_001447.2 filamin-A isoform 1 [Homo sapiens] 0.468 0.224 0.190 -2.16079285191852-2.3 7910729815990.3 76 0.1809 0.1024 0.21133 0.15721 0.20068
O O O NP_003676.2 far upstream element-binding protein 2 [Homo sapiens] 0.470 0.286 0.246 -1.80611473752538-2.02 855565591770.4057 0.3673 0.08488 0.33727 0.17079 0.23015
O O O NP_002622.2 6-phosphogluconate dehydrogenase, decarboxylating isoform 1 [Homo sapiens] 0.472 0.325 0.354 -1.62282071026336-1.497 15660998970.3247 -V X 0.56818 0.32123 0.17322
O O O NP_612451.1 coiled-coil domain-containing protein 124 [Homo sapiens] 0.487 0.433 0.358 -1.20906118622418- .48312 31848593-V 0.6453 0.2198 -V 0.27078 0.44464
O O O NP_005712.1 actin-related protein 3 isoform 1 [Homo sapiens] 0.492 0.390 0.272 -1.35685186631597-1.8784 559417030.6431 0.2473 0.2809 -V 0.28935 0.25458
O O O NP_002261.3 transportin-1 isoform 1 [Homo sapiens] 0.493 0.244 0.331 -2.03223131678823-1.593568934986620.404 0.08023 0.2492 0.44984 0.18242 0.36179
O O O BAD97174.1
acidic (leucine-rich) nuclear phosphoprotein 
32 family, member B variant, partial [Homo 
sapiens] 
0.498 0.296 0.384 -1.75608724112683-1.381491693058650.441 X 0.1503 0.51733 X 0.25031
O O O AAH00201.1 WD repeat domain 1 [Homo sapiens] 0.501 0.263 0.176 -1.92576860581421-2. 0276 20057148-V 0.2969 0.2295 0.06116 0.29172 -V
O O O NP_055687.1 zinc finger and BTB domain-containing protein 5 [Homo sapiens] 0.502 0.801 0.361 -0.320486120713456- .4 02141528224X 0.8008 -V X 0.34364 0.37821
O O O NP_031401.1 TAR DNA-binding protein 43 [Homo sapiens] 0.502 0.376 0.550 -1.41308957361503-0.8 26410775107280.54 4 0.06892 0.5162 0.78493 0.44385 0.42105
O O O NP_004584.1 transformer-2 protein homolog beta isoform 1 [Homo sapiens] 0.505 0.291 0.209 -1.77991773935075-2.26089911632880.44 5 0.1399 X 0.2694 0.18047 0.17606
O O O NP_001145.1 annexin A5 [Homo sapiens] 0.508 0.374 0.250 -1.41850412899862- .9 731 956897230.5413 X 0.2069 0.36219 0.19996 0.18925
O O O EAX05140.1 protocadherin 18, isoform CRA_b [Homo sapiens] 0.512 0.512 0.968 -0.965314733790281-0.04669276280402440.44 7 0.5274 0.5684 1.31978 X 0.61652
O O O NP_001646.2 coatomer subunit delta isoform 1 [Homo sapiens] 0.524 0.196 0.486 -2.35144252194724-1.03959355074952-V 0.2335 0.1584 -V 0.55188 0.42105
O O O AAB51246.1 scaffold protein Pbp1 [Homo sapiens] 0.526 0.314 0.268 -1.6697858227507-1.898831830127810.125 0.5036 X 0.36603 0.25374 0.18471
O O O CAG47005.1 RPLP1 [Homo sapiens] 0.528 0.136 0.191 -2.87689006673108-2.38496424654008X 0.04227 0.23 0.10909 0.2482 0.21706
O O O NP_036457.1 microtubule-associated protein RP/EB family member 1 [Homo sapiens] 0.534 0.459 0.292 -1.12421993693151-1.77 996325111170.65 5 0.266 X -V X 0.2924
O O O NP_003124.1 signal recognition particle 9 kDa protein isoform 2 [Homo sapiens] 0.543 0.345 0.592 -1.53672631506831-0.7551973085670830.50 2 0.2484 0.2794 0.61728 0.88889 0.27122
O O O NP_004716.1 mitotic checkpoint protein BUB3 isoform a [Homo sapiens] 0.562 0.178 0.239 -2.49188916415655-2.06 908438993420.1 45 0.02452 0.3143 0.28752 X 0.19015
O O O NP_006793.1 splicing factor 3A subunit 3 isoform 1 [Homo sapiens] 0.562 0.240 0.186 -2.06039727964396- .423615634036480.359 0.1205 X -V 0.26302 0.10976
O O O NP_001937.2 dual specificity protein phosphatase 6 isoform a [Homo sapiens] 0.567 1.612 0.787 0.68920968830163-0.3460433628985931.457 2.473 0.9072 0.90827 0.76982 0.68213
O O O NP_004896.1 peroxiredoxin-6 [Homo sapiens] 0.576 0.286 0.159 -1.80389660228519-2.65325 219885790.1 1 0.4552 0.2159 0.25793 0.10585 0.1131
O O O NP_000994.1 60S acidic ribosomal protein P1 isoform 1 [Homo sapiens] 0.578 0.135 0.128 -2.89137518531835-2.969280860560070.23 5 0.03305 X 0.12037 0.10047 0.16223
O O O NP_003748.1 eukaryotic translation initiation factor 3 subunit I [Homo sapiens] 0.585 0.641 0.330 -0.641941381694508-1.59 07497175513X 0.6394 0.6423 0.65402 0.23714 0.09911
O O O NP_004893.1 RNA-binding protein 39 isoform b [Homo sapiens] 0.585 0.198 0.449 -2.33642766458248-1.1 603412256303X 0.1864 0.2096 0.29976 0.59773 X
O O O NP_006494.1 26S proteasome regulatory subunit 6B isoform 1 [Homo sapiens] 0.601 0.290 0.353 -1.7838866415537-1.50273564943293X 0.3936 0.1872 0.63735 0.1483 0.273
O O O NP_000217.2 keratin, type I cytoskeletal 9 [Homo sapiens] 0.618 0.894 0.543 -0.161115446122722-0.8819698941341721.556 0.559 0.568 X 0.71788 0.36738
O O O NP_115963.1 protein dpy-30 homolog isoform 1 [Homo sapiens] 0.635 0.254 0.074 -1.97709959788992-3. 5944764828943X 0.2571 0.2509 -V 0.07289 0.07479
O O O AAQ15252.1 PP13296 [Homo sapiens] 0.639 0.216 0.585 -2.209227962138-0.77 152397014053X 0.2565 0.176 0.58514 X -V
O O O EAX03455.1 HLA-B associated transcript 3, isoform CRA_b [Homo sapiens] 0.642 0.439 0.317 -1.18754284841954-1.655396389933340.7141 0.164 X 0.39124 X 0.24366
O O O NP_006537.3 insulin-like growth factor 2 mRNA-binding protein 1 isoform 1 [Homo sapiens] 0.649 0.586 0.380 -0.771684096177844-1.394146 77582550.367 0.2842 1.106 0.45579 0.41425 0.27137
O O O AAA35922.1 G protein beta subunit [Homo sapiens] 0.655 0.427 0.244 -1.22836791872502-2.034454493306560.761 0.2284 0.291 X 0.19451 0.29369
O O O NP_000372.1 E3 ubiquitin-protein ligase Midline-1 isoform 1 [Homo sapiens] 0.672 0.182 0.331 -2.45442694396497-1.5 458040806871X 0.2299 0.135 -V 0.50813 0.15411
O O O NP_002806.2 26S proteasome non-ATPase regulatory subunit 11 [Homo sapiens] 0.707 0.112 0.224 -3.15579112915027-2.1607 063791909X 0.1961 0.02831 -V 0.13479 0.3125
O O O NP_057005.1 protein CutA isoform 2 precursor [Homo sapiens] 0.722 0.180 0.117 -2.47006247676397-3.100532527511650.1223 0.06985 0.3493 -V 0.1398 0.09337
O O O NP_006800.2 mitochondrial import receptor subunit TOM34 [Homo sapiens] 0.779 0.523 0.599 -0.935117148415146-0.739992224127246X -V 0.523 1.04319 -V 0.1543
O O O BAG57859.1 unnamed protein product [Homo sapiens] 0.816 0.593 0.277 -0.754260967570715-1.8 1649050460010.9629 0.2228 X X 0.23084 0.32331
O O O NP_001934.2 desmoglein-2 preproprotein [Homo sapiens] 0.982 0.211 0.314 -2.24365984774815-1.6 130358197051X 0.2137 0.2086 0.11366 0.08696 0.74129
O O O AAH01913.2 VAT1 protein, partial [Homo sapiens] 1.029 0.219 1.004 -2.19000941602480.00606000897383074X 0.2041 0.2342 1.53894 0.46948 X
O O O NP_003745.1 eukaryotic translation initiation factor 3 subunit F [Homo sapiens] 1.050 0.209 0.492 -2.25911560248234-1.02211001230975X 0.2812 0.1366 1.06918 0.08688 0.32113
O O O NP_004406.2 desmoplakin isoform I [Homo sapiens] 1.094 0.092 0.297 -3.44449793518962-1.7520 300484996X 0.09301 0.0907 0.16431 0.09461 0.63171
O O O NP_003391.1 exportin-1 [Homo sapiens] 1.140 0.548 2.338 -0.868805648291551.225458969146870.3345 0.7607 -V X 3.89105 0.78555
O O O NP_002783.1 proteasome subunit alpha type-7 [Homo sapiens] 1.213 0.288 1.388 -1.79485775937470.4725181897760390.3238 0.2526 X 0.41545 2.3596 -V
O O O NP_004699.1 programmed cell death protein 5 [Homo sapiens] 1.340 0.603 0.054 -0.729770092762002-4. 00 2597740426-V -V 0.603 0.08183 X 0.02697
O O O NP_001003.1 40S ribosomal protein S8 [Homo sapiens] 1.427 0.300 1.375 -1.736965594166210.4590286831977630.44 4 -V 0.1526 3.34784 0.33875 0.43725
O O O BAH12828.1 unnamed protein product [Homo sapiens] 1.518 0.478 0.048 -1.06355992988579-4.36946648365072X 0.9223 0.0346 -V -V 0.04838
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O O O Q9Y2T1.1
RecName: Full=Axin-2; AltName: Full=Axin-
like protein; Short=Axil; AltName: Full=Axis 
inhibition protein 2; AltName: Full=Conductin 
1.518 0.361 1.485 -1.46813200439445.570459685090766X 0.4101 0.3128 3.84615 0.30553 0.30331
O O O AAH06199.3 LAP3 protein, partial [Homo sapiens] 1.605 0.186 1.626 -2.423526234895170.701686158207104X 0.253 0.1198 X 3.08642 0.16639
O O O CAH18082.1 hypothetical protein [Homo sapiens] 1.980 7.256 0.409 2.85918439722579-1.2902743249311X 14.29 0.2221 0.75873 0.19616 0.27174
O O O NP_036558.3 splicing factor 3B subunit 3 [Homo sapiens] 0.093 0.275 0.314 -1.86249647625007-1. 731 409759017-V -V 0.275 0.31358 X -V
O O O AAD43021.1 COP9 complex subunit 4 [Homo sapiens] 0.110 0.169 0.145 -2.56234612165381-2.78659636189081-V 0.1693 X -V X 0.14493
O O O NP_001670.1 sodium/potassium-transporting ATPase subunit beta-3 [Homo sapiens] 0.154 0.322 0.259 -1.63531551807177-1.95121476442072X -V 0.3219 X -V 0.2586
O O O NP_003121.1 sorcin isoform A [Homo sapiens] 0.241 0.803 0.569 -0.317426702652422-0.813114191346289X +V 0.8025 X -V 0.56915
O O O NP_008869.1 small nuclear ribonucleoprotein Sm D1 isoform 1 [Homo sapiens] 0.281 0.599 0.401 -0.739131261384321-1.31961793420016-V -V 0.5991 -V -V 0.40064
O O O AAH01238.1 DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 [Homo sapiens] 0.295 0.240 0.366 -2.05949493725602-1.44837 39461205X -V 0.2399 0.36643 X -V
O O O NP_055223.1 trafficking protein particle complex subunit 3 isoform 1 [Homo sapiens] 0.309 0.162 0.252 -2.62771648711947-1.98732086592925X 0.1618 -V X -V 0.25221
O O O AAH01041.3 NSUN2 protein, partial [Homo sapiens] 0.326 0.294 0.470 -1.76513084829462-1.08882003329859-V 0.2942 X X 0.47015 -V
O O O NP_000961.2 60S ribosomal protein L6 isoform 1 [Homo sapiens] 0.382 0.298 0.171 -1.74903842646678-2.5 91 62786681-V 0.2975 X -V 0.17085 X
O O O NP_004485.1 hepatoma-derived growth factor isoform a [Homo sapiens] 0.391 0.076 0.134 -3.72356288956372-2. 0342396588874X -V 0.0757 0.13365 X -V
O O O NP_002563.1 platelet-activating factor acetylhydrolase IB subunit beta isoform a [Homo sapiens] 0.484 0.286 0.140 -1.80540859722627-2.83471121580473X -V 0.2861 -V 0.14017 X
O O X NP_006616.1 serine/arginine-rich splicing factor 10 isoform 1 [Homo sapiens] 0.004 0.189 N/A -2.40698094440779N/A -V 0.188 0.1891 -V -V X
O O X AAH31061.1 Minichromosome maintenance complex component 4 [Homo sapiens] 0.158 N/A 0.369 N/A -1.43756875373358-V X -V 0.32787 0.41051 -V
O O X Q9NV06.2
RecName: Full=DDB1- and CUL4-associated 
factor 13; AltName: Full=WD repeat and SOF 
domain-containing protein 1
0.220 0.395 N/A -1.34007544159762N/A -V 0.4564 0.3336 -V X -V
O O X DAA00041.1 TPA_exp: neuregulin 1 isoform HRG-beta1 [Homo sapiens] 0.452 0.281 N/A -1.83187147042305N/A X 0.3707 0.1911 X -V -V
O O X AAF33021.1 MYB-binding protein 1A [Homo sapiens] 0.590 N/A 0.379 N/A -1.40031377391397-V -V -V 0.58377 0.4122 0.14057
O O X NP_002788.1 proteasome subunit beta type-5 isoform 1 [Homo sapiens] 0.696 0.567 0.193 -0.818833825730023-2.3 49 0 6970135-V -V 0.5669 -V X 0.19279
O O X NP_006827.1 eIF-2-alpha kinase activator GCN1 [Homo sapiens] 0.893 0.123 N/A -3.02749849277803N/A X 0.04518 0.2001 X -V -V
O O X Q8IY17.2
RecName: Full=Neuropathy target esterase; 
AltName: Full=Patatin-like phospholipase 
domain-containing protein 6
0.917 0.366 0.078 -1.44890239384089- .678 7190511264X -V 0.3663 0.07813 -V -V
O O X NP_003012.1 small glutamine-rich tetratricopeptide repeat-containing protein alpha [Homo sapiens] 1.063 0.213 N/A -2.23053290887566N/A X 0.3732 0.05296 X -V -V
O O X BAC04812.1 unnamed protein product [Homo sapiens] N/A N/A 0.100 N/A -3.32768736417605-V -V X -V X 0.0996
O O X NP_000512.1 beta-hexosaminidase subunit beta isoform 1 preproprotein [Homo sapiens] N/A N/A 0.140 N/A -2.83450897356133-V -V X 0.14019 -V X
O O X NP_001632.2 DNA-(apurinic or apyrimidinic site) lyase [Homo sapiens] N/A N/A 0.144 N/A -2.79680538088048-V -V X -V 0.14391 -V
O O X NP_006136.1 dnaJ homolog subfamily B member 1 isoform 1 [Homo sapiens] N/A N/A 0.220 N/A -2.18301003676225-V X -V -V X 0.22022
O O X NP_001782.1 cell division control protein 42 homolog isoform 1 precursor [Homo sapiens] N/A N/A 0.221 N/A -2.17951105027151X -V -V -V 0.22075 -V
O O X 1XFU_O
Chain O, Crystal structure of anthrax edema 
factor (EF) truncation mutant, EF-delta 64 in 
complex with calmodulin 
N/A N/A 0.236 N/A -2.08270258933025X -V -V -V -V 0.23607
O O X NP_005222.2 src substrate cortactin isoform a [Homo sapiens] N/A N/A 0.238 N/A -2.06970216663007X -V -V -V X 0.23821
O O X NP_001370.1 DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] N/A N/A 0.264 N/A -1.9214363308063X -V -V -V -V 0.26399
O O X AAF18437.1 CHORD containing protein-1 [Homo sapiens] N/A N/A 0.353 N/A -1.50029217673417-V -V -V 0.35348 -V -V
O O X BAG51207.1 unnamed protein product [Homo sapiens] N/A N/A 0.491 N/A -1.02715405150373X -V -V X 0.49068 -V
O O X BAG63952.1 unnamed protein product [Homo sapiens] N/A 0.021 N/A -5.56388081305413N/A X 0.02114 -V X -V -V
O O X AAH66915.1 MARCKS-like 1 [Homo sapiens] N/A 0.068 N/A -3.88725983927301N/A X -V 0.06758 X -V -V
O O X NP_003160.2 transcription elongation factor SPT5 isoform a [Homo sapiens] N/A 0.255 N/A -1.97143084780323N/A -V 0.255 -V -V X -V
O O X BAH14363.1 unnamed protein product [Homo sapiens] N/A 0.347 N/A -1.52699243208383N/A -V 0.347 X X -V -V
O O X AAX11430.1 cell growth-inhibiting protein 34 [Homo sapiens] N/A 0.425 N/A -1.23412583591027N/A -V 0.4251 -V -V -V -V
O O X NP_005380.2 protein-L-isoaspartate(D-aspartate) O-methyltransferase isoform 1 [Homo sapiens] N/A 0.426 N/A -1.23107466443625N/A -V X 0.426 X -V -V
O O X EAX06635.1 hCG2033311 [Homo sapiens] N/A 0.436 N/A -1.1969383249087N/A -V X 0.4362 -V X -V
O O X NP_004784.2 lon protease homolog, mitochondrial isoform 1 precursor [Homo sapiens] N/A 0.659 N/A -0.601211852366231N/A X 0.6592 -V X -V -V
O O X NP_005709.1 actin-related protein 2/3 complex subunit 4 isoform a [Homo sapiens] N/A N/A N/A N/A N/A X +V +V X -V -V
Detected in -VacA only
rep #1 rep #2 rep #1 rep #2 exp #1 exp #2 exp#3 exp #1 exp #2 exp#3
O O X EAX03526.1
LSM2 homolog, U6 small nuclear RNA 
associated (S. cerevisiae), isoform CRA_b 
[Homo sapiens]
N/A N/A N/A N/A N/A -V -V -V -V -V -V
O O X NP_002009.1 protein flightless-1 homolog isoform 1 [Homo sapiens] N/A N/A N/A N/A N/A -V -V -V -V -V -V





rendered in scatter plot (Fig. 3.6C)
rep #1 (-V in H, +V in M) rep #2 (-V in M, +V in H)
abundance ratio calculated by -V/+V (H: heavy Arg/Lys, 
M: intermediate Arg/Lys, -V: detected only in -V, +V: 
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Table 3.1. (cont.) 
 
O O X NP_004229.1 E3 ubiquitin-protein ligase TRIP12 isoform c [Homo sapiens] N/A N/A N/A N/A N/A -V -V -V -V X -V
O O X AAH50345.2 SEPT10 protein [Homo sapiens] N/A N/A N/A N/A N/A X -V -V X -V -V
O O X AAI11067.1 RBM25 protein [Homo sapiens] N/A N/A N/A N/A N/A X -V -V X -V -V
O O X AAK01924.1 CGI-201 protein, short form [Homo sapiens] N/A N/A N/A N/A N/A X -V -V X -V -V
O O X BAA20823.1 KIAA0368, partial [Homo sapiens] N/A N/A N/A N/A N/A X -V -V X -V -V
O O X BAG59677.1 unnamed protein product [Homo sapiens] N/A N/A N/A N/A N/A X -V -V X -V -V
O O X EAL23879.1
similar to Nuclear protein Hcc-1 (HSPC316) 
(Proliferation associated cytokine-inducible 
protein CIP29) [Homo sapiens]
N/A N/A N/A N/A N/A X -V -V X -V -V
O O X NP_000476.1 adenine phosphoribosyltransferase isoform a [Homo sapiens] N/A N/A N/A N/A N/A X -V -V X -V -V
O O X NP_004138.1 developmentally-regulated GTP-binding protein 1 [Homo sapiens] N/A N/A N/A N/A N/A X -V -V X -V -V
O O X NP_006510.1 dynein light chain Tctex-type 1 isoform 1 [Homo sapiens] N/A N/A N/A N/A N/A X -V -V X -V -V
O O X NP_002564.1 platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] N/A N/A N/A N/A N/A X -V -V -V X -V
O O X NP_003851.1 barrier-to-autointegration factor [Homo sapiens] N/A N/A N/A N/A N/A X -V -V -V X -V
O O X NP_004847.2 kinesin-like protein KIF23 isoform 2 [Homo sapiens] N/A N/A N/A N/A N/A X -V -V -V X -V
O O X NP_057230.1 trafficking protein particle complex subunit 4 isoform 1 [Homo sapiens] N/A N/A N/A N/A N/A X -V -V -V X -V
O O X NP_004392.1 DNA fragmentation factor subunit alpha isoform 1 [Homo sapiens] N/A N/A N/A N/A N/A X -V -V -V -V X
O O X NP_004588.1 small nuclear ribonucleoprotein Sm D2 isoform 1 [Homo sapiens] N/A N/A N/A N/A N/A -V X -V -V X -V
Detected in +VacA only
rep #1 rep #2 rep #1 rep #2 exp #1 exp #2 exp#3 exp #1 exp #2 exp#3
O O X NP_003661.1 class E basic helix-loop-helix protein 40 [Homo sapiens] N/A N/A N/A N/A N/A X +V +V +V +V X
Not determined
rep #1 rep #2 rep #1 rep #2 exp #1 exp #2 exp#3 exp #1 exp #2 exp#3
O X X NP_036590.1 mitochondrial import inner membrane translocase subunit Tim13 [Homo sapiens] N/A N/A N/A N/A N/A -V X +V -V X -V
O X X NP_006796.1 heterogeneous nuclear ribonucleoprotein A0 [Homo sapiens] N/A N/A N/A N/A N/A +V X -V -V -V -V
O X X NP_005639.1 elongin-C isoform a [Homo sapiens] N/A N/A N/A N/A N/A +V -V -V -V -V X
Secreted proteins
rep #1 rep #2 rep #1 rep #2 exp #1 exp #2 exp#3 exp #1 exp #2 exp#3
O O O NP_008966.1 keratocan precursor [Homo sapiens] 0.051 0.150 0.140 -2.73696559416621-2.84157063739552-V -V 0.15 0.13951 -V -V
O O O
NP_002017.1
fibronectin isoform 3 preproprotein [Homo 
sapiens]
0.057 0.126 0.131 -2.99194344512894-2.933966543005290.1257 -V X 0.1241 0.13761 -V
O O O NP_006175.2 nucleobindin-1 precursor [Homo sapiens] 0.131 0.178 0.176 -2.4895106196355-2.50 475929284960.1662 0.1628 0.2052 0.15354 0.19916 -V
O O O
NP_001892.1
connective tissue growth factor precursor [Homo 
sapiens] 
0.168 0.782 0.887 -0.35451352451365-0.1729517934531940.9542 0.7475 0.6447 1.01451 0.88496 0.76161
O O O
NP_006174.1
neurotensin/neuromedin N preproprotein 
[Homo sapiens] 
0.169 0.310 0.270 -1.68997016975164- .889078923216930. 153 0.316 0.2985 0.33245 0.20751 X
O O O
NP_000588.2
insulin-like growth factor-binding protein 2 
isoform a precursor [Homo sapiens] 
0.181 0.217 0.229 -2.20667284762571-2.124310016680820.166 0.228 0.2559 0.25893 0.24907 0.18008
O O O
NP_036374.1
dickkopf-related protein 1 precursor [Homo 
sapiens] 
0.250 0.212 0.254 -2.23831757913263-1. 775 5409026130.2618 0.2426 0.1314 0.2918 0.2681 0.20186
O O O
AAQ04552.1
non-classical cadherin XB31alpha1 [Homo 
sapiens] 
0.313 0.197 0.173 -2.3455644591546-2.531092054441620.2192 X 0.1743 0.25634 0.10989 0.15279
O O O NP_002336.1 lumican precursor [Homo sapiens] 0.395 0.182 0.124 -2.46076672913396-3.0 10 497653880.2387 -V 0.1246 0.16858 0.10405 0.0995
O O X NP_004384.4 dystroglycan preproprotein [Homo sapiens] 0.602 0.137 0.236 -2.86870026901092- .085413776019640.1865 X 0.08732 0.39667 0.16815 0.14207
O O X
EAW62494.1
MAM domain containing 2, isoform CRA_b 
[Homo sapiens] 
0.662 0.084 0.131 -3.57733640834498-2.9 59 6709810740.08807 -V 0.07948 0.13797 0.22492 0.02912
O O X
1COH_A
Chain A, Structure Of Haemoglobin In The Deoxy 
Quaternary State With Ligand Bound At The Alpha 
Haems 
0.662 1.628 0.966 0.703396061472504-0.04990364652952921.959 .557 0.369 0.92251 1.47449 0.501
O O X NP_000468.1 serum albumin preproprotein [Homo sapiens] 0.789 2.227 1.148 1.154907199047670.1992240315002220.6834 X 3.77 1.29955 0.96712 1.17758
O O X NP_000217.2 keratin, type I cytoskeletal 9 [Homo sapiens] 0.841 0.406 2.459 -1.301159229792791. 825247073010.2448 X 0.5668 X 2.25124 2.66738
O O X
NP_002207.2
inter-alpha-trypsin inhibitor heavy chain H2 
precursor [Homo sapiens] 
1.524 23.848 0.070 4.57579637532908-3.8271728295939238.54 9.156 X 0.10359 X 0.03731
O O X
NP_000574.2
vitamin D-binding protein isoform 1 precursor 
[Homo sapiens] 
1.726 12.233 2.415 3.612714208498671.271956356205652.461 33.81 0.4282 0.65789 4.17188 X
Evaluated in
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rendered in scatter plot (Fig. 3.6C) abundance ratio calculated by -V/+V (H: heavy Arg/Lys, 
M: intermediate Arg/Lys, -V: detected only in -V, +V: 
detected only in +V, X: not detected)
abundance ratio calculated by -V/+V (H: heavy Arg/Lys, 
M: intermediate Arg/Lys, -V: detected only in -V, +V: 














rendered in scatter plot (Fig. 3.6C)
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alpha-fetoprotein isoform 1 precursor [Homo 
sapiens] 1.989 152.400 0.216 7.25171909260596-2.21190843894123+V +V
152.4 0.07943 0.51787 0.05025
O O X
NP_001613.2
alpha-2-HS-glycoprotein isoform 2 preproprotein 
[Homo sapiens] 2.171 14.956 0.581 3.90269748638612-0.7846030606030420.4414 2.268 42.16 0.08718 0.5339 1.12045
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Proteins detected in both -VacA and +VacA (146 proteins)
NCBI Ref. Seq. Protein Names Subclass
NP_003065




NP_005906 DNA replication licensing factor MCM6;MCM6;ortholog DNA helicase(PC00011);hydrolase(PC00121)
NP_002583 Proliferating cell nuclear antigen;PCNA;ortholog DNA polymerase processivity factor(PC00015)
AAF33021 Myb-binding protein 1A;MYBBP1A;ortholog
DNA-directed DNA polymerase(PC00018);transcription 
factor(PC00218)
NP_003676
Far upstream element-binding protein 2;KHSRP;ortholog
enzyme modulator(PC00095);mRNA splicing 
factor(PC00148);ribonucleoprotein(PC00201);serine 
protease(PC00203)
NP_001960 Eukaryotic translation initiation factor 5;EIF5;ortholog
G-protein modulator(PC00022);translation initiation 
factor(PC00224)
NP_003312
Elongation factor Tu, mitochondrial;TUFM;ortholog
G-protein(PC00020);hydrolase(PC00121);translation 





elongation factor(PC00222);translation initiation 
factor(PC00224)
NP_002098 Histone H3.3;H3F3A;ortholog histone(PC00118)
NP_003507 Histone H2A type 2-A;HIST2H2AA3;ortholog histone(PC00118)
AAI28106 Histone H4;HIST1H4A;ortholog histone(PC00118)
AAA52651 Histone H3.1;HIST1H3A;ortholog histone(PC00118)
NP_003510 Histone H2B type 1-L;HIST1H2BL;ortholog histone(PC00118)
AAA63192 Histone H2B type 2-E;HIST2H2BE;ortholog histone(PC00118)






AAA03427 Non-POU domain-containing octamer-binding protein;NONO;orthologmRNA splicing factor(PC00148)
BAC03738 Nucleolin;NCL;ortholog mRNA splicing factor(PC00148)
NP_006793 Splicing factor 3A subunit 3;SF3A3;ortholog mRNA splicing factor(PC00148)
NP_008869 Small nuclear ribonucleoprotein Sm D1;SNRPD1;ortholog
mRNA splicing 
factor(PC00148);ribonucleoprotein(PC00201)
NP_003133 Lupus La protein;SSB;ortholog ribonucleoprotein(PC00201)
AAQ15252 La-related protein 4;LARP4;ortholog ribonucleoprotein(PC00201)
NP_002286 40S ribosomal protein SA;RPSA;ortholog ribosomal protein(PC00202)
AAH16736 Heterogeneous nuclear ribonucleoprotein F;HNRNPF;orthologribosomal protein(PC00202)
NP_000977 60S ribosomal protein L24;RPL24;ortholog ribosomal protein(PC00202)
NP_006147 NEDD8;NEDD8;ortholog ribosomal protein(PC00202)
NP_001000 40S ribosomal protein S5;RPS5;ortholog ribosomal protein(PC00202)
NP_001003 40S ribosomal protein S8;RPS8;ortholog ribosomal protein(PC00202)
AAH00606 60S ribosomal protein L14;RPL14;ortholog ribosomal protein(PC00202)
NP_001007 40S ribosomal protein S12;RPS12;ortholog ribosomal protein(PC00202)
NP_001005 40S ribosomal protein S10;RPS10;ortholog ribosomal protein(PC00202)
NP_000961 60S ribosomal protein L6;RPL6;ortholog ribosomal protein(PC00202)
NP_001015 40S ribosomal protein S21;RPS21;ortholog ribosomal protein(PC00202)
nucleic acid binding (PC00171)
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Table 3.2. (cont.) 
  
NP_000980 60S ribosomal protein L30;RPL30;ortholog ribosomal protein(PC00202)
AAB00969 40S ribosomal protein S7;RPS7;ortholog ribosomal protein(PC00202)
AAH02488 Plasminogen activator inhibitor 1 RNA-binding protein;SERBP1;orthologRNA binding protein(PC00031)
Q9NV06 DDB1- and CUL4-associated factor 13;DCAF13;ortholog RNA binding protein(PC00031)
NP_009193 Protein/nucleic acid deglycase DJ-1;PARK7;ortholog
RNA binding protein(PC00031);cysteine 
protease(PC00081);transcription factor(PC00218)
NP_001950 Elongation factor 1-beta;EEF1B2;ortholog translation elongation factor(PC00222)
NP_003748 Eukaryotic translation initiation factor 3 subunit I;EIF3I;orthologtranslation initiation factor(PC00224)
NP_001900 Cathepsin D;CTSD;ortholog aspartic protease(PC00053)
NP_003065




NP_004172 Ubiquitin carboxyl-terminal hydrolase isozyme L1;UCHL1;orthologcysteine protease(PC00081)
NP_036525 Phosphoribosylformylglycinamidine synthase;PFAS;ortholog cysteine protease(PC00081);ligase(PC00142)
NP_005906 DNA replication licensing factor MCM6;MCM6;ortholog DNA helicase(PC00011);hydrolase(PC00121)
NP_003676
Far upstream element-binding protein 2;KHSRP;ortholog
enzyme modulator(PC00095);mRNA splicing 
factor(PC00148);ribonucleoprotein(PC00201);serine 
protease(PC00203)
Q8IY17 Neuropathy target esterase;PNPLA6;ortholog esterase(PC00097)
CAA04006 Neutral alpha-glucosidase AB;GANAB;ortholog glucosidase(PC00108)
NP_000512 Beta-hexosaminidase subunit beta;HEXB;ortholog glycosidase(PC00110)
NP_003312
Elongation factor Tu, mitochondrial;TUFM;ortholog
G-protein(PC00020);hydrolase(PC00121);translation 





elongation factor(PC00222);translation initiation 
factor(PC00224)
AAA35922 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2;GNB2;ortholog
heterotrimeric G-
protein(PC00117);hydrolase(PC00121)
NP_003225 Transferrin receptor protein 1;TFRC;ortholog metalloprotease(PC00153)
AAH06199 Cytosol aminopeptidase;LAP3;ortholog metalloprotease(PC00153)
NP_003356 Cytochrome b-c1 complex subunit 1, mitochondrial;UQCRC1;orthologme alloprotease(PC00153)
NP_003745 Eukaryotic translation initiation factor 3 subunit F;EIF3F;ortholog
metalloprotease(PC00153);translation initiation 
factor(PC00224)
NP_002778 Proteasome subunit alpha type-2;PSMA2;ortholog protease(PC00190)
NP_002785 Proteasome subunit beta type-2;PSMB2;ortholog protease(PC00190)
NP_009193 Protein/nucleic acid deglycase DJ-1;PARK7;ortholog
RNA binding protein(PC00031);cysteine 
protease(PC00081);transcription factor(PC00218)
NP_008996 Hsp90 co-chaperone Cdc37;CDC37;ortholog chaperone(PC00072);kinase activator(PC00138)
EAX03455 Large proline-rich protein BAG6;BAG6;ortholog enzyme modulator(PC00095)
NP_003676
Far upstream element-binding protein 2;KHSRP;ortholog
enzyme modulator(PC00095);mRNA splicing 
factor(PC00148);ribonucleoprotein(PC00201);serine 
protease(PC00203)
NP_002283 Laminin subunit beta-2;LAMB2;ortholog
extracellular matrix linker protein(PC00101);protease 
inhibitor(PC00191);receptor(PC00197)
NP_002284 Laminin subunit gamma-1;LAMC1;ortholog
extracellular matrix linker protein(PC00101);protease 
inhibitor(PC00191);receptor(PC00197)




NP_001960 Eukaryotic translation initiation factor 5;EIF5;ortholog
G-protein modulator(PC00022);translation initiation 
factor(PC00224)
NP_003312
Elongation factor Tu, mitochondrial;TUFM;ortholog
G-protein(PC00020);hydrolase(PC00121);translation 





elongation factor(PC00222);translation initiation 
factor(PC00224)
NP_006487 Guanine nucleotide-binding protein G(k) subunit alpha;GNAI3;orthologheterotrimeric G-protein(PC00117)
AAA35922 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2;GNB2;ortholog
heterotrimeric G-
protein(PC00117);hydrolase(PC00121)
BAF82120 G2/mitotic-specific cyclin-B1;CCNB1;ortholog kinase activator(PC00138)
NP_006827 eIF-2-alpha kinase activator GCN1;GCN1;ortholog kinase modulator(PC00140)
NP_002558 Phosphatidylethanolamine-binding protein 1;PEBP1;ortholog protease inhibitor(PC00191)
NP_001226 Serpin H1;SERPINH1;ortholog serine protease inhibitor(PC00204)
NP_006382 Importin-7;IPO7;ortholog small GTPase(PC00208);transporter(PC00227)






Table 3.2. (cont.) 
  
AAH08633 Actin, cytoplasmic 1;ACTB;ortholog actin and actin related protein(PC00039)
NP_006358 Adenylyl cyclase-associated protein 1;CAP1;ortholog actin family cytoskeletal protein(PC00041)
NP_001312 Cysteine and glycine-rich protein 2;CSRP2;ortholog actin family cytoskeletal protein(PC00041)
NP_065174 Coronin-1B;CORO1B;ortholog non-motor actin binding protein(PC00165)
NP_005498 Cofilin-1;CFL1;ortholog non-motor actin binding protein(PC00165)
AAH00201 WD repeat-containing protein 1;WDR1;ortholog non-motor actin binding protein(PC00165)
NP_003079 Fascin;FSCN1;ortholog non-motor actin binding protein(PC00165)
NP_036457 Microtubule-associated protein RP/EB family member 1;MAPRE1;ortholognon-motor microtubule binding protein(PC00166)
NP_006078 Tubulin beta-4A chain;TUBB4A;ortholog tubulin(PC00228)
AAH20946 Tubulin beta chain;TUBB;ortholog tubulin(PC00228)
BAB14016 Tubulin beta-6 chain;TUBB6;ortholog tubulin(PC00228)









AAH68456 14-3-3 protein zeta/delta;YWHAZ;ortholog chaperone(PC00072)
BAG70050 Nucleophosmin;NPM1;ortholog chaperone(PC00072)
AAV38817 14-3-3 protein theta;YWHAQ;ortholog chaperone(PC00072)




NP_002148 10 kDa heat shock protein, mitochondrial;HSPE1;ortholog chaperonin(PC00073)
AAK74072 Endoplasmin;HSP90B1;ortholog Hsp90 family chaperone(PC00028)
NP_031381 Heat shock protein HSP 90-beta;HSP90AB1;ortholog Hsp90 family chaperone(PC00028)






AAC03787 Malate dehydrogenase, mitochondrial;MDH2;ortholog dehydrogenase(PC00092)
NP_000680 Retinal dehydrogenase 1;ALDH1A1;ortholog dehydrogenase(PC00092)
CAA25833 Glyceraldehyde-3-phosphate dehydrogenase;GAPDH;orthologdehydrogenase(PC00092)
BAA23735 Cytochrome b5 type B;CYB5B;ortholog oxidase(PC00175)








AAF33021 Myb-binding protein 1A;MYBBP1A;ortholog
DNA-directed DNA polymerase(PC00018);transcription 
factor(PC00218)
NP_055687 Zinc finger and BTB domain-containing protein 5;ZBTB5;orthologKRAB box transcription factor(PC00029)
NP_009193 Protein/nucleic acid deglycase DJ-1;PARK7;ortholog
RNA binding protein(PC00031);cysteine 
protease(PC00081);transcription factor(PC00218)












cell adhesion molecule(PC00069);signaling 
molecule(PC00207)
NP_001892 Connective tissue growth factor;CTGF;ortholog growth factor(PC00112)
NP_001545 Protein CYR61;CYR61;ortholog growth factor(PC00112)
















NP_036525 Phosphoribosylformylglycinamidine synthase;PFAS;ortholog cysteine protease(PC00081);ligase(PC00142)
NP_004437 Bifunctional glutamate/proline--tRNA ligase;EPRS;ortholog ligase(PC00142)
NP_001117 Adenylosuccinate synthetase isozyme 2;ADSS;ortholog ligase(PC00142)
NP_003365 Voltage-dependent anion-selective channel protein 1;VDAC1;ortholog





NP_006382 Importin-7;IPO7;ortholog small GTPase(PC00208);transporter(PC00227)









NP_002283 Laminin subunit beta-2;LAMB2;ortholog
extracellular matrix linker protein(PC00101);protease 
inhibitor(PC00191);receptor(PC00197)
NP_002284 Laminin subunit gamma-1;LAMC1;ortholog
extracellular matrix linker protein(PC00101);protease 
inhibitor(PC00191);receptor(PC00197)
NP_003391 Exportin-1;XPO1;ortholog receptor(PC00197)
NP_002283 Laminin subunit beta-2;LAMB2;ortholog
extracellular matrix linker protein(PC00101);protease 
inhibitor(PC00191);receptor(PC00197)
NP_002284 Laminin subunit gamma-1;LAMC1;ortholog
extracellular matrix linker protein(PC00101);protease 
inhibitor(PC00191);receptor(PC00197)
NP_001934 Desmoglein-2;DSG2;ortholog cadherin(PC00057);cell junction protein(PC00070)
NP_002296 Galectin-1;LGALS1;ortholog

























NP_001934 Desmoglein-2;DSG2;ortholog cadherin(PC00057);cell junction protein(PC00070)
Proteins detected in supernatant (13 proteins)
NCBI Ref. Seq. Protein Names Subclass
NP_001613 Alpha-2-HS-glycoprotein;AHSG;ortholog protease inhibitor(PC00191)




extracellular matrix protein (PC00102)
cell adhesion molecule (PC00069)
transfer/carrier protein (PC00219)
membrane traffic protein (PC00150)
isomerase (PC00135)
lyase (PC00144)














NP_002207 Inter-alpha-trypsin inhibitor heavy chain H2;ITIH2;ortholog serine protease inhibitor(PC00204)
NP_001125 Alpha-fetoprotein;AFP;ortholog transfer/carrier protein(PC00219)
NP_000574 Vitamin D-binding protein;GC;ortholog transfer/carrier protein(PC00219)
NP_001892 Connective tissue growth factor;CTGF;ortholog growth factor(PC00112)












calcium-binding protein(PC00060);cell adhesion 
molecule(PC00069)






nucleic acid binding (PC00171)




Figure 3.6. VacA-dependent alterations in the cellular protein synthesis 
profile. Monolayers of AZ-521 cells were pre-conditioned for labeling by 
incubating at 37 °C in culture medium lacking Met, Arg, and Lys, in order to 
promote the intracellular depletion of Met, Arg, and Lys. After 0.5 h, the 
monolayers were incubated in the absence of VacA (-VacA) in culture medium 
containing 50 μM L-azidohomoalanine (AHA) (a Met analog), and, “heavy 
labeled” Arg and Lys (13C6 15N4 Arg and 13C4 15N2 Lys). As a counterpart, the pre-
conditioned monolayers were incubated in the presence of VacA (250 nM) 
(+VacA) in culture medium containing 50 μM AHA, and “intermediate labeled” 
Arg and Lys (13C6 Arg and d4 Lys; d refers to deuterium) (C; replicate #1). After 4 
h, the cells were lysed, and the cell lysates, collected separately from -VacA, or, 
+VacA condition, were combined in a single tube (to evaluate cell-associated 
proteins). The culture supernatants were collected and combined in the same 
manner to evaluate secreted proteins. To evaluate a possible technical bias, 
referring to disproportionate incorporation of the “heavy labeled”, or, 
“intermediate labeled” Arg and Lys, the experiment was conducted in technical 
replicates by swapping the culture media, containing either “heavy labeled” or 
“intermediate labeled” Arg and Lys, between cells incubated in the absence or 
presence of VacA (C; replicate #2). The proteins that were newly synthesized 
during the 4 h incubation period were selectively captured by covalent bond 
formation (using Click Chemistry) between the alkyne moeity of AHA and azide- 
coated agarose beads. After stringent washing, to remove intrinsic proteins, the 
captured proteins were fragmented with trypsin, and analyzed using LC-MS for 
identification and quantification of individual proteins. The number of proteins, 
which were detected in cells incubated in the absence of VacA (-VacA), or, 
presence of VacA (+VacA), was rendered as a Venn diagram (A), and individual 
proteins were annotated using the PANTHER database (B). 165 proteins were 
identified in the Homo sapiens database, and categorized based on the 
speculated protein function. (C) The relative abundance of 376 newly  
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Figure 3.6. (cont.) 
synthesized proteins (A; common to both -VacA and +VacA (357 cell-associated, 
and 19 secreted)) was calculated by dividing the abundance of proteins in cells 
incubated in the presence of VacA by the abundance of proteins in cells 
incubated in the absence of VacA (C), which generated from 6 data sets (the 
data were combined from 3 independent experiments in replicates). 297 proteins 
(288 cell-associated, and 9 secreted) with Coefficient of variance (CV) smaller 
than 0.5 among the ≤ 6 values were considered statistically significant, and 






















Figure 3.7. VacA-dependent inhibition of host protein synthesis is largely 






Figure 3.7. (cont.)  
AZ-521 cells were incubated at 37 °C in the absence or presence of VacA (250 
nM), or, 50 μM Thapsigargin (positive control for p-eIF2α). After incubation (A, F: 
0.5, 1, 2, 4, 8 h; B: 0.5, 1.5, 3.5, 7,5 h; G: 0.5 h), the cells were lysed and 
evaluated using immunoblot analyses for relative mTORC1 activity (calculated by 
p-S6K divided by total S6K) (A), relative GCN2 activity (calculated by p-GCN2 
divided by total GCN2) (F) or GCN2 kinase activity on eIF2 (calculated by p-
eIF2α divided by total eIF2α) (G), or, further incubated for 30 min in medium 
containing 50 μM L-homopropargylglycine (HPG, a methionine analog) and fixed 
then analyzed for cellular incorporated HPG, which corresponds to proteins 
newly synthesized during the last 30 min of incubation period (B). Alternatively, 
cells were transiently co-transfected (C - E) with expression plasmids harboring 
either the gene encoding Rheb wildtype fused with a Flag motif (Flag-Rheb wt), 
Rheb kinase mutant fused with a Flag motif (Flag-Rheb D60K), or, no genes 
(empty vector), along with (or without) an expression plasmid harboring the gene 
encoding S6K1 fused at the amino terminus with the myc epitope tag (myc-S6K) 
(C - E). After 24 h, the cells were incubated at 37 °C in the absence or presence 
of VacA (250 nM). After incubation (C: 1h; D, E: 0.5 h), the cells were lysed and 
evaluated using immunoblot analyses for relative mTORC1 activity within cells 
expressing the Rheb constructs (manifested by p-myc-S6K with regards to total 
myc expression levels) (C), or, further incubated in medium containing 50 μM L-
homopropargylglycine (HPG, a methionine analog) and fixed then 
immunostained with a Flag motif antibody (D, E). The cells were then analyzed 
for cellular incorporated HPG,which corresponds to proteins newly synthesized 
during the last 30 min of incubation period, and, Flag signals, which corresponds 
to relative intracellular expression of Flag-Rheb wt. The cells transfected with a 
plasmid encoding Flag-Rheb wt were gated into Rheb (-), or, (+) subpopulations 
based on the relative Flag-Rheb wt expression levels (D), and then evaluated for 
incorporated HPG within each subpopulation (E). The data were combined from 
3 independent experiments (represented as mean ± SD). Statistical significance 
(α = 0.05) was calculated using one-way ANOVA (corrected using the Dunnett’s 





Figure 3.8. VacA-dependent depletion of cellular amino acids. AZ-521 cells 
were incubated at 37 °C in the absence or presence of VacA (250 nM). After 1 h, 
the cells were lysed and evaluated using immunoblot analyses for relative amino 
acid deficiencies (calculated by p-GCN2 divided by total GCN2) (A), or evaluated 
using GC-MS analyses to measure cellular levels of 18 of the 20 amino acids (B, 
C). Arg and Cys were not quantified because preparation of the samples for 
analysis converts arginine to citrulline, and cysteine to cystine. (B) The relative 
abundance of each amino acid was calculated by % over total mass prior to 
VacA exposure (mean ± SD). (C) The relative levels of each amino acid within 
cells exposed to VacA were compared to the levels or each amino acid within 
cells incubated in the absence of VacA, which for each amino acid, was 
normalized to 1.0. Essential amino acids (which need to be acquired 
extracellularly), or, non-essential amino acids that were not included in the 
culture medium, and hence, must be generated through mitochondrial conversion 
of TCA intermediates into amino acids, are indicated. The data were combined 
from the 3 independent experiments (represented as mean ± SD). Statistical 
significance (α = 0.05) was calculated for the difference in relative levels of amino 
acid deficiencies (A) or individual amino acids (C) between cells incubated in the 
absence (empty bars) or presence (filled bars) of VacA, using the two-tailed 




Figure 3.9. The incorporation of glutamine into TCA cycle is decreased in a 
VacA-dependent manner. Monolayers of AZ-521 cells were incubated at 37 °C 
in the absence or presence of VacA (250 nM) in glutamine tracer medium 
(DMEM lacking glutamine supplemented with 2 mM ¹³C5 glutamine and 10% 
Fetal Bovine Serum). After 5, 15, 30, 60, or 120 min, the cells were collected by 
scraping from plates. After homogenization, the cell lysates were analyzed using 
GC-MS for relative abundance of cellular metabolites that did not incorporate 
(m+0), or, incorporated ¹³C (m+5: glutamine, or glutamate; m+4: succinate, 
fumarate, malate, citrate, or aspartate), which derived from ¹³C5 glutamine in the 
tracer medium. (A) Glutamine conversion into TCA cycle intermediates is 
depicted. (B) Intracellular levels of each evaluated metabolite, which was 
normalized to cells incubated in the absence of VacA at t = 0 min as 100%, were 
combined from 3 independent experiments, and rendered as bar graphs (mean ± 
SD). Statistical significance (α = 0.05) was calculated for the differences in  
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Figure 3.9. (cont.) 
relative levels of individual metabolites between cells incubated in the absence 






































Figure 3.10. Intracellular amino acids are shunted to mitochondria for 
energy production within VacA intoxicated cells. AZ cells were incubated at 
37 °C in the absence or presence of purified VacA (250 nM), without or with 100 
μM Rotenone (inhibitor for Complex I in the respiratory chain). After 1 h, the cells 
were lysed and analyzed by Immunoblot for for for total GCN2, p-GCN2, or, β-
actin, and rendered as bar graphs for relative amino acid deficiency, which were 
combined from 3 independent experiments (represented as mean ± SD). 







Figure 3.11. VacA-dependent depletion of cellular amino acids. AZ-521 cells 
were incubated at 37 °C in the absence or presence of VacA (250 nM). After 1 h, 
the cells were lysed, and cellular levels of 18 of the 20 amino acids were 
quantified using GC-MS analysis. Arg and Cys were not quantified because 
preparation of the samples for analysis converts arginine to citrulline, and 
cysteine to cystine. The levels of each amino acid within cells exposed to VacA 
were compared to the levels or each amino acid within cells incubated in the 
absence of VacA, which for each amino acid, was normalized to 1.0. The data 
were combined from the 3 independent experiments (represented as mean ± 
SD). Statistical significance (α = 0.05) was calculated for the difference in relative 
level of individual amino acid levels between cells incubated in the absence 





CHAPTER 4: Conclusions and Future Directions 
 
4.1. Introduction 
The overall objective of the work described in this dissertation was to 
understand the underlying mechanisms by which H. pylori colonizes the harsh 
environment of the human stomach. H. pylori is the only known gastric pathogen 
that colonizes the highly acidic environment within the human stomach, although 
H. pylori is not easily culturable in acidic conditions in vitro. Within patients who 
have been chronically infected with H. pylori, several alterations in gastric 
physiology were observed, including increase in overall gastric pH (Wang et al., 
2008), and deterioration of the gastric epithelial barrier (Fujikawa et al., 2003). 
These alterations found in H. pylori infected patients generally create more 
favorable niche for H. pylori colonization, suggesting the possibility that H. pylori 
manipulates the host gastric epithelial layer in order to colonize and also persist 
within the human stomach. Extensive studies to characterize their virulence 
mechanisms have revealed that H. pylori employs several different host 
modulators to subvert host cell regulations, with VacA and CagA that are the 
most extensively studied effectors/toxins due to their importance in the 
mechanisms underlying H. pylori colonization of the human stomach. In 
particular, the studies in this dissertation elucidated the cellular actions of VacA 





4.2. Host responses towards VacA-dependent cellular stress induced 
during H. pylori infection 
VacA is a pore forming toxin that targets host mitochondria. Once secreted 
from bacteria, the toxin enters host cells through sphingomyelin-mediated cellular 
binding, and migrates to mitochondria in a manner dependent on the host 
endolysosomal trafficking (Kim and Blanke, 2012). The pore forming actions 
within mitochondria result in permeabilization of the inner membrane, disrupting 
the proton gradient, which is essential for a respiratory production of ATP. 
Although the possible consequences of such VacA cellular actions are not well 
understood, it appears to support H. pylori colonization, because the level of 
cytotoxicity of different VacA allelic forms are highly correlated with the incidence 
of H. pylori-dependent gastric disease including peptic ulcer and gastric cancer 
(Polk and Peek, 2010). 
In the 2nd Chapter of this dissertation, I investigated the host cellular changes 
that incur in response to VacA cellular actions. In mammalian cells, maintaining 
cellular homeostasis is critical to retain cellular viability and functions. Under 
metabolic stress, the cells systematically sense and strive to restore the 
metabolic balance, which are often mediated by mTORC1, a central metabolic 
sensor and regulator within mammalian cells. I hypothesized that VacA-
dependent metabolic stress is sensed by host cells through mTORC1-mediated 
mechanism, and results in mTORC1-mediated host responses that are generally 
induced to restore the metabolic balance. The studies revealed that mTORC1 
activity, which, when inhibited, is indicative of metabolic stress, is inhibited by H. 
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pylori infection in a VacA-dependent manner, suggesting host sensing of the 
VacA-induced cellular stress. Furthermore, the studies revealed that when 
inhibited by VacA, mTORC1 mediated induction of autophagy, a recycling 
mechanism through which cells recycle intracellular compartments through 
degradation. From autophagic recycling, cells can secure extra carbon and 
energy sources under metabolic stress, which can facilitate restoring the 
metabolic balance under metabolic stress. With an effort to characterize the 
metabolic stress that directly results in mTORC1 inhibition within VacA 
intoxicated cells, the studies revealed that cellular amino acids become deficient 
in a manner dependent on VacA actions at mitochondria, although the 
mechanistic association was not understood.  
Together, these studies in the 2nd Chapter support the model that VacA 
induced metabolic stress (energy or amino acid deficiency) are sensed by 
mTORC1, and resulted in induction of a catabolic response (autophagy). In 
addition, because mTORC1 senses a range of metabolic stress and orchestrates 
overall metabolic homeostasis through regulating catabolic and biosynthetic 
process, VacA-dependent mTORC1 inhibition indicates a global metabolic shift 
within VacA intoxicated cells during H. pylori infection (Fig. 4.1). 
 
4.3. Host translational capacity is limited in a VacA dependent manner 
during H. pylori infection 
The studies in the 2nd chapter identified mTORC1 as a key metabolic sensor 
and regulator that mediates sensing of VacA induced metabolic stress (energy 
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and amino acid deficiency) and induction of autophagy, which led to two 
remaining gaps in knowledge. 1) the mechanistic association between VacA-
dependent mitochondrial stress and amino acid deficiency, and 2) possible 
alterations in host biosynthetic capabilities within VacA intoxicated cells. 
mTORC1 is a central metabolic regulator that, when inhibited upon metabolic 
stress, maintains cellular homeostasis by inducing catabolic process including 
autophagy, and also by limiting biosynthetic processes, suggesting the possibility 
that VacA inhibition of mTORC1 can also result in alteration in the biosynthetic 
processes within cells, and provided the premise for the studies conducted in the 
3rd Chapter. 
The studies in this chapter revealed that host protein synthesis was inhibited 
during H. pylori infection in a VacA-dependent manner. The inhibition of overall 
protein synthesis was manifested by the majority of cellular proteins were 
inhibited in a non-discriminative manner at the translational level, which supports 
the idea that VacA-dependent inhibition of host protein synthesis resulted from 
critical metabolic changes, rather than particular translational regulatory circuits. 
The finding of VacA-dependent deficiency in cellular amino acids, the building 
blocks for de novo protein synthesis, is supportive of the idea, and was 
recapitulated in the 3rd Chapter. In addition, the studies revealed that several 
amino acids that were generally synthesized from TCA intermediates within 
mitochondria (cataplerosis) were reduced in a VacA-dependent manner, 
suggesting a possible link between VacA-dependent alterations in mitochondria 
and cellular amino acid deficiency. Under energy stress, cells may repurpose 
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non-TCA cycle metabolites (including amino acids) to facilitate mitochondrial 
energy production. The studies revealed that VacA disruption of host 
mitochondrial energy production is causally associated with the cellular amino 
acid deficiency within VacA intoxicated cells.  
Together, the studies revealed that, upon VacA induction of energy stress at 
mitochondria, cellular responses to such energy stress resulted in deficiency in 
amino acids, which could contribute to inhibiting host protein synthesis. Along 
with the studies in the 2nd Chapter, these studies support the model that, during 
H. pylori infection, secreted VacA induces global metabolic shift, resulting 
induction of catabolic autophagy and suppression of host protein synthesis.  
 
4.4. Future directions 
VacA is a major host modulator of H. pylori that, although the molecular 
mechanism was not well understood, largely supports H. pylori remodeling of the 
harsh human gastric environment during infection. The studies in the 2nd and 3rd 
chapter revealed that a global metabolic shift resulted from VacA actions within 
host cells, resulting in a series of host metabolic responses including autophagy 
and limited proteins synthesis. However, the studies did not address how VacA 
alters host cell biology during H. pylori infection. Thus, future works to evaluate 
possible consequences of VacA manipulation of host metabolism can extend the 
current understanding of H. pylori pathogenesis, as well as the associated gastric 




 Among several possible consequences of VacA-dependent inhibition of host 
protein synthesis, our studies provided the premise to evaluate a possible 
alteration in host production of gastric mucus. In the earlier studies that employed 
a gastric slice model to study VacA-dependent inhibition of cellular protein 
synthesis, robust protein synthesis activities (HPG incorporation) were detected 
predominantly at the gastric pits under non-treated conditions (Fig. 3.1F). In 
accordance, immuno-fluorescence signals corresponding to S6 phosphorylated 
at serine 235/236 (p-S6), which correlates with increased translation of mRNAs 
(Peterson and Schreiber, 1998), were also detected predominantly at the gastric 
pits (Fig. 4.2). The signals were reduced in a VacA=dependent manner (Fig. 4.2), 
suggesting VacA-dependent inhibition of protein synthesis at the gastric pits 
during Hp infection.  
 Among several suggested barrier functions of the gastric pits against Hp 
infection is through mucus secretion (Navabi et al., 2013). The gastric pits are 
highly enriched in gastric mucous cells (Navabi et al., 2013), which create an 
effective protection barrier against infection through mucus production. For 
example, Muc5AC secreted from the gastric pits form a rigid mucus barrier and 
protects from the gastric acidity or Hp bacteria, with a continuous and robust 
secretion (about 1 µm/min across 150 -300 µm thickness in rat stomach) (Atuma 
et al., 2001) to repel approaching bacteria (Navabi et al., 2013). Because VacA-
dependent inhibition of protein synthesis can impact a wide range of proteins 
(possibly including mucins) at the translation level, I speculate that host mucus 
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production is hampered during Hp infection in a manner resulted from VacA 


















Figure 4.1. VacA-dependent global metabolic shift within host cells during 






Figure 4.2. VacA-dependent suppression of mRNA stability at the gastric 
pits. Gastric tissue slices isolated from C57BL/6J mice were incubated at 37 °C 
in the absence or presence of VacA (250 nM), or, 1 μM Rapamycin (a small 
molecule that inhibits S6 phosphorylated at S235/236(p-S6) through directly 
inhibiting mTORC1 kinase activity corresponding to p-S6). After 1 h, the tissue 
slices were fixed and evaluated by fluorescence microcopy for relative green 
fluorescence, which corresponded to p-S6. Fluorescence images shown are 
representative of those using tissue collected from stomachs of 3 different mice. 
Green signals indicate p-S6, blue signals indicate nuclei, and red signals indicate 
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